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Glossary of terms 
 
ATP adonosine triphosphate 
BAT brown adipose tissue 
BMI body mass index 
CO2 carbon dioxide 
Coup-TFII chicken ovalbumin upstream promotor transcription factor II 
DR-1 direct repeat element with one base between repeats 
EMSA electrophoretic mobility shift assay 
GDP guanosine diphosphate 
Myod myogenic differentiation 1 
p300 p300/CBP-associated factor 
PCR polymerase chain reaction 
Ppar peroxisome proliferator activated receptor 
PPRE Ppar response element 
ROS reactive oxygen species 
Rxr retinoid X receptor 
TR thyroid hormone receptor 





Representation of protein and gene names 
Gene or mRNA (non-human): first letter capitalised, italic  e.g. Ucp3 
Protein (non-human):   first letter capitalised    e.g. Ucp3 
Gene or mRNA (human):  all letters capitalised, italic  e.g. UCP3 
Protein (human):   all letters capitalised    e.g. UCP3 
 
Exception: Consistent with existing literature the thyroid hormone receptor (TR) is written 
‘all letters capitalised’ regardless of origin. 
Summary 
Introduction 
The first member of the family of uncoupling proteins to be discovered was uncoupling 
protein 1 (Ucp1) or thermogenin, as it was initially called (Nicholls et al., 1978). Ucp1 is 
specifically located in the inner membrane of mitochondria in brown adipose tissue (BAT), 
the central heating organ of small endotherm vertebrates (Cannon et al., 1982). Moreover, 
until today Ucp1 is regarded the one central component that in fact defines a fat tissue to be 
genuine BAT (Sell et al., 2004). The molecular function of Ucp1 is to facilitate a proton flux 
from the mitochondrial intermembrane space into the matrix circumventing ATP synthesis 
(Nicholls & Locke, 1984). In other words ATP synthesis becomes “uncoupled” from the 
proton pumps of the respiratory chain. Since a portion of the energy amount stored in the 
proton motive force of the gradient across the mitochondrial inner membrane is not 
chemically conserved during uncoupled respiration, it is released as heat. In BAT this process 
is complemented by high molar amounts of Ucp1 located in an enormous number of 
mitochondria that are fueled by lipid droplets specifically altered in size and composition to 
allow fast substrate provision. Hence BAT is an organ highly specialized to allow efficient 
nonshivering thermogenesis (Klingenspor, 2003). 
Ucp1 function can be activated by fatty acids and inhibited by purine nucleotides such as 
GDP (Cunningham et al., 1986; Nicholls & Locke, 1984). It is not yet fully understood, how 
the proton flux across the mitochondrial inner membrane itself is accomplished by Ucp1 and 
several hypotheses have been put forward (Figure 1). The principal mechanisms suggested 
include a simple proton channel concept (Klingenberg & Winkler, 1985) as well as models in 
which fatty acids act as steric or catalytic cofactors (Shabalina et al., 2004 ;Rial et al., 2004). 
Ucp1 might in fact not even be a proton importer, but rather an anion exporter. If 
unprotonated fatty acid anions would be transported from the mitochondrial matrix into the 
intermembrane space they would be able to return in their protonated form by a so-called flip-
flop mechanism and thereby indirectly facilitate a proton flux into the matrix (Garlid et al., 
1996). 
In 1997 two paralogues of Ucp1 were discovered and named Ucp2 and Ucp3 (Vidal-Puig et 
al., 1997; Boss et al., 1997; Fleury et al., 1997). These two novel uncoupling proteins share 
the same genomic locus being directly neighbouring genes. They are about 75% identical to 
each other on the amino acid level, while both share about 55% identity with Ucp1. It was 
soon established that these novel Ucps serve a different purpose than thermogenesis 
(Nedergaard et al., 1999). 
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Figure 1 – Models of uncoupling protein function. (A) The uncoupling protein acts as a proton 
channel. (B) A fatty acid anion acts as catalytic component, passing on protons via its carboxyl group. 
(C) A fatty acid anion acts as steric activator of uncoupling protein function. (D) Fatty acid anions are 
exported from the mitochondrial matrix, protonated in the intermembrane space und re-enter the 
matrix by a flip-flop mechanism. IMS = intermembrane space, FA(-) = fatty acid (anion), H+ = proton. 
 
The Ucp3 gene is predominantly expressed in skeletal muscle and BAT (Vidal-Puig et al., 
1997). One of the first observations doubting a role in thermogenesis - an energy wasting 
mechanism - was the transcriptional upregulation of the Ucp3 gene upon starvation (Boss et 
al., 1998). Further studies reported additional physiological situations of increased Ucp3 
expression, among them acute exercise (Tsuboyamakasaoka et al., 1998), streptozotocin-
induced diabetes (Stavinoha et al., 2004) and cold exposure (Larkin et al., 1997; von Praun et 
al., 2001). Weigle and coworkers noticed that a common physiological parameter of these 
situations is an elevation of circulating fatty acid levels and proposed this to be the 
responsible cue (Weigle et al., 1998). This model was fortified by lipid infusion experiments 
that did indeed lead to Ucp3 upregulation. Based on these observations further experiments 
led to the hypothesis that it is the function of Ucp3 to export fatty acid anions from the 
mitochondrial matrix (Himms-Hagen & Harper, 2001). 
The biochemical properties of Ucp3 as measured in mitochondrial proton leak assays, 
however, are quite similar to those of the thermogenic protein Ucp1. Consequently another 
hypothesis regards Ucp3 to be a mediator of ‘mild uncoupling’ thereby mitigating the 
generation of reactive oxygen species (ROS) (Echtay et al., 2002; Echtay et al., 2003). A 
controversial third model takes into account both physiological and biochemical data. In 
analogy to one of the models of Ucp1 function it has been proposed that Ucp3 exports fatty 
acid anions which are then protonated and can re-enter the mitochondrial matrix uncatalyzed 
by a so called flip-flop-mechanism (Figure 1D). This process would lead to a net proton flux 
across the inner mitochondrial membrane and thus mildly uncouple respiration from ATP 






















Figure 2 – Published regulatory mechanisms of Ucp3 gene expression. The 
proximal promoter region comprises a triple E-Box binding Myod and a DR-1 site, 
that functions as response element for heterodimers of either Ppars or TR with 
Rxrα. Upon binding the heterodimer recruits p300, which acetylates surrounding 
histones and Myod, thereby initiating transcription. Ac – Acetyl-group, PPRE – 
Ppar response element, TRE – TR response element. (modified from Solanes et 
al., 2003) 
 
On the molecular level transcription of the Ucp3 gene is regulated by a complex machinery of 
transcription factors and has been thoroughly investigated in skeletal muscle tissue (Figure 2). 
The proximal Ucp3 promoter region exhibits a triple E-Box that binds myogenic 
differentiation factor 1 (Myod) (Solanes et al., 2000). A direct repeat DR-1 element in close 
proximity can serve as binding site for various heterodimers with one partner always being 
the retinoid X receptor (Rxrα) while the second partner can be a peroxisome proliferator 
activated receptor (Pparα or Pparδ) (Pedraza et al., 2006; Solanes et al., 2003) or a thyroid 
hormone receptor (TR) (Solanes et al., 2005). Upon binding the heterodimer recruits a 
cofactor with acetylase activity (probably p300/CBP-associated factor (p300)) which 
acetylates Myod as well as surrounding histones. While histone acetylation leads to increased 
promoter accessibility, activation of Myod by acetylation is thought to trigger the 
transcription process itself (Solanes et al., 2003). 
This arrangement seems to comprehensively account for the physiological cues that have been 
observed to increase Ucp3 transcription in skeletal muscle. The effect of free fatty acid levels 
is mediated by PPARs, nuclear receptor that are activated and imported into the nucleus upon 
binding of fatty acids as ligand. An alternative thyroid hormone signal is integrated via TR 
while tissue specificity is established by the necessity for Myod. Despite this substantial 
knowledge on Ucp3 gene regulation many questions have not been addressed yet. In BAT for 
instance these implicated mechanisms have never been confirmed and at least the presence of 
Myod can be doubted. 
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Serendipitously our group got hold of an animal model perfectly suited to address these 
remaining questions. Shortly after the discovery of Ucp3 in 1997 individual Djungarian 
hamsters with a BAT specific lack of Ucp3 were identified in our Phodopus sungorus 
breeding colony. By breeding littermates of these individuals an inbred line was established. 
All hamsters of this line were devoid of Ucp3 expression in BAT proving heritability of this 
trait (Liebig et al., 2004). 
 
Aims & scope 
All proposed hypotheses regarding the physiological function of Ucp3 are at least in part 
based on the transcriptional regulation of this gene. This fact illustrates how important 
knowledge of the regulation of a gene is to be able to infer its role. Our mutant hamster 
model, however, could not be fully explained by the existing model of transcriptional control 
and thereby challenged its integrity. 
During my PhD study period I addressed open questions on Ucp3 regulation employing two 
parallel approaches. On the one hand our mutant hamster model served as a tool to identify 
the unknown regulatory pathway affected by this mutation. On the other hand an unbiased 
analysis of the hamster Ucp3 promoter aimed at the identification and verification of so far 
unknown transcription factor binding sites. 
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Results & Discussion 
Chapter 1 - Chicken ovalbumin upstream promoter transcription factor II regulates 
uncoupling protein 3 gene transcription in Phodopus sungorus 
In chapter 1 I report on the results of an unbiased sequence analysis of the P. sungorus Ucp3 
promoter. An alignment with the syntenic genomic regions of other vertebrates revealed a 
high conservation of the known binding sites for Myod and Ppar heterodimers confirming 
their importance. In the same region we identified a further well conserved sequence element 
resembling a putative Coup-TFII binding site. Coup-TFII has been reported to be able to 
interact with Ppar factors, Myod and p300 and is involved in skeletal muscle development 
(Bailey et al., 1998). Furthermore it coregulates a number of key metabolic genes, which led 
us to investigate this candidate in detail (Robinson et al., 1999; Eubank et al., 2001; Cabrero 
et al., 2003;Lou et al., 1999). 
We found Coup-TFII to be coexpressed with Ucp3 in skeletal muscle and in BAT. In skeletal 
muscle of starved and in BAT of cold-exposed hamsters the mRNA levels of these two genes 
were highly correlated with each other in individual samples. This interdependece was absent 
in control animals implying that the effect of Coup-TFII is dependent on other transcriptional 
activators already present on the promoter. Consistently, in reporter gene assays we observed 
a strong induction of Ucp3 promoter activity by Coup-TFII on the background of other known 
transcriptional regulators of Ucp3 expression but not alone. 
In electrophoretic mobility shift assays (EMSA) we proved physical binding of the Coup-TFII 
protein to an inverted repeat response element about 800bp upstream of the proximal 
promoter. We mutated this element to investigate the contribution of both repeat half-sites on 
Coup-TFII interaction in both EMSA and reporter gene studies. Mutation of the 5’ half-site 
led to loss of Coup-TFII binding, while disruption of the 3’ half-site only mildly affected 
binding. Concordantly, reporter gene assays with a mutation 3’ half-site did not affect 
expression of the reporter, while a lack of the 5’ half-site led to complete loss of expression. 
Surprisingly, the latter mutation did not only affect Coup-TFII dependent transcription but did 
also completely prevent activation of the promoter by Myod, Rxrα and p300 cotransfection. 
This observation is not consistent with Coup-TFII simply being a direct transcriptional 
activator and led us to postulate a so far unknown repressor protein, that has to be deactivated 
or displaced by Coup-TFII. 
In this study the complex machinery of transcription factors controlling Ucp3 expression has 
been expanded by a further player. Notably, Coup-TFII appears to be the factor, that 
determines the final appropriate rate of gene transcription. Unfortunately, this factor is a 
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so-called orphan nuclear receptor, i.e. a nuclear receptor with unknown activating ligand or 
even without such a ligand at all. Thus, Coup-TFII cannot easily be interpreted as a sensor for 
a certain physiological signal (such as Pparα linking fatty acid levels to Ucp3 transcription). 
Our study implicates that activation of Ucp3 by Coup-TFII is rather dependent on Coup-TFII 
expression levels itself, a process about which little is known so far. On the functional level, 
however, Coup-TFII has been hypothesized to be a negative regulator of glucose-induced 
gene expression (Lou et al., 1999). The activation of genes implicated in lipid metabolism like 
lipoprotein lipase (Robinson et al., 1999) and Ucp3 appears to be a complementing aspect, 
broadening the role of Coup-TFII to regulate the shift in substrate usage from carbohydrates 
to fatty acids. Therefore, positive regulation of Ucp3 by Coup-TFII strengthens its proposed 
role in lipid metabolism. 
 
Chapter 2 – An intronic single base exchange leads to brown adipose tissue specific 
lack of Ucp3 and an altered body weight trajectory 
Chapter 2 covers our analysis of Djungarian hamsters with a tissue specific lack of Ucp3 
mRNA and protein. We initially sequenced the entire Ucp3 gene and compared sequences 
derived from mutant and wildtype animals. Two positions within the first intron proved to be 
the only difference in this gene. By performing reporter gene assays with constructs 
harbouring the first intron in all four possible haplotypes we determined the base position, that 
leads to BAT specific Ucp3 deficiency. The responsible allele could be identified in breeding 
colonies across the world including three, that were established from animals caught in 
Siberia independently from each other. We concluded, that this allele naturally occurs within 
the wild population. 
We analyzed this binding site in silico and were able to identify corresponding elements in the 
first intron of seven other vertebrate species including humans. The pattern of conserved 
bases in this comparison reveals a putative forkhead factor binding site with the wildtype 
version of the polymorphic position being conserved in all species. 
On the phenotypic level we observed a differential body weight trajectory between genotypes. 
Interestingly, heterozygous hamsters tended to resemble homozygous mutants in this respect, 
although Ucp3 expression in these animals is only mildly affected. It seems that small 
changes in Ucp3 expression can already lead to a full scale impact on body weight. This 
observation may be useful to re-evaluate human association studies, in which a certain UCP3 
promoter polymorphism (rs1800849; -55(C/T)) is associated with an altered BMI or 
waist-to-hip ratio (Otabe et al., 2000; Cassell et al., 2000). The close proximity of the UCP2 
____________________________________________________________Summary
6
gene has always raised the question whether this effect can be clearly attributed to UCP3 or to 
possible other polymorphisms within linkage disequilibrium (Walder et al., 1998). Our study 
proves that an effect on the Ucp3 promoter and hence its transcriptional regulation can very 
well be the causal link to an altered body weight. We so far cannot, however, decide between 
an effect attributable to lack of Ucp3 in BAT and to a mildy reduced expression in skeletal 
muscle. While on the one hand the drastic difference in BAT Ucp3 expression seems tempting 
to be held responsible, on the other hand skeletal muscle tissue accounts for a huge proportion 
of energy expenditure.  
Regarding the mechanistic regulation of Ucp3 we identified an essential component of tissue 
specific gene regulation, probably a forkhead domain containing protein. 
 
Chapter 3 – Brown adipose tissue specific lack of Ucp3 is associated with impaired 
cold tolerance and reduced transcript levels of metabolic genes 
We further extended the phenotypical analysis of hamsters lacking BAT Ucp3 as I report in 
Chapter 3. In Chapter 2 I already described an impact of this mutation on body weight 
development, here we investigated whether this may be a consequence of defective BAT 
function.  
Hamsters of both homozygous genotypes were subjected to decreasing ambient temperatures 
while we measured oxygen consumption and CO2 production. From this data set we derived 
and compared basal metabolic rate, maximal oxygen consumption, thermal conductance, 
respiratory quotient and cold tolerance limit (Heldmaier, 1974; Heldmaier & Ruf, 1992; 
Heldmaier et al., 1982). All of these metabolic parameters seemed to be comparable between 
genotypes except cold tolerance, which was significantly impaired in mutant animals. This 
pattern implies defective thermogenic mechanisms on the background of an overall 
unchanged metabolism. 
To explore whether BAT specific nonshivering thermogenesis or rather skeletal muscle 
mediated shivering thermogenesis is affected by altered Ucp3 levels we injected hamsters 
with norepinephrine. This treatment induces maximal nonshivering thermogenesis without 
shivering, while in our cold exposure experiments the animals employed both shivering and 
nonshivering thermogenic mechanisms. Therefore, the provoked rise in metabolic rate can be 
used to dissect the contribution of both shivering and nonshivering thermogenic mechanisms 
(Böckler et al., 1982). We analyzed individual values plotted against the respective body mass 
due to the high dependency between these parameters. The individual data points of 
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nonshivering thermogenic capacity of mutant hamsters were lower than expected from the 
wildtype regression, suggesting a brown fat specific thermogenic abnormality. 
By analysis of gene expression we were able to demonstrate, that this defect is likely to be the 
physiological manifestation of a global decrease in metabolic gene expression in BAT. We 
measured mRNA levels of genes implicated in all major metabolic pathways including fatty 
acid mobilization, oxidation and synthesis, glucose import, glycolysis and citric acid cycle as 
well as ketone body utilization. Strikingly, 15 out of 16 genes analyzed displayed at least a 
trend towards lower mRNA levels in mutant hamsters.  
Taken together these findings strongly suggest that Ucp3 is not itself an a priori thermogenic 
protein, but rather a component of the machinery delivering energy to thermogenic 
mechanisms in BAT. Furthermore this study demonstrates that the body weight phenotype we 
describe in chapter 2 might well be a consequence of impaired thermogenesis in BAT.  
 
Chapter 4 – Marsupial Ucp1 sheds light on the evolution of mammalian nonshivering 
thermogenesis 
In chapter 4 I present a publication that for the first time unequivocally proves the presence of 
Ucp1 in marsupial species and suggests the presence of an archetypical BAT in these early 
mammals. 
My contribution to this study included the initial in silico analysis of genomic sequences and 
deduction of primers amplifying Ucp-like sequence fragments from Monodelphis domestica 
DNA. I cloned and sequenced these amplicons to infer nested oligonucleotides used to screen 
genomic M. domestica BAC libraries. This screening finally led to the definitive identification 
of all three marsupial uncoupling protein genes by phylogenetic inference and genomic 
localization between syntenic, neighbouring genes as compared to the human genome. 
Furthermore, I brought in my expertise in the comparative analysis of promoter sequences. 
The eutherian Ucp1 gene is regulated by a condensed enhancer sequence packed with 
transcription factor response elements (Silva & Rabelo, 1997). This enhancer box is located 
about 1kb upstream of the transcriptional start site and is essential for BAT specific and cold 
induced gene expression. I was able to pinpoint this enhancer box in a conserved formation in 
all eutherian mammals under investigation including the ancient afrotherian species Echinops 
telfairi but not in the marsupial M. domestica. Thus the condensed enhancer box first evolved 
in eutherian mammals, although the response elements located within this box may already be 
present dispersed across the marsupial promoter. The alignment of all six identified enhancer 
boxes and analysis of conservation did not only support the existence of several published 
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response elements but also highlighted a well conserved region encompassing a novel Ppar 
response element (PPRE). 
 
Chapter 5 – Rapid single step subcloning procedure by combined action of type II 
and type IIs endonucleases with ligase 
Several of the methods I employed during my studies demand the subcloning of a DNA 
fragment from a given entry vector into one or more destination vector(s). A typical example 
would be the cloning of a PCR amplified promoter fragment followed by subcloning into 
destination vectors with different reporter genes. Another representative scenario is cloning of 
a coding sequence and subsequent subcloning into multiple expression vectors harbouring 
different promoters and/or tags. A standard laboratory practise is to excise the desired 
fragment, open the destination vector with the same restriction enzyme(s) and to purify and 
re-ligate the respective restriction products. This principal procedure is performed on a daily 
basis in innumerable variations in molecular biology labs around the world. In our hands it 
routinely includes an overnight ligation step decelerating progress. Alternative single step 
procedures based on recombinases (e.g. the Gateway® technique, Invitrogen) permit 
successful subcloning much faster but require recombinase recognition sites in all employed 
vectors, thus effectively limiting options to vectors sold by the same company. 
In chapter 5 I describe a single step subcloning procedure independent of specialized 
sequence elements on the destination vector. The sole requirement is a certain restriction 
enzyme recognition site as it is found in the cloning site of virtually all plasmid vectors. All 
required steps can be performed within one hour, in a single tube and at room temperature. 
Subcloning is facilitated by combination of a so-called ‘outside cutter’ restriction enzyme 
(type IIs) with a regular type II endonuclease and ligase. Specifically designed sequence 
elements of the entry vector and a regular restriction enzyme recognition site of the 
destination vector are randomly cut and ligated. The desired combination of insert and 
destination vector is the sole stable product, while all other intermediates are constantly 
re-digested. After one hour the complete mixture can be applied to transform competent 
bacterial cells without further purification.  
In our experiments we provide proof of principle by the repeated, successful subcloning of a 
promoter fragment from a modified pGEM-T easy (Promega) entry vector into a pEGFP-N1 

























Figure 3 – Regulation of Ucp3 gene expression extended by novel findings. An upstream 
inverted repeat binds Coup-TFII, which deactivates or displaces a repressor of Ucp3 gene 
transcription. Downstream of the transcriptional start site an intronic forkhead factor response 
element governs brown adipose tissue (BAT) specific gene expression. Mechanisms depicted 
in gray shades are explained in Figure 2.  
 
Conclusion 
The basal machinery underlying Ucp3 transcription in skeletal muscle had been described 
previously and comprises Myod, Pparα/δ, TR and p300. I employed an unbiased promoter 
analysis and investigated a mutant hamster model devoid of Ucp3 in brown adipose tissue to 
elucidate further mechanisms of transcriptional control. 
Identification of a phylogenitically conserved promoter element led to the discovery of 
Coup-TFII being the factor, that may determine the final appropriate transcript levels in both 
skeletal muscle and BAT. Coup-TFII function is facilitated by deactivation or displacement of 
a so far unknown repressor protein (Figure 3). Coup-TFII is implicated in the regulation of a 
shift in energetic substrate usage from carbohydrates to fat and thereby substantiates a role of 
Ucp3 in lipid metabolism. 
By thorough investigation of Djungarian hamsters with a defect in Ucp3 transcription we 
were able to identify a putative forkhead factor binding site essential for BAT specific Ucp3 
mRNA expression (Figure 3). This is the first and only tissue specific mechanism of Ucp3 
regulation known so far. Furthermore the far distal, intronic location of this regulatory 
element seems exceptional in itself. 
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On the phenotypic level lack of Ucp3 in BAT led to a global decrease in metabolic gene 
expression that in turn seemed to be responsible for a defective BAT nonshivering 
thermogenesis. Mutant hamsters also displayed an increased body weight, that might be 
attributed to this disrupted mechanism of ‘wasting’ energy. These data implicate that Ucp3 is 
necessary to sustain high metabolic rates in BAT. 
Taken together, our analysis of the transcriptional regulation of Ucp3 yielded two novel 
regulatory mechanisms with unique and remarkable characteristics, offers valuable clues 
about the physiological role of Ucp3 and demonstrates the power of promoter analysis to 
elucidate regulation, function and origin of a gene. 
____________________________________________________________Summary
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Abstract
Background: Ucp3 is an integral protein of the inner mitochondrial membrane with a role in lipid
metabolism preventing deleterious effects of fatty acids in states of high lipid oxidation. Ucp3 is
expressed in brown adipose tissue and skeletal muscle and controlled by a transcription factor
complex including PPARalpha, MyoD and the histone acetyltransferase p300. Several studies have
demonstrated interaction of these factors with chicken ovalbumin upstream promoter
transcription factor II (Coup-TFII). This nuclear receptor is involved in organogenesis and other
developmental processes including skeletal muscle development, but also co-regulates a number of
metabolic genes. In this study we in silico analyzed the upstream region of Ucp3 of the Djungarian
hamster Phodopus sungorus and identified several putative response elements for Coup-TFII. We
therefore investigated whether Coup-TFII is a further player in the transcriptional control of the
Ucp3 gene in rodents.
Results: By quantitative PCR we demonstrated a positive correlation of Coup-TFII and Ucp3 mRNA
expression in skeletal muscle and brown adipose tissue in response to food deprivation and cold
exposure, respectively. In reporter gene assays Coup-TFII enhanced transactivation of the Ucp3
promoter conveyed by MyoD, PPARalpha, RXRalpha and/or p300. Using deletions and mutated
constructs, we identified a Coup-TFII enhancer element 816–840 bp upstream of the
transcriptional start site. Binding of Coup-TFII to this upstream enhancer was confirmed in
electrophoretic mobility shift and supershift assays.
Conclusion: Transcriptional regulation of the Coup-TFII gene in response to starvation and cold
exposure seems to be the regulatory mechanism of Ucp3 mRNA expression in brown adipose and
skeletal muscle tissue determining the final appropriate rate of transcript synthesis. These findings
add a crucial component to the complex transcriptional machinery controlling expression of Ucp3.
Given the substantial evidence for a function of Ucp3 in lipid metabolism, Coup-TFII may not only
be a negative regulator of glucose responsive genes but also transactivate genes involved in lipid
metabolism.
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Uncoupling protein 3 (Ucp3) is a member of the family of
uncoupling proteins, which are located in the inner mito-
chondrial membrane and uncouple the respiratory chain
from ATP synthesis by dissipating the proton motive force
[1,2]. The physiological function of Ucp3 is subject to an
ongoing debate [3]. Regulation of Ucp3 expression sug-
gests a role in lipid metabolism. Skeletal muscle Ucp3
transcription is increased in response to food deprivation,
a robust mechanism consistently observable in man,
rodents and even fish [4]. Further physiological condi-
tions positively regulating Ucp3 include cold exposure
[5,6], acute exercise [7] and streptozotocin-induced diabe-
tes [8]. Increased levels of circulating free fatty acids (FFA)
are common to all these physiological states; infusion
experiments imply that these are the primary cause for
Ucp3 upregulation [9]. Therefore it has been suggested,
though not proven experimentally, that Ucp3 is a fatty
acid anion carrier [10].
The biochemical properties of the protein as measured in
mitochondrial proton leak assays by parallel recording of
membrane potential and oxygen consumption infer a role
for Ucp3 in the defense against radical oxygen species
(ROS), mitigating their generation by mild uncoupling
[11]. This possible function is corroborated by the finding
that a product of ROS induced lipid peroxidation, 4-
hydroxy-2-nonenal, specifically induces uncoupling by
Ucp3 and that even a small reduction of membrane
potential markedly decreases ROS production [12]. A con-
troversial hypothesis which takes into account both phys-
iological and biochemical data emphasizes that the export
of fatty acids or hydroperoxy fatty acids and subsequent
protonated re-influx of a certain fraction into the matrix
would result in a net proton import detectable as mild
uncoupling [13,14]. This mechanism would reduce ROS
production and at the same time reduce the level of non-
esterified fatty acids in the matrix susceptible to peroxida-
tion, thereby preventing deleterious effects in states of
high lipid oxidation.
Ucp3 is predominantly expressed in skeletal muscle
(SKM) and brown adipose tissue (BAT), both tissues with
exceptionally high lipid oxidation capacities. The princi-
pal molecular constituents of Ucp3 gene regulation have
recently been identified by several copious studies. Het-
erodimers of peroxisome proliferator activated receptor α
(PPARα) and the retinoic X receptor α (RXRα) bind to a
response element (PPRE) within the proximal promoter
region and activate transcription depending on the pres-
ence of myogenic differentiation antigen 1 (MyoD).
MyoD binds to a series of non-canonical E-boxes directly
adjacent to the transcriptional start site (TSS). Induction is
enhanced by the coactivator p300 protein (p300), which
acetylates MyoD and possibly surrounding histones [15].
Furthermore, the PPRE in the Ucp3 promoter is multifunc-
tional, i.e. can alternatively be targeted by heterodimers of
the thyroid hormone receptor (TR) and RXRα stimulating
expression in the presence of MyoD [16]. The ligands of
PPARα (fatty acids) and TRs (T3) along with the require-
ment of MyoD indicate that this mechanism is involved in
the acute response of Ucp3 expression in SKM to physio-
logical stimuli. However, to our knowledge neither BAT-
specific nor differentiation specific regulation has been
characterized in detail to date.
Notably several studies have demonstrated interaction of
PPARs, MyoD and/or p300 with chicken ovalbumin
upstream promoter transcription factor II (Coup-TFII,
official gene name: Nr2f2) [17-20]. This nuclear receptor
is involved in organogenesis and other developmental
processes [21] including SKM development [22], but also
co-regulates a number of metabolic genes [18,23-25].
In this study we analyzed the upstream region of Ucp3 of
the Djungarian hamster Phodopus sungorus in silico and
identified several putative response elements for Coup-
TFII. We therefore investigated whether Coup-TFII is a fur-
ther player in the transcriptional control of the Ucp3 gene
in rodents.
Results
Structure of the hamster Ucp3 gene
We successfully cloned the genomic Ucp3 locus of the
hamster. Primers to amplify fragments of the upstream
region (approx. -3500 to +50) were deduced from con-
served segments of corresponding rodent genomic
sequences. Resulting PCR products were sequenced and
served as a framework to select primers for gap closure.
We extended this contig to the putative 5' adjacent gene.
Ucp3 introns were amplified with exonic primers based on
the known hamster cDNA [GenBank: AF271265] and on
the exon 1 sequence obtained as described above. The
resulting genomic contig of 12,720bp included 3632 bp
of Ucp3 5' gene flanking region as well as all Ucp3 exons
and introns; the sequence of the terminal exon extends
210 bp 3' of the stop codon [GenBank: AY523564].
We identified two novel splice variants of the Ucp3 tran-
script in BAT [GenBank: DQ244043, DQ244044; not
shown]. One transcript is characterized by partial mobili-
zation of the second intron, presumably resulting in a pre-
mature stop [GenBank: DQ244044], the other lacks the
second exon, possibly leading to alternative usage of the
next in frame start codon wich is located in exon3 [Gen-
Bank: DQ244043].
In our 5' RACE analysis, the TSS was variable within a
range of 72 bp (Fig. 1). To determine a reference point for
relative sequence positions we arbitrarily chose positionPage 2 of 15
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obtained in BAT and SKM cDNA RACE experiments,
respectively. Of six additional sequenced clones, one con-
tained a start site at -49 (SKM), two at -20 (both BAT), one
at -3 (SKM), one at +16 (SKM) and at +23 (BAT). Thus the
TSS did not show a distinct tissue specificity.
Analysis of the UCP3 promoter
We compared rodent and human proximal promoter
sequences to classify promoter elements by their conser-
vation (Fig. 1). Of the elements recently characterized by
Solanes and coworkers (2003, 2004) – mediating tran-
scriptional activation by PPARα, TRs and MyoD – the
PPRE/TRE was located within a region that is identical in
the compared species. The 21 bp long MyoD-binding tri-
ple E-box only differs in three nucleotides of the first
repeat and is otherwise identical. In contrast, two TATA-
like boxes identified in the human promoter [26] are
absent in the known rodent sequences. By in silico analysis
of the hamster Ucp3 promoter we detected several puta-
tive nuclear receptor binding sites, among them 28 ele-
ments predicted to possibly bind Coup-TFII.
Sequencing of hamster Coup-TFII and qPCR
To derive homologous primers for qPCR we cloned and
sequenced a 325 bp fragment of Coup-TFII [GenBank:
DQ44042] comprising coding regions of exon 2 and 3.
Hamster sequences were 98% identical with the murine
orthologue. The deduced amino acid sequences of ham-
ster and mouse are identical. In a first experiment we
determined mRNA expression levels of Coup-TFII and
Ucp3 by qPCR analysis in a panel of nine tissues of ham-
sters housed under standard laboratory conditions and
fed ad libitum (Fig. 2). Ucp3 levels were highest in SKM
and BAT, much lower in heart and white adipose tissue
and virtually absent in all other tested tissues. Coup-TFII
was well detectable in all analyzed tissues with highest
amounts in kidney and SKM. The individual variation for
both Ucp3 and Coup-TFII was maximal in SKM. Ucp3
mRNA levels in BAT were about 50% of SKM expression,
interestingly the same is true for Coup-TFII.
To explore a possible coregulation of Ucp3 and Coup-TFII
we exposed hamsters to cold and food deprivation, phys-
iological challenges known to upregulate Ucp3 expression
[6,27] (Fig. 3A). In SKM food deprivation led to a signifi-
Alignment of the human and three rodent proximal Ucp3 promoter regionsFigure 1
Alignment of the human and three rodent proximal Ucp3 promoter regions. Positions of identical bases are marked 
(*). The PPRE/TRE (box) as well as the MyoD binding triple E-box (dashed box) are highly conserved. Two TATA-like boxes 
(bold) can only be found in the human promoter. Transcriptional start sites of P. sungorus were identified within a wide range 
(black background), the arbitrarily chosen reference TSS is indicated (#). Rn = R. norvegicus, Mm = M. musculus, Ps = P. sungorus, 
Hs = H. sapiensPage 3 of 15
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exposed hamsters Ucp3 was not systematically upregu-
lated but displayed an increased individual variation. A
similar degree of variation without significant cold-
induced regulation was observed for Coup-TFII. To test for
a possible coregulation we measured Ucp3 and Coup-TFII
transcript abundancies and compared respective levels of
control and challenged animals (Fig. 3B and 3C). Under
control conditions no correlation was observed. However,
we detected a highly significant correlation (r2 = 0.834, p
< 0.001) between Ucp3 and Coup-TFII levels in challenged
animals.
Luciferase reporter gene assays with cotransfected 
transcription factors
We tested Coup-TFII in cotransfection reporter gene assays
with regard to its potential in coactivating a Ucp3 pro-
moter fragment of 2244 bp cloned into the luciferase
reporter gene vector pGL3basic (-2244Ucp3luc). To evalu-
ate the influence of Coup-TFII we compared cotransfec-
tions with or without expression vectors for PPARα,
MyoD, RXRα and/or the histone acetyltransferase p300,
factors known to regulate Ucp3 expression [15] (Fig. 4A).
Without Coup-TFII none of the tested factors upregulated
-2244Ucp3luc more than 5-fold. Cotransfection of several
factors exhibited a synergistic effect, which was aug-
mented by p300, e.g. adding RXRα to MyoD hardly
increased reporter gene activity, but in the presence of
Expression level of Coup-TFII and Ucp3 mRNA in tissues of P. sungorusFigure 2
Expression level of Coup-TFII and Ucp3 mRNA in tissues of P. sungorus. Coup-TFII mRNA is expressed in all examined 
tissue types as measured by qPCR. Ucp3 mRNA is found together with Coup-TFII mRNA in BAT and SKM. Both display highest 
variability in SKM (SKM/BAT n = 9, other tissues n = 3). Black dots represent individual results, bars are mean values. WAT = 
white adipose tissue, SKM = skeletal muscle, BAT = brown adipose tissue.Page 4 of 15
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(47-fold) was achieved by a cotransfection of PPARα,
MyoD and p300 in the presence of the synthetic PPARα
agonist Wy14,643.
Cotransfection of Coup-TFII systematically increased
reporter gene expression in all combinations tested.
Together with a single other factor it was particularly effec-
tive with MyoD or p300, attaining an additional 3–5 fold
induction. In combination with multiple factors Coup-
TFII cotransfection consistently led to an approximate
doubling of induction. The maximal induction in com-
parison to the basal construct activity was achieved in
combination with RXRα, MyoD and p300 (95-fold),
which is two fold higher than the maximal level observed
in any experiment without Coup-TFII (ligand-activated
PPARα + MyoD + p300, 47-fold). The dimension of
induction by Coup-TFII is illustrated by comparison with
the PPARα activation through the ligand Wy14,643 on a
background of PPARα, MyoD and p300. Here transactiva-
tion by Coup-TFII and the ligand Wy14,643, respectively,
is in the same order of magnitude.
To exclude that overexpression of any nuclear receptor or
Coup-TF family member unspecifically leads to an induc-
tion of the Ucp3 promoter we utilized an expression vector
for Coup-TFI, which is a close Coup-TFII relative sharing
85.5% of identical amino acid sequence, as a control.
Replacing Coup-TFII by Coup-TFI in cotransfections with
transcription factor combinations did not lead to activa-
tion of the Ucp3 promoter, but conversely downregulated
reporter gene activity (Fig. 4A), possibly due to competi-
tion for RXRα. We therefore conclude that Coup-TFII spe-
cifically transactivated the Ucp3 promoter in synergy with
other known transcription factors and coactivators.
To locate the responsible cis element, we studied the
potential of Coup-TFII to activate several reporter gene
deletion constructs (Fig. 4B). Coup-TFII transfection
alone in this assay increased luciferase activity on -
2244Ucp3luc 16-fold while all other constructs are much
less sensitive. There is, however, a certain unspecific effect
on the empty pGL3 basic vector, that can also be seen for
all constructs used. This handicap was absent when we
cotransfected the deletion constructs with MyoD, RXRα
and p300, the combination exhibiting the strongest effect
on -2244Ucp3luc. The Coup-TFII effect is limited to -
2244Ucp3luc, locating the crucial region between nucle-
otides -1307 to -664, which are exclusively found on this
construct. We identified several possible binding sites for
Coup-TFII in this fragment: -1269 (A), -901 (B), -837 and
-827 (C), -807 (D) and -779 (E).
Electrophoretic mobility shifts assays
We tested five oligonucleotide probes corresponding to
the putative response elements A-E (see above) for bind-
ing of Coup-TFII in electrophoretic mobility shift assays.
Elements A, B, D and E did not display any specific inter-
action (Fig. 5A). For element C we were able to show a
strong complex formation in the presence of Coup-TFII,
Response of Coup-TFII and Ucp3 mRNA expression to physiological challenges inducing lipid utilizationFigure 3
Response of Coup-TFII and Ucp3 mRNA expression to physiological challenges inducing lipid utilization. (A) 
Expression of Coup-TFII and Ucp3 mRNA in BAT of cold exposed and SKM of food deprived hamsters as compared to control 
conditions. Shown are mean values with standard error, * = p < 0,05. (B) Relationship of Ucp3 and Coup-TFII mRNA levels in 
SKM and BAT of hamsters housed under standard conditions with ad libitum access to food; r2 = 0.211, p = not significant (SKM 
n = 9, BAT n = 9). (C)Correlation of Ucp3 and Coup-TFII mRNA abundancies in SKM of food deprived and BAT of cold 
exposed animals; r2 = 0.834, p < 0.001 (SKM n = 9, BAT n = 9).Page 5 of 15
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Coup-TFII transactivates the Ucp3 promoter in cotransfection reporter gene assaysFig re 4
Coup-TFII transactivates the Ucp3 promoter in cotransfection reporter gene assays. (A) Activity of reporter gene 
construct -2244UCP3luc in cotransfection experiments with various transcription factors (fold change relative to basal -
2244UCP3luc level). Coup-TFII coactivates the Ucp3 promoter in all combinations. It is especially effective together with MyoD, 
RXRα and p300. Coup-TFI does not activate reporter gene expression demonstrating a specific effect of Coup-TFII. (B) Iden-
tification of the region mediating Coup-TFII transctivation by analysis of deletion reporter gene constructs. Shown in the upper 
panel is the basal activity and induction by Coup-TFII of all constructs, in the lower panel the experiment was repeated on a 
background of MyoD, RXRα and p300 (note the different axis scaling). The shaded area highlights the region that is exclusively 
found on -2244UCP3luc and is responsible for the Coup-TFII effect in both setups.
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body. Binding of proteins to this probe was effectively
blocked by competition with the unlabelled oligonucle-
otide.
The antibody was specific for Coup-TFII and did not bind
the close relative Coup-TFI. Virtually all Coup-TFII was
detected in the nuclear fraction (Fig. 5B).
Nuclear extracts from skeletal muscle tissue of food
deprived (n = 3) and control (n = 3) hamsters were able to
form a bandshift on element C of comparable size. In two
Coup-TFII binds to a conserved element of the Ucp3 promoterFig re 5
Coup-TFII binds to a conserved element of the Ucp3 promoter. (A) Electrophoretic mobility shift assay with candi-
date probes A-E and nuclear extracts of HEK293 cells. Overexpression of Coup-TFII leads to formation of a specific complex 
on probeC only, that can be supershifted with a Coup-TFII antibody. All complexes are subject to competition with 100 fold 
molar excess of unlabelled probe C. (B) Western Blot of protein fractions of HEK293 cells with a Coup-TFII-antibody. Coup-
TFII is specifically detected in the nuclear fraction and absent in untransfected cells. M = Marker, - = mock transfected, CI = 
Coup-TFI transfected, CII = Coup-TFII transfected. (C) Alignment of the human and rodent promoter regions of the Ucp3 
gene (Ps: -821 to -857). The positions of identical bases are marked (*). The putatively Coup-TFII binding elements (box, 
dashed box) located on probe C are conserved in all rodent species. In the murine promoter they are found in reverse order 
slightly more upstream. The human promoter does not feature comparable sequences in the compared region. Rn = R. norvegi-
cus, Mm = M. musculus, Ps = P. sungorus, Hs = H. sapiens (D) Electrophoretic mobility shift assay with skeletal muscle nuclear 
extracts from control and food deprived hamsters. The complex shown is of a size comparable to the Coup-TFII complex 
above. Starvation induces complex formation in comparison to control conditions.Page 7 of 15
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than in control conditions (Fig. 5D).
The two elements present in oligonucleotide C form a
functional repeat as is typical for binding sites of nuclear
receptor dimers. This inverse repeat is conserved in the rat
Ucp3 promoter, and also found slightly more upstream in
the murine promoter albeit in reverse order (Fig. 5C).
Mutational analyses of the Coup-TFII binding element
We further analysed the two repeat elements on oligonu-
cleotide C (Cwt) by disrupting the 5' half (Cmut5'), the 3'
half (Cmut3') or both (Cmut5'3') on bandshift assay
probes (Fig. 6D). We chose to change two bases of the 3'
half-site into adenine and two bases of the inverse 5' half-
site into thymine correspondingly. These probes were
employed either labelled with nuclear extracts of mock or
Coup-TFII transfected cells or unlabelled as competitors
for the interaction of Coup-TFII with element C (Fig. 6A).
All mutated probes displayed a reduced complex forma-
tion with Coup-TFII (Fig. 6B). While probes Cmut5' and
Cmut5'3' did not show any significant complex forma-
tion, probe Cmut3' still formed a complex that was
weaker in intensity and slightly smaller than the wt probe.
In competition assays the mutated competitor oligonucle-
otides were less efficient in competing Coup-TFII complex
formation on the Cwt probe than the unlabelled Cwt oli-
gonucleotide itself (Fig. 6C). Again Cmut5' and Cmut5'3'
generated a similar pattern of no binding of Coup-TFII to
these mutated elements. Mutation Cmut3' did not
entirely loose its ability to compete complex formation,
which is in line with its demonstrated retained capability
of interaction with Coup-TFII.
We introduced the same mutations Cmut5' and Cmut3'
into our reporter gene vector -2244UCP3luc generating -
2244Cmut5'luc and -2244Cmut3'luc (Fig. 7). Disruption
of the 3'half-site on -2244Cmut3'luc did not lower respon-
Disruption of the 5' half-site leads to loss of Coup-TFII bindingFigure 6
Disruption of the 5' half-site leads to loss of Coup-TFII binding. (A) Electrophoretic mobility shift assay with element 
C and mutated derivatives (compare (D)). Bands were quantified, background corrected and analyzed. Probe = labelled oligo-
nucleotide used; comp. = unlabelled competitor oligonucleotide used; CII = nuclear extract of Coup-TFII transfected HEK293 
cells; mock = nuclear extract of mock transfected HEK293 cells. (B) Quantification of complex intensity on labelled probes 
Cwt, Cmut5', Cmut3' and Cmut5'3'. Probe Cmut3' retained a lowered ability to bind Coup-TFII while Cmut5'and 
Cmut5'3'were unable to do so. (C) Accordingly unlabelled competitor probe Cmut3' was still able to partially compete for 
Coup-TFII binding to the labelled wt probe, while Cmut5' and Cmut5'3' were not. (D) Overview of the probes used in electro-
phoretic mobility shift assays. Probe Cwt represents element C, the mutated derivatives are depicted below.Page 8 of 15
(page number not for citation purposes)
24
BMC Molecular Biology 2007, 8:1 http://www.biomedcentral.com/1471-2199/8/1
____________________________________________________________Chapter 1siveness to Coup-TFII alone or on a background of MyoD,
RXRα and p300, but did even proportionally increase
luciferase activity by a small amount. Conversely, -
2244Cmut5'luc was devoid of any luciferase activity in all
conditions tested and displayed a pattern resembling our
empty control vector pGL3 basic.
Discussion
A prominent hypothesis considers uncoupling protein 3
(Ucp3) to be a crucial component of lipid metabolism
with implications for the regulation of body weight and
composition [3]. This role is further substantiated by the
identification of polymorphisms/alleles in the human
Ucp3 gene that are associated with an elevated body mass
index [28]. A more detailed analysis of the machinery reg-
ulating Ucp3 transcription is therefore of importance for
identifying regulatory networks controlling energy parti-
tioning.
Our comparison of previously characterized Ucp3 pro-
moter elements in rat, mouse and human with the ham-
ster sequence, shows full conservation of the binding sites
for MyoD, PPARα/RXRα and TR/RXRα heterodimers. The
sequence alignment furthermore demonstrates that two
TATA-like boxes present in the human promoter [26] are
absent in rodent sequences including the hamster. This
might prove to be crucial considering, that in the study of
Riquet and coworkers (2003) the activities of human con-
structs were investigated in murine tissue.
The TSS of the human Ucp3 gene is quite variable and dis-
plays a distinct tissue specificity, whereas in mouse the
TSS is located at a single site [29]. Our result of variable
TSS in P. sungorus demonstrates that the constancy in
mouse does not reflect a common trait of rodent species.
However, in the hamster the TSS did not show a distinct
tissue specificity as found in humans.
By in silico analysis we identified Coup-TFII as a candidate
transcription factor for the regulation of Ucp3 expression.
Coup-TFII is a 45 kD nuclear orphan receptor and mem-
ber of the COUP-TF family. The amino acid sequence of
the ligand binding and the DNA binding domain is con-
served across species to a very high extent (human vs. Dro-
sophila ~90%) indicating an important role for these
domains. Coup-TFII has mainly been described as a cru-
cial factor in developmental processes [21,22].
By qPCR we measured Ucp3 and Coup-TFII transcript lev-
els in a panel of nine different tissues. We confirmed that
Disruption of the 5' half-site leads to complete loss of activityFigure 7
Disruption of the 5' half-site leads to complete loss of activity. Reporter gene assays with mutated luciferase con-
structs. In the upper panel basal luciferase activity and induction by Coup-TFII is shown, in the lower panel the experiment was 
repeated on a background of MyoD, RXRα and p300. Disruption of the 3' half site on -2244Cmut3'luc did not lower activity in 
any condition tested. Disrupting the 5' half-site on -2244Cmut5'luc led to a complete loss of basal activity and responsiveness to 
Coup-TFII and MyoD, RXRα and p300.Page 9 of 15
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sion. Coup-TFII was detected in both tissues, but in line
with previous data on human adult tissue distribution
[30] is rather ubiquitously expressed with highest levels in
kidney, liver and heart. Contrary to reports that Coup-TFII
is expressed in preadipocytes and myoblasts and down-
regulated during differentiation [23,31], we were able to
detect considerable amounts of Coup-TFII transcript in
BAT and SKM tissue. Apparantely cell culture systems are
devoid of the appropriate physiological stimuli promot-
ing Coup-TFII mRNA expression in tissues. This is sup-
ported by the absence of Coup-TFII in human embryonal
kidney cells as shown in our Western blot experiment
(Fig. 5B) despite its presence in human kidney tissue in
vivo [30]. It has been demonstrated that Coup-TFII plays
an important role in the regulation of several genes encod-
ing key metabolic enzymes [18,23-25], which are cer-
tainly regulated in terminally differentiated cells.
Ucp3 gene expression was upregulated in SKM of food
deprived hamsters. In line with the function of Coup-TFII
in metabolic regulation we also observed a significant
increase of mRNA expression in response to this chal-
lenge. Probably owing to the short duration of cold expo-
sure in our study we did not observe a significant cold
induced increase in Ucp3 mRNA expression in BAT as
published previously [5,6]. However, Coup-TFII and Ucp3
mRNA expression in BAT displayed a similar cold-
induced increase in variation. The resemblance of expres-
sion levels in SKM and BAT and the response to physio-
logical stimuli culminates in a highly significant
correlation of Coup-TFII and Ucp3 mRNA abundancy
under challenged conditions (food deprivation and cold).
The absence of such a correlation in the control group sug-
gests that Coup-TFII requires additional factors in order to
enhance Ucp3 mRNA expression which must be recruited
and/or activated beforehand.
We could support this model in reporter gene assays, in
which Coup-TFII strongly coactivated Ucp3 promotor
activity in synergy with PPARα, MyoD, RXRα and/or
p300, while the effect of Coup-TFII was much lower
alone. These constituents of the well described basal tran-
scription factor complex in our experiments affected Ucp3
expression as described previously [15], i.e. strong activa-
tion by PPARα/RXRα and p300, dependent on agonist
stimulation and presence of MyoD. Coup-TFII specifically
enhanced expression in synergy with these factors.
In contrast to our data, Coup-TFII has been shown to neg-
atively interact with MyoD and p300 in SKM, reducing
their potential to activate E-box driven reporter gene con-
structs [17]. This discrepancy may be explained by a differ-
ential recruitment of the multiple COUP-TF family
cofactors in different physiological environments [e.g. N-
Cor, SMRT, RIP140, SRC-1; for a review see [32]]. The spe-
cific complex of transcription factors, to which Coup-TFII
is recruited, may determine the final function as described
for interaction with the glucocorticoid receptor [33]. In
general, COUP-TF proteins display a conflicting pattern of
positive or negative interaction with nuclear receptors like
PPARs or the estrogen receptor depending on the target
gene [discussed in [18]]. There are genes where transcrip-
tion is increased by PPARs and decreased by COUP-TFs
[e.g. malic enzyme [19]] as well as genes for which the sit-
uation is opposite [e.g. transferrin [20]] or at which both
PPARs and COUP-TFs act synergistically [e.g. lipoprotein
lipase [18]]. Even a complete reversal of the effect of
Coup-TFII on a single target has been reported [23]; tran-
scription of the phosphoenolpyruvate carboxykinase gene
is induced or repressed by Coup-TFII in a tissue specific
manner.
Interestingly, specific PPARγ agonists upregulate Coup-
TFII in the heart [24] and also Ucp3 gene expression in
BAT and SKM [34,35], although to our knowledge no
direct interaction of PPARγ with the Ucp3 promoter has
been verified so far. This effect might therefore be due to
PPARγ mediated transactivation of Coup-TFII, which in
turn enhances Ucp3 expression.
We were able to confine the sequence element mediating
the Coup-TFII effect to -1307 to -664 by utilizing reporter
gene deletion constructs. -2244UCP3luc was the only con-
struct being induced by Coup-TFII on a background of
MyoD, RXRα and p300 and was exclusively activated high
above an unspecific effect by Coup-TFII alone.
Of five candidate elements A-E within this region tested
by electrophoretic mobility shift assays we confirmed spe-
cific binding of Coup-TFII to element C. Notably, element
C did not only show complex formation with overex-
pressed Coup-TFII but also with nuclear extracts of ham-
ster SKM (Fig. 5D). Extracts of all six animals tested were
able to form a complex of comparable size and food dep-
rivation of hamsters led to an increase in band intensity.
The element is located at -816 to -840 and constitutes a
functional repeat structure. By mutational analyses we
were able to confine Coup-TFII binding to the 5' half-site
of this element. In reporter gene assays disruption of this
site surprisingly led to a complete loss of activity and
responsiveness to any treatment tested. While this fact cer-
tainly underlines the importance of this element, its indif-
ference to MyoD, RXRα and p300 treatment is in conflict
with the retained effect of this treatment on -664UCP3luc
and -243UCP3luc, that are also devoid of this element. It
seems that the element exhibits a function beyond direct
transactivation by Coup-TFII, that depends on the pres-
ence of the surrounding region. These characteristics point
towards a model of Coup-TFII deactivating or displacing aPage 10 of 15
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repressor could be expected to bind in proximity to the 5'
half-site of elementC, possibly even to the 3' half-site of
this same element. In the light of this hypothetical model
several formerly negligible seeming facts gain relevancy:
Mutated construct -2244Cmut3'luc displayed an overall
increase of luciferase activity as compared to -
2244UCP3luc (Fig. 7). Deletion construct -664UCP3luc
had a higher basal activity and could be activated by
MyoD, RXRα and p300 to a higher extent than -
2244UCP3luc (Fig. 4B). The complex size of bandshift
probe Cmut5' was slightly changed (Fig. 6A).
This model alone, however, does not account for the acti-
vation of -2244UCP3luc by MyoD, RXRα, p300 and
PPARα in the absence of cotransfected Coup-TFII. There-
fore there would have to be an endogenous Coup-TFII
expression in HEK293 cells that we can either not detect
with our Western blots or is induced by transfection of fac-
tors like MyoD and p300. At present we cannot decide
wether repressor displacement/deactivation itself or sub-
sequent direct coactivation is the dominant means of
Coup-TFII mediated transcriptional induction.
The conservation of the inverse repeat structure and its
Coup-TFII binding site across rodent species suggests an
important role for this element; its preservation in the
murine promoter despite an obvious event of rearrange-
ment during evolution supports this role. The upstream
location of the binding element and its synergy with
PPARα resembles a comparable situation, where Coup-
TFII directly coactivates the lipoprotein lipase gene in
cooperation with PPAR/RXR heterodimers as described
previously [18]. Notably lipoprotein lipase is a crucial
determinant of fatty acid uptake from circulating triglycer-
ides.
An explanation of the link between increased lipid utiliza-
tion and the recruitment of Coup-TFII in BAT and SKM is
hampered by the lack of knowledge about a specific lig-
and and the posttranslational mechanism of activation. It
is beyond the scope of this study to clarify whether Coup-
TFII is directly regulated in response to FFA levels and thus
possibly conveys FFA-dependent Ucp3 transcription. Our
qPCR data indicate that de novo synthesis of Coup-TFII is
the dominant means of target gene upregulation rather
than ligand binding or posttranslational modification. So
far, transcription of Coup-TFII has been linked to MAP
kinase pathway activity [36] and the presence of ETS fam-
ily transcription factors [37]. Further research is required
to clarify whether these mechanisms represent a link
between lipid utilization and Coup-TFII upregulation.
On the functional level beyond its role in organismic
development Coup-TFII has been assumed to be an inte-
gral part of the glucose response complex, where it func-
tions as an inhibitor of glucose dependent activators [25].
This hypothesis is based on the ability of Coup-TFII to
inhibit upstream stimulatory factor (USF)-dependent
transactivation of a glucose response element in the L-type
pyruvate kinase gene (PKLR) and a similar finding regard-
ing the ATPA gene encoding the alpha subunit of the F1F0
ATP synthase complex [38]. Recently, Bardoux and cow-
orkers (2005), after discovering a role for Coup-TFII in
insulin secretion and sensitivity, assigned Coup-TFII as an
important regulator of glucose homeostasis [39]. Our
finding of Coup-TFII upregulation in states of augmented
lipid oxidation confirms these models and extends them
to a new aspect. The inhibition of glucose induced gene
transcription may occur in conjunction with a positive
regulation of lipid metabolism genes like Ucp3 and lipo-
protein lipase.
Conclusion
Coup-TFII is a strong activator of Ucp3 gene transcription
by binding to an upstream element in the Ucp3 promoter
as shown by luciferase assays and electrophoretic mobility
shift assays. Coup-TFII mRNA expression correlates with
Ucp3 mRNA levels in tissues of hamsters subjected to
physiological challenges inducing lipid oxidation. Tran-
scriptional upregulation of the Coup-TFII gene in response
to these challenges seems to regulate the Ucp3 gene in
brown adipose and skeletal muscle tissue determining the
final appropriate rate of Ucp3 mRNA synthesis. The mech-
anism of Coup-TFII inducing Ucp3 transcription seems to
involve displacement/deactivation of an unknown repres-
sor. These findings add a crucial component to the com-
plex transcriptional machinery controlling expression of
Ucp3. At the same time they further manifest a function of
Coup-TFII in the regulation of lipid metabolism genes.
Methods
Animal experimentation and nucleic acid preparations
Djungarian hamsters (Phodopussungorus) were housed
under standard laboratory conditions with ad libitum
access to food (Hamsterzuchtdiät 7014, Altromin) and
water unless stated otherwise. All experiments involving
animals were conducted in accordance with the German
animal welfare law. For tissue dissections hamsters were
sacrificed by CO2 exposure. Genomic DNA was prepared
from spleen with the DNeasy Tissue Kit (Qiagen). We
either cold exposed hamsters to 4°C ambient temperature
for 24 hours (n = 9) or food deprived hamsters for 48
hours at room temperature (n = 12). A third group of
hamsters was kept at room temperature and fed ad libitum
to serve as control group (n = 12). All hamsters were of an
age of 10 to 15 months. We obtained samples of
suprasternal BAT and hindlimb SKM (Musculus quadri-
ceps) from 9 animals of each group. From three control
group hamsters we also dissected samples of inguinalPage 11 of 15
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Samples were frozen in liquid nitrogen, total RNA pre-
pared with Trizol (Invitrogen) and quantified photomet-
rically. We dissected the entire leg musculature of three
control and starved animals for tissue nuclear protein
extracts.
Primer design, sequencing and sequence analysis
All sequencing reactions were carried out by a commercial
service provider (MWG Biotech). Primer sequences were
selected using the program Primer3 (Code available at
[40]). Primers to amplify fragments of the Ucp3 genomic
locus were deduced from conserved regions of corre-
sponding genomic sequences from the ENSEMBL mouse
and rat genomic databases (ENSMUSG00000032942,
ENSRNOG00000017716), from cDNA sequences of the
putative 5' adjacent gene [GenBank: AU020772,
AI170065] and from P. sungorus Ucp3 cDNA [Genbank:
AF271265]. PCR products were cloned and sequenced.
Assembled contigs were resequenced with homologous
primers and a minimum 5-fold coverage. To analyse the P.
sungorus Ucp3 transcript 2 μg of RNA were reverse tran-
scribed into cDNA with oligo-dT-primers and Superscript
II reagents (Invitrogen). We deduced PCR primers from
the assembled genomic contig to amplify, clone and
sequence two overlapping fragments representing exon1
to exon6 and exon2 to exon7 of the Ucp3 transcript,
respectively. Sequencing results were visualized, edited
and assembled in the GAP4 module of the Staden
Sequence Analysis Package [41]. All sequence alignments
were conducted with ClustalW [42]. Promoter sequences
were analyzed for putative transcription factor binding
sites by considering results obtained with the programs
AliBaba2.1, MATCH™ and PATCH™ [43] all based upon
the TRANSFAC® database [44].
Mapping the transcriptional start site (TSS)
To determine TSS by 5' rapid amplification of cDNA ends
(5' RACE), 1 μg of SKM and BAT total RNA was reverse
transcribed into RACE-ready first-strand cDNA using an
amplification kit (BD SMART RACE, Clontech). We PCR-
amplified the 5'-end with the Ucp3 specific reverse primer
ATGGCTTGAAATCGGACCTTCACCAC combined with
the kit primer mix according to the manual. Products were
cloned into pCR2.1-TOPO (Invitrogen) and independent
clones were picked and sequenced.
Real time qPCR
We cloned a fragment of P. sungorus Coup-TFII [GenBank:
DQ244042] representing parts of exon2 and 3 by deduc-
ing heterologous primers from conserved regions of the
respective mouse and rat transcripts. Nested, homologous
primers were inferred for qPCR analysis. SuperScript® III
Platinum® SYBR® Green Two-Step qRT-PCR Kit (Invitro-
gen) was used to reverse transcribe total RNA prepared as
described above and to measure mRNA expression levels
on an iCycler IQ (Biorad). The PCR Mix was supple-
mented with 20 nM Fluorescein (Biorad). Amplification
efficiency was calculated based on dilution series standard
curves by the Biorad iCycler IQ 3.0 software and used to
determine starting quantity levels (PCR base line sub-




GGGCTTA, TCCAGCAGCTTCTCCTTGAT. Group differ-
ences were tested for significance with the Mann-Whitney
rank sum test, correlations were calculated by the Spear-
man rank order method (SigmaStat 3.1, Systat Software).
Vector origins and construction
Expression vectors pCMV-SPORT6 harbouring the com-
plete coding sequence of human Coup-TFII
(IMAGE:5177487), COUP-TFI (IMAGE:2824138) and
murine MyoD in pME18S-FL (IMAGE:1499265) were
obtained from the "Deutsches Resourcenzentrum für
Genomforschung" (RZPD, Berlin) and verified by
sequencing. Human full length RXRα in pSG5 was kindly
provided by A. Baniahmad (Gießen, Germany), human
p300 in pCMVβ by C. Platzer (Jena, Germany) and human
PPARα in pCMV7 by H. Shimano (Tokyo, Japan).
A region comprising a BamHI fragment from -2244 to +38
of the Ucp3 gene was amplified by Pfu polymerase (Fer-
mentas). It was cloned into a BglII site of pGL3 basic
(Promega) exploiting the endogenous, compatible
BamHI sites to generate -2244Ucp3luc. Subsequently,
three different deletion constructs were cloned (outlined
in Fig. 4B). By restriction with BglII and religation we cre-
ated -2244BglIIdel Ucp3luc, bearing a 1161 bp deletion
from -1307 to -146. The construct -664Ucp3luc was gener-
ated by restriction of -2244Ucp3luc with the compatible
enzymes XbaI and NheI, but owing to a XbaI site in the
vector backbone we applied a partial restriction followed
by gel purification and religation of the appropriate frag-
ment. We constructed -243Ucp3luc by restriction of -
664Ucp3luc with BfrBI and SmaI and religation of the aga-
rose gel purified larger fragment.
For mutational analyses of element C we constructed two
further reporter gene constructs -2244Cmut5'luc and -
2244Cmut3'luc by PCR overlap extension site directed
mutagenesis as described previously [45]. To mutate the
first half-site (Cmut5') we used the overlapping mutated
primers TCAAGGACATTTTCTTCCCA and CCTTGGGAA-
GAAAATGTCCT, to mutate the second half-site (Cmut3')
ACTTCCCAAGGAAACACAGC and GCTGTGTTTCCTT-
GGGAAGT. For both primer pairs we designed the outer
primers TCACTGTTGTCTCTGCTGCC and GCAG-
CAGCCATCCTTAGAAC to produce an amplicon includ-Page 12 of 15
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two resulting mutated fragments were cloned into pGEM-
Teasy (Promega) and sequenced to verify the introduced
mutation. BglII-fragments derived from these vectors were
subcloned into -2244BglIIdel Ucp3luc and again
sequenced to guarantee successful subcloning of the
respective mutated site.
Cell culture and luciferase assays
We utilized the human embryonal kidney cell line
HEK293 as a heterologous system for our reporter gene
studies. Cells were grown in DMEM supplemented with
10% FCS and split every second day. For luciferase assays
cells were detached by trypsin and passaged onto 12 well-
plates. Cells were transfected by the calcium-phosphate
method using the ProFection Kit (Promega). We used 25
ng reporter gene construct, 1.25 ng phRL-tk (Promega),
500 ng for each expression vector and added empty
pcDNA3 (Invitrogen) to a final mass of 2 μg and added
100 μl of precipitate solution per well to the medium. For
every vector combination we prepared three replicate
wells. Cells were incubated with the transfection mixture
for 16 hours, medium was changed and cells harvested 24
hours later. When 10 μM of the PPARα ligand Wy14,643
was applied as a stimulant, it was added in DMSO during
the medium change. In all measurements without stimu-
lant, medium was supplied with the same volume of
DMSO only. Luciferase activity was measured with the
Dual Luciferase Reporter Assay System (Promega). Initial
experiments revealed that cotransfection of cells with vec-
tors driving expression of nuclear receptors systematically
affected phRL-tk activity, a known handicap of this system
[46]. We therefore used primary, unnormalized data for
activity calculations. To validate these data we measured
protein content by the Bradford method and confirmed
that this normalization did not result in values signifi-
cantly different from unnormalized data. All results are
shown as fold changes relative to the basal activity of the
respective construct used.
Electrophoretic mobility shift assay
HEK293 cells were harvested in 200 μl homogenisation
buffer (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.5
mM DTT, 20 mM NaF), homogenized in a glass potter
and centrifuged (3300 g, 15 min, 4°C). The pellet was
resuspended in 100 μl low salt buffer (20 mM HEPES, 1.5
mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 20 mM NaF,
25% (v/v) glycerol) and subsequently mixed with 100 μl
high salt buffer (= low salt buffer with 1.2 M KCl). The
mixture was agitated vigorously for 30 min at 4°C and
centrifuged (25,000 g, 30 min, 4°C). The supernatant
containing nuclear proteins was purified with a Microcon
YM-50 column (Millipore), aliquoted and stored at -
80°C. All above mentioned buffers were supplied with
protease inhibitors (Complete Mini Protease Inhibitor
Cocktail Tablet, Roche) and phosphatase inhibitors
(Phosphatase Inhibitor Cocktail II, Sigma). Protein con-
centrations were measured by the Bradford method with
BSA as a standard.
For tissue nuclear extracts we excised the complete leg
musculature of a hamster and grinded it in liquid nitrogen
to yield a fine powder. The powder was treated as
described above with the following modifications. We
used 1 ml homogenisation buffer, washed the pellet in 1
ml homogenisation buffer and subsequently used 200 μl
of high and low salt buffer. We did not employ the con-
centrator column for tissue extracts.
Complementary oligonucleotides were annealed by heat-
ing to 80°C in TE (10 mM Tris/HCl, 1 mM EDTA) and
slow cooling to room temperature. Double strands were
further purified by elution from a 12% polyacrylamide
gel. Three pmol of the resulting doublestrand were endla-
belled with T4 polynucleotide kinase and [γ-32P]ATP and
purified with a ChromaSpin+10-TE column (Clontech).





GACACATGAGGGTT. Sequence of mutated element C




For gel retardation assays we incubated 3 μg (HEK293) or
20 μg (tissue) nuclear extract with ~7.5 fmol probe for 20
min on ice in a final volume of 2 μl containing 4% (v/v)
glycerol, 1 mM MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 50
mM NaCl, 10 mM Tris/HCl (pH 7.5) and 50 μg/ml
poly(dIdC)·poly(dIdC). Samples were analyzed by elec-
trophoresis in a 5.2% nondenaturing polyacrylamide gel
at 4°C and 200 V for 3 hours in 0.5 × TBE. The gel was
exposed to a phosphoscreen for 18 hours. For competi-
tion assays we included a 2–100 fold molar excess of unla-
belled oligonucleotide in the reaction. For supershift
assays we added 1 μl of Coup-TFII antibody (Santa Cruz,
sc6576-X). The specificity of this antibody and the pres-
ence of Coup-TFII protein in the nuclear fraction of trans-
fected cells was confirmed by Western blot.
Densitometrical quantification of band intensities was
performed with the software ImageJ 1.34s [47]. All values
were background corrected.
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Uncoupling protein 3 (Ucp3) is a transport protein of the inner mitochondrial membrane and 
presumably implicated in the maintenance or tolerance of high lipid oxidation rates. Ucp3 is 
predominantly expressed in skeletal muscle and brown adipose tissue and regulated by a 
transcription factor complex involving PPARα, MyoD and Coup-TFII. By analysis of a 
mutant Djungarian hamster model lacking Ucp3 transcription specifically in brown adipose 
tissue we were able to identify a putative forkhead transcription factor binding site conferring 
tissue specificity. A naturally occurring, intronic point mutation disrupting this site leads to 
brown adipose tissue specific loss of Ucp3 expression and an altered body weight trajectory. 
Our findings provide insight into tissue specific Ucp3 regulation and for the first time 
unambiguously demonstrate that changes in Ucp3 expression can interfere with body weight 
regulation. 
 
Key words: uncoupling protein 3, brown adipose tissue, body mass, forkhead domain, intronic 




Uncoupling protein 3 (Ucp3) belongs to the group of anion carrier proteins and is located 
within the inner mitochondrial membrane. It is predominantly expressed in skeletal muscle 
and brown adipose tissue [1;2]. Initially described as a homologue of the classical brown fat 
thermogenic Ucp1 it was soon established that Ucp3 has a function other than thermogenesis. 
One major argument against a thermogenic role was the positive transcriptional regulation of 
the Ucp3 gene in response to starvation in which activation of an energy wasting mechanism 
seems unlikely [3]. Many studies describe Ucp3 upregulation in response to physiological 
situations associated with increased plasma fatty acid levels and lipid utilization including 
cold exposure [4], acute exercise [5] and streptozocin-induced diabetes [6] as well as direct 
lipid infusion [7]. The inferred relevance of this anion carrier protein in lipid metabolism is a 
cornerstone of the hypothesis of Ucp3 being a fatty acid anion exporter, a biochemical 
function necessary to eliminate free fatty acid from the mitochondrial matrix and not assigned 
to a specific protein previously [8]. This molecular function of Ucp3 however is subject to an 
ongoing debate [9]. Despite its obviously different role in vivo, certain biochemical properties 
of the protein as measured in mitochondrial proton leak assays resemble those of Ucp1, i.e. 
causing a GDP-sensitive inducible proton leak [10]. Therefore other major hypotheses 
consider Ucp3 to primarily be a proton translocator, pyruvate transporter, superoxide 
transporter, constituent of a radical defense system and constituent of the mitochondrial Ca2+ 
uniporter (reviewed in [9] and [11]). 
Apart from the controversy about the actual molecular function there is general consent that 
Ucp3 is implicated in the maintenance or tolerance of high lipid oxidation rates by either 
being an integral part of fatty acid metabolism or an accompanying phenomenon. In addition 
to its localisation in tissues with highest β-oxidative capacities and its regulation by serum 
free fatty acid levels there is complementary evidence for a role in lipid metabolism from a 
different perspective. In a number of association and linkage studies, polymorphisms in the 
human UCP3 locus have been reported to influence markers of obesity like BMI and waist-to-
hip ratio [12;13]. Since Ucp3 and Ucp2 share the same genomic locus and are well within 
linkage disequilibrium it has been problematic to assign association of the respective 
phenotype to a polymorphism in either of the paralogues [14]. 
In our breeding colony of the Djungarian hamster Phodopus sungorus we identified animals 
lacking Ucp3 mRNA expression exclusively in brown adipose tissue (BAT) without 
phenotypic consequences for resting metabolic rate [15]. We further analyzed this mutation 
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on a broad genetic background to elucidate the affected regulatory mechanism and the 
phenotypic consequences. 
The expression of Ucp3 is controlled by an interacting network of multiple factors including 
PPARα/RXRa heterodimers, MyoD, Coup-TFII and several more [16;17]. The function of all 
these known components of the machinery controlling Ucp3 transcription is mediated by a 
genomic region upstream of Ucp3 exon 1. We here report on a novel intronic regulatory 
element which is essential for brown fat Ucp3 transcription and thereby confers tissue 
specificity of Ucp3 expression. We show that disruption of this element leads to BAT specific 




DNA sequence analysis 
We chose primers for comparative sequencing of the hamster Ucp3 locus with the software 
Primer3 (code available at [18]) based on Genbank entry AY523564 to yield overlapping 
PCR fragments of about 500 bp in length. Amplicons were Sanger sequenced from both ends. 
Sequences were aligned and analysed with the GAP module of the Staden Package [19]. 
Sequence positions and variations are named following nomenclature recommendations and 
based on Genbank entry AY523564 [20]. Accordingly positions in intron 1 are called 
“intervening sequence 1” IVS1+x, counting from the first base +1 of this intron. Positions 
outside introns are given relative to the A (+1) of start codon ATG in AY523564. Analyses of 
transcription factor binding sites were conducted with Match™ [21]. 
For two sequence variations located in Ucp3 intron 1 we developed restriction fragment 
length polymorphism (RFLP) assays. The region surrounding IVS1+1505A constitutes a 
recognition site for AarI which is absent when the IVS1+1505G-allele is present. At 
IVS1+2668A there is an Eco57I site that is lacking if the IVS1+2668G-allele is present. We 
amplified a genomic fragment including both polymorphic sites with primers 
TGTCCTGATGGCTCCTCTCTA / CCCCAGGAACTTCACAACTG and digested with 
either AarI (Fermentas) or Eco57I (Fermentas). 
To genotype a larger number of animals we utilized the Pyrosequencing® technique 
employing the PSQ 96MA system (Biotage AB). We first amplified a long intronic DNA 
fragment with primers CAAGTCACCCAGCAGCCTA /  GGCGGCATCTATCTGGAATA. 
In a second, nested PCR we used primers CAGTACCTCCTGCTGGGAAG and 
5`-biotinylated Biotin-AGTCAGACCTTGGCTCTCCA to amplify a 248 bp long region 
encompassing IVS1+1505. The total yield of biotin labelled PCR product was immobilized 
on 3µl Steptavidin labelled Sepharose beads (GE Healthcare) at room temperature. Single 
stranded DNA was prepared at a Vacuum Work Station (Biotage AB) and transferred into a 
PSQ reaction plate (Biotage AB) where the sequencing primer 
GCCTGAATAAGTGTTTTCT was annealed. Pyrosequencing® reactions were performed 
using the PyroGoldTM SNP reaction kit (Biotage AB) following the manufacturer´s manual. 
The sequence to analyse was defined as TAACACRCCTG and the dispensation order for the 
single nucleotide injection was calculated to be GTACACGAGC (bold: polymorphic site) by 
the PSQ 98MA software (Version 2.1, Biotage AB). Results were calculated and analysed by 
the PSQ 98MA software. 
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Animal growth, body mass and composition 
To study the phenotypic consequences of the two alleles if Ucp3 intron 1 in vivo, on a broad 
genetic background and in all genotypes we crossed heterozygous hamsters. To identify 
founder animals we genotyped position IVS1+1505 of 90 animals randomly chosen from our 
colony. The progeny of 14 heterozygous breeding pairs displayed an allele frequency of 0,5 
for IVS1+1505G and 0,5 for IVS1+1505A in 171 animals as expected. The alleles were 
distributed among genotypes in accordance with Hardy-Weinberg equilibrium. The body 
weight of all animals was continuously monitored on a weekly basis. On day 81±3 after birth 
66 hamsters were transferred to an ambient temperature of 4°C for two days and sacrificed.  
All determinations of body fat mass and femur length were performed under isoflurane 
anesthesia with DEXA (PIXImus2 scanner, software version 1.46.007, GE Medical Systems, 
Madison, Wisconsin, USA). The head of the animals was excluded from the measurement. 
Bone mass is not included in DEXA-provided values for total body mass (head excluded) and 
lean mass. 
Animal experiments were conducted in accordance with the German animal welfare law. 
Quantitative PCR 
We extracted total RNA from BAT and skeletal muscle with TRIzol (Invitrogen) and 
quantified photometrically. RNA was reverse transcribed with the Superscript III First Strand 
Synthesis Kit (Invitrogen). To quantify transcript levels by qPCR we used ImmoMix 
(Bioline) supplemented with SYBR Green (Bioline) and 20 nM Fluorescein (Biorad) on an 
iCycler (Biorad). The efficiency of amplification was calculated based on dilution series 
standard curves by the Biorad iCycler IQ 3.0 software and used to determine starting quantity 
levels (PCR base line subtracted) normalized to β-actin levels. Primers: β-actin 
AGAGGGAAATCGTGCGTGAC, 
CAATAGTGATGACCTGGCCGT; Ucp3 AGGAAGGAATCAGGGGCTTA, 
TCCAGCAGCTTCTCCTTGAT. Results were statistically analysed by t-tests 
(SigmaStat 3.1, Systat Software). 
 
Vector construction 
Using genomic DNA of animals either homozygous for [IVS1+1505G; IVS1+2668A] or 
[IVS1+1505A; IVS1+2668G], we PCR amplified fragments of 4338 bp spanning position 
-4234 to +103 of the Ucp3 genomic locus with primers CCTTGGGAAGTCAATGTCCT / 
CCAGGGGGAAGGTGAGTAGGTCT and Pfu polymerase (Fermentas). Amplicons were 
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used in a nested Pfu-PCR to amplify the region between positions -4027 to +14 with primers 
GGGGGAAGGGAAACGGGGAGAC / GAAGTCCAACCATGGTGCCCAGCAG, the 
latter of which is heterologous in one base position (underlined) creating a NcoI recognition 
site around the endogenous start codon of the Ucp3 gene. Respective amplicons were digested 
with BglII and NcoI, the resulting fragment spanning the region between -3555 to +3 gel 
purified and cloned into the respective restriction sites of pGL3-basic (Promega). By 
sequencing we identified clones without PCR introduced errors representing the two alleles 
[IVS1+1505G; IVS1+2668A] and [IVS1+1505A; IVS1+2668G] (corresponds to #1 and #2 in 
Figure 2A). 
We next generated constructs representing the two alleles not present in our colony 
[IVS1+1505A; IVS1+2668A] and [IVS1+1505G; IVS1+2668G] (corresponds to #3 and #4 in 
Figure 2A). To do so we cut vectors #1 and #2 into two fragments each with KpnI 
(Fermentas) with both fragments either containing IVS1+1505 or IVS1+2668. These 
fragments were gel purified and ligated crosswise. 
Reporter gene assays 
HIB1B cells were grown in DMEM/F12 (Gibco) containing 10% FCS (Biochrom) until 
confluence. To differentiate the cells we decreased FCS content to 7% and added 17nM 
insulin (Sigma) for approx. 10 days. C2C12 cells were grown in DMEM containing 10% FCS 
until confluence and switched to DMEM with 2% horse serum to induce differentiation. 
Both cell lines were transfected by the nucleofection method (Amaxa) according to the 
manufacturer`s recommendations for the respective cell line. After nucleofection cells were 
incubated for an additional 24 hours with fresh medium. 20µM Rosiglitazone solved in 
ethanol and 10µM Wy14,643 in DMSO were added during this medium change where stated. 
In all measurements without stimulant, medium was supplied with a comparable volume of 
DMSO and ethanol only. Photinus luciferase activity was measured with components of the 
Dual Luciferase Reporter Assay System (Promega). All measurements were replicated at least 
three times independently including nucleofection. 
 
Electrophoretic mobility shift assay 
HIB1B cells on a 10cm culture plate were harvested after full differentiation and 24h 
stimulation with 20µM Rosiglitazone and 10µM Wy14,643 and nuclear protein was isolated; 
complementary oligonucleotides were annealed and labelled as described before [17]. 





For gel retardation assays we incubated 3µg nuclear extract with ~7.5 fmol probe for 20 min 
on ice in a final volume of 2µl containing 4% (v/v) glycerol, 1mM MgCl2, 0.5mM EDTA, 
0.5mM DTT, 50mM NaCl, 10mM Tris/HCl (pH 7.5) and 50µg/ml poly(dIdC)·poly(dIdC). 
Samples were analyzed by electrophoresis in a 5.2% nondenaturing polyacrylamide gel at 4°C 
and 200V for 3 hours in 0.5xTBE. The gel was exposed to a phosphoscreen for 18 hours. 
Western Blot 
Total protein was prepared from skeletal muscle and BAT of control hamsters and protein 
concentrations determined using the Bradford method. 30 µg protein was loaded on a 
SDS-PAGE and transferred to a nitrocellulose membrane (Hybond-C extra, Amersham 
Biosciences) in a semi-dry electroblotting chamber. Successful protein transfer was controlled 
by Ponceau staining of the membrane. Ucp3 protein was detected using a rabbit Ucp3 
antibody (kindly provided by R. Porter, Dublin) in turn bound by a goat anti-rabbit-IgG-
horseradish peroxidase-conjugated secondary antibody (Dako) and developed by a 
chemiluminescence reagent (Supersignal, Pierce). 
Statistical analysis 
We statistically analyzed the body weight development of hamsters with different genotype. 
Raw body mass data were included into a 2-Way Repeated-Measures ANOVA with “sex” (m, 
f) and “genotype” (IVS1+1505: AA, GA, GG) as factors for between-comparisons and “age” 
as within-comparison factor (33 measurements) (Statistika ’99 Edt., StatSoft Inc.). All 
complete individual data sets were included, collected between week 4 and week 36 of age. 
The mRNA expression levels of the Ucp3 gene as measured by qPCR were tested for group 




The hamster Ucp3 gene exhibits two alleles 
To detect possible sequence variations associated with the lack of Ucp3 expression in BAT 
we sequenced 12,721 bp of the P. sungorus Ucp3 gene including all seven exons, all introns 
and 3632 bp of the promoter region. We compared sequences derived from two wildtype with 
two Ucp3 deficient (“mutant”) hamsters. Sequences were identical except for two positions 
within the first intron (Figure 1A). At position IVS1+1505 both wildtype hamsters were 
heterozygous G/A, while both mutant animals were homozygous for allele A. At position 
IVS1+2668 wildtype hamster were heterozygous G/A while mutant animals were 
homozygous for G (Fig. 1 A). 
We developed RFLP assays for both sequence variations IVS1+1505G>A and 
IVS1+2668A>G and genotyped 43 hamsters of our breeding colony. Genotype distribution 
indicated the presence of two haplotypes [IVS1+1505G; IVS1+2668A] and [IVS1+1505A; 
IVS1+2668G]. 
 
A single base exchange is responsible for expression phenotype 
To elucidate whether these two polymorphic sites are responsible for the expression 
phenotype we constructed four different reporter gene vectors all harbouring a minimal Ucp3 
promoter, the first exon, the complete first intron and the untranslated region of the second 
exon. The endogenous ATG was utilized as start codon for the luciferase open reading frame. 
The four vectors represent all possible haplotypes of the two intron 1 polymorphic sites as 
indicated in Figure 2A. 
Nucleofection of these vectors into differentiated HIB1B brown adipocytes revealed allele 
specific reporter gene expression (Figure 2B). Basal activity of vectors #1 and #4 was 10-fold 
higher than of #2 and #3. Induction by PPAR agonists led to a strong increase of expression in 
#1 and #4 but not in #2 and #3. In this condition the two vectors exhibiting IVS1+1505G 
displayed an about 100-fold higher reporter gene activity than vectors with IVS1+1505A. 
Thus both basal activity and induction by PPAR agonists was dependent on the presence of a 
G at position IVS1+1505. 
In differentiated C2C12 myotubes we did not observe differences in basal expression levels of 
the four vectors. Upon stimulation with PPAR agonists however the expression of vectors 
with IVS1+1505G was slightly upregulated, while vectors with IVS1+1505A retained their 




Ucp3 expression is silenced by allele IVS1+1505A in vivo 
We analyzed Ucp3 expression of 2 days cold exposed hamsters at the age of 83±3 days with 
respect to genotypes at positions IVS1+1505 and IVS1+2668. In BAT, Ucp3 mRNA 
expression showed marked differences based on genotypes at respective polymorphic sites 
(Figure 3A). Heterozygous animals had a 30% lower mRNA abundance than homozygous 
IVS1+1505G animals while homozygous IVS1+1505A hamsters were virtually devoid of 
Ucp3 mRNA. In SKM Ucp3 mRNA expression was lowest in homozygous IVS1+1505A and 
significantly different from homozygous +IVS1+1505G animals with an intermediary level in 
heterozygous hamsters.  
The Ucp3 protein level of control animals reflected the mRNA data. There was a clear 
genotype- and tissue-specific difference in expression (Figure 3B). 
 
Mutant allele is naturally occurring  
To determine allele frequencies we cumulated RFLP results from the 43 animals initially 
genotyped and of 90 animals genotyped to establish heterozygous breeding pars. By 
pyrosequencing we genotyped an additional 97 animals randomly chosen from our breeding 
colony totalling 230 hamsters. Of these 105 were homozygous IVS1+1505G, 104 
heterozygous and 21 homozygous IVS1+1505A resulting in an allele frequency of 0,68 for 
IVS1+1505G and 0,32 for IVS1+1505A (Figure 4). The observed genotypes were in Hardy-
Weinberg equilibrium. 
To evaluate the worldwide distribution of IVS1+1505A we collected samples from five 
different breeding colonies of P. sungorus in the US, Canada and Europe (Figure 4), two of 
which were established independently from the Marburg colony. Most Djungarian hamsters in 
research laboratories nowadays can be traced back to K. Hoffmann and J. Figalas colony at 
the Max Planck institute in Andechs, Germany [22]. This is true for our own animals (allele 
frequency IVS1+1505A = 0,37) as well as for the commercial supplier Wrights of Essex (UK) 
where J. Mercer (0,97) and A. Loudon (1,00) obtained their founder animals (personal 
communication and [23]). S. Steinlechner (0,03) and C. Wynne-Edwards (0,23) trapped 
animals in Siberia in the wild and established independent colonies in their laboratories that 
have never been interbred with animals of a different origin (personal communication and 
[24]). In samples of hamsters from both colonies we identified the mutant allele. Since in 
S. Steinlechner’s samples we only found a single heterozygous animal we confirmed our 
____________________________________________________________Chapter 2
42
result by genotyping offspring of this animal and could again identify IVS1+1505A. 
T. Bartness’ hamsters (IVS1+1505A = 0,07) originate from the Hoffmann/Figala line and 
were interbred with animals from S. Steinlechner and C. Wynne-Edwards (personal 
communication). Taken together the allele IVS1+1505A was found in every colony analysed 
including all independently established ones. 
 
Differential complex formation in EMSA 
One potential link between a sequence variation and a defective transcriptional regulation is 
the loss or impairment of a transcription factor binding site. To investigate this possibility we 
performed electrophoretic mobility shift assays with probes representing the polymorphic 
intronic site IVS1+1505 and nuclear extracts isolated from the brown adipocyte cell line 
HIB1B stimulated with Wy14,643 and Rosiglitazone. This cell culture system had proven to 
be a suitable environment to visualize the allele specific expression phenotype in our reporter 
gene assays. On the wildtype probe we observed complex formation that was absent when 
using the mutant oligonucleotide (Figure 5A). 
 
Identification of a forkhead domain binding element in several 
vertebrate species 
The sequence element surrounding IVS1+1505 was identified in the first intron of the Ucp3 
gene in all analyzed vertebrates (Figure 5B). Among these, G at position IVS1+1505 is 
conserved. We derived a consensus sequence from this alignment and analysed it for potential 
transcription factor binding sites. Considering the pattern of conserved bases, a binding site 
for forkhead domain transcription factors is predicted.  
 
G allele at position IVS1+1505 led to an altered body weight 
development 
We kept offspring of heterozygous breeding pairs at room temperature under long day 
condition (16:8 h L:D) with ad libitum access to food and water and monitored body weight. 
At the age of 81±3 days 66 animals were transferred to 4°C ambient temperature for two days, 
sacrificed and organ weights determined. We weighed suprasternal BAT, interscapular BAT, 
inguinal WAT and spleen, none of which displayed a significant difference with respect to 
genotype at IVS1+1505. The same was true for the difference in body mass before and after 
cold exposure (supplemental data). 
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We did, however, find a differential development of body weight (Figure 6). Both male and 
female animals being homozygous IVS1+1505G displayed a lower body mass than carriers of 
IVS1+1505A. Heterozygous hamsters tended to behave in a similar way as hamsters 
homozygous IVS1+1505A. This pattern of genotype specific body weight trajectories was 
very similar in male and in female hamsters. The development of body weight over time was 
significantly influenced by the genotype of the animals (Table 1).  
To allocate this difference we measured body composition of 108 hamsters aged 259 to 289 
days by DEXA, but we did not detect any significant genotype effects on body composition. 
As a measure for body size we determined the lengths of the femur of all animals from these 
X-ray pictures and did not find a significant genotype effect on size (supplemental data). The 
significant difference in body mass trajectories was neither clearly attributable to fat or lean 




In our breeding colony of the Djungarian hamster Phodopus sungorus we identified animals 
exhibiting a hereditable BAT specific lack of Ucp3 mRNA [15]. We were able to pinpoint the 
underlying genetic variation by re-sequencing of the Ucp3 gene in several animals. 
Surprisingly it was located in the first intron far away from all known regulatory elements 
known so far, which are located in the proximal promoter region and further upstream 
[16;17;25]. Differential complex formation in electrophoretic mobility shift assays imply a 
function as binding site for a transcriptional regulator. 
In reporter gene assays as well as in vivo allele IVS1+1505A led to complete loss of 
expression in BAT only, while in skeletal muscle cells only a mild phenotype could be 
observed. Therefore the affected element very probably is a regulator of tissue specific Ucp3 
expression. So far the molecular basis of this tissue specificity has been unknown and 
differences in the activity of known transcription factors like PPARα and δ have been 
implicated [26]. Our findings prove the presence of a distinct intronic regulatory element that 
is responsible and essential for BAT specific expression of Ucp3. Analysis of the conserved 
consensus sequence based on sequence comparison of several vertebrate species revealed a 
binding site for a forkhead domain transcription factor. 
More than 40 members of this transcription factor family are known to date [27] and for many 
of these factors a role in adipose tissue metabolism and other Ucp3 related fields has been 
described [28-31]. On the one hand this corroborates the view of a forkhead factor being 
responsible for BAT specific Ucp3 transcription, on the other hand together with the sheer 
number of family members it prevents a straight forward candidate approach. Furthermore 
most of the forkhead factor family members have not even been investigated in detail so far.  
The presence of Ucp3 in both skeletal muscle and brown adipose tissue has been reported for 
all species analysed in this respect so far including mice [1] and rats [2]. Since hamsters 
carrying the IVS1+1505G allele display this known distribution of Ucp3, we consider 
IVS1+1505A to be the more recently emerged allele. Our screening for IVS1+1505A and 
IVS1+1505G in several international breeding colonies of P. sungorus identified 
IVS1+1505A to be present in all colonies including three independently founded ones. This 
clearly shows that the mutation generating IVS1+1505A did not occur in captivity but in the 
wild. In fact it indicates a rather high allele frequency in the wild population being 
incidentally trapped for three times at different times and places. Without any knowledge 
about the actual allele frequencies in the wild, however, we can merely conclude the lack of 
any dramatic negative consequences of IVS1+1505A regarding overall fitness. 
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Beyond this study the knowledge about the existence of IVS1+1505A and its primary 
expression phenotype may prove valuable to further study the function of Ucp3. So far there 
are Ucp3(-/-) mouse models available and transgenic mice overexpressing the protein [32-35]. 
With the Djungarian hamster we now have access to an animal model with a tissue specific 
lack of expression that can be applied to elucidate the tissue specific protein function. 
Furthermore knowledge about IVS1+1505A will help researchers working with Djungarian 
hamsters to select animals of the appropriate genotype for their respective study. 
The implication of Ucp3 in the regulation of body mass has long been disputed. There are 
several studies that describe an interrelation of polymorphisms within the human UCP3 gene 
and markers of obesity, especially -55(T/C) located in the promoter region [12-14]. The 
proximity of the UCP2 gene has always raised the question whether these effects can 
doubtlessly be ascribed to UCP3 or possibly to additional polymorphisms within linkage 
disequilibrium [14]. In this study we demonstrate that a change in Ucp3 expression can be 
responsible for an altered body weight development. In this respect heterozygous hamsters 
seemed to resemble homozygous IVS1+1505A rather than homozygous IVS1+1505G 
hamsters. This dominant body weight phenotype would imply that small changes of Ucp3 
expression levels could already lead to a full scale impact on body weight development. 
The involvement of Ucp3 in energy balance is substantiated by its transcription being 
correlated to serum fatty acid levels and its presence in tissues with exceptional β-oxidative 
capacities [7]. The absence of a body weight phenotype in Ucp3(-/-) mice [34;35], however, 
questioned the relevance of Ucp3 in this context. Our demonstration of a differential body 
weight development in response to an altered Ucp3 expression reopens this discussion. In fact 
it cannot be ruled out that comparable effects were merely overlooked in Ucp3(-/-) mice. All 
published analyses of body weight development in these animal models utilized far less 
animals and shorter study periods than in this study and would probably not have revealed an 
effect of this size. In contrast to Ucp3(-/-) mice, however, our hamster model lacks Ucp3 
specifically in BAT, whereas skeletal muscle expression is only mildly impaired. 
Nevertheless we cannot decide on the tissue that fundamentally accounts for the body weight 
divergence. While a complete lack of Ucp3 in BAT seems tempting to be held responsible, 
even a small change in skeletal muscle may significantly contribute to this phenotype given 
the huge fraction of body mass and metabolism it represents. In any case it is surely 
worthwhile to comparatively resequence the human UCP3 intron 1 to identify possible SNPs 
in this novel regulatory region. 
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Taken together we have identified an intronic element within the Ucp3 gene that is essential 
for BAT expression of this gene and constitutes a forkhead domain transcription factor 
binding site. A naturally occurring mutation disrupting this element in the homozygous state 
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 Figure legends 
 
Figure 1 – The Ucp3 gene of Phodopus sungorus exhibits two sequence variations. (A) The 
genomic organisation of the seven Ucp3 exons. There are two polymorphic sites at 
IVS1+1505 and IVS1+2668 in the first intron. TSS – transcriptional start site, ATG – start 
codon, Stop – stop codon. (B) Gel images of the restriction fragment length polymorphism 
genotyping method.  
 
Figure 2 – Reporter gene assays revealed the point mutation responsible for the lack of Ucp3 
expression to be at position IVS1+1505. (A) Schematic representation of the four reporter 
gene vector constructs utilized. All four possible haplotypic combinations were tested. (B) 
Luciferase activity is shown relative to the activity of unstimulated construct #1 representing 
the wildtype allele, errors are standard deviation. In HIB1B cells both constructs containing 
IVS1+1505G showed a 10-fold higher basal activity than constructs harbouring IVS1+1505A 
while position IVS1+2668 did not seem to play a role. Stimulated with PPAR agonists this 
difference increased to 100-fold. In C2C12 cells basal activity of all constructs is comparable. 
When stimulated IVS1+1505G constructs increased activity by ~50%, while IVS1+1505A 
constructs did not change expression. 
 
Figure 3 – Ucp3 expression in vivo was silenced by IVS1+1505A. (A) Ucp3 mRNA 
abundance in tissues from cold exposed animals as measured by qPCR relative to 
homozygous IVS1+1505G, errors are standard deviation. In brown adipose tissue (BAT) 
Ucp3 mRNA abundance was significantly different from each other in all three genotypes 
with homozygous IVS1+1505A hamsters being virtually devoid of expression. In skeletal 
muscle (SKM) only homozygous animals differed significantly from each other with an 
intermediate Ucp3 mRNA level in heterozygotes. *** = p<0.001, * = p<0,05, n(BAT) = 53 
(17/26/20), n(SKM) = 46 (15/15/16). (B) Western Blots of protein isolated from tissues of 
animals under control conditions. The above difference in mRNA amounts is reflected on the 
protein level. Homozygous IVS1+1505A hamsters did not show any detectable Ucp3 protein 
in BAT. In skeletal muscle the Ucp3 protein level of these animals is slightly decreased. 
 
Figure 4 – The allele frequencies of IVS1+1505G (white) and IVS1+1505A (black) in six 
international colonies proved the occurrence of both alleles in the natural habitat. The 
colonies Klingenspor, Steinlechner and Wynne-Edwards are completely independent and 
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have never been interbred. Hamsters from Mercer and Loudon can be traced back to the same 
source as our (Klingenspor) hamsters. The Bartness animals are a product of interbreeding 
hamsters from all these lines. 
 
Figure 5 – Differential DNA-protein complex formation occurs on a sequence element 
conserved in vertebrates. (A) Electrophoretic mobility shift assay with a probe harbouring 
IVS1+1505 surrounded by 15bp on both sides incubated with HIB1B nuclear extracts. With 
probe IVS1+1505G (WT) we observed a clear complex formation that was absent with probe 
IVS1+1505A (Mut). (B) Alignment of the responsible intronic element of several vertebrate 
species. The consensus sequence of conserved bases constitutes a forkhead domain 
transcription factor binding site. * = fully conserved position, bold = IVS1+1505, underlined 
= EMSA probe. Hs=Homo sapiens, Pt=Pan troglodytes, Cf=Canis familiaris, Bt=Bos taurus, 
Rn=Rattus norvegicus, Mm=Mus musculus, Md=Monodelphis domestica, Ps=Phodopus 
sungorus. 
 
Figure 6 – Body weight development was dependent on the genotype of hamsters. The body 
weight of hamsters was monitored on a weekly basis beginning with weaning. Shown is the 
mean absolute body weight with standard errors. Wt = homozygous IVS1+1505G, het = 
heterozygous, mut = homozygous IVS1+1505A. 
 
Table 1 – We statistically analysed body weight data by 2-Way Repeated-Measures ANOVA. 
The genotype of an animal significantly influenced the development of body weight with age 
in both sexes. 
 
 
Table 1  
 
Parameter p-value 
Sex < 0.001 
Genotype 0.010 
Age < 0.001 
Sex x Genotype 0.920 
Sex x Age < 0.001 






Supplemental table 1 
On day 81±3 after birth 66 hamsters were transferred to an ambient temperature of 4°C for 
two days and sacrificed. Δ Body mass indicates the change in body mass over these two days. 






sBAT iBAT iWAT Spleen Sex Genotype 
IVS1+1505 
SD SD
F GG 27,3 2 -0,2 41,0 126,7 43,7 614,1 152,9 75,8 52,9
2   
F AA 2 -    
M GG 3   
M AG 3  13 ,1 






upplemental table 2 
e measured body composition of 108 hamsters aged 259 to 289 days by DEXA, but we did 
ot detect any significant genotype effects on body composition. As a measure for body size 
e determined the lengths of the femur of all animals from these X-ray pictures 
.u.=arbitrary units) and did not find a significant genotype effect on size. 
,71 4,63 
97,00 4,50 
F AA 30,32 5,26 19,51 3,32 6,96 2,02 99,25 3,42 
38,02 4,73 24  9, 3 1






g g mg SD mg SD mg SD mg SD 
,9 4,7 119,2




























46,8 130,7 43,3 645,6 79,0 36,0







Body mass Lean mass Fat mass Femur length Sex Genotype 
IVS1+1505 g SD g SD g SD a.u. SD 
F GG 31,04 4,82 19,48 2,41 7,79 2,43 98
F AG 31,69 3,94 19,22 1,98 8,50 2,11 
M GG ,59 3,03 26 2,2 00,60 2,63 
3,20 1,98 4,76 
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Uncoupling protein 3 is located within the mitochondrial inner membrane of brown adipose 
tissue and skeletal muscle. It is thought to be implicated in lipid metabolism and defense 
against reactive oxygen species. We previously reported on a mutation in our breeding colony 
of Djungarian hamsters (Phodopus sungorus), that leads to brown adipose tissue specific lack 
of uncoupling protein 3 expression. In this study we compared wildtype with mutant hamsters 
on a broad genetic background. Hamsters lacking uncoupling protein 3 in brown adipose 
tissue displayed a reduced cold tolerance due to impaired nonshivering thermogenesis. This 
phenotype is associated with a global decrease in expression of metabolic genes but not of 
uncoupling protein 1. These data implicate that uncoupling protein 3 is necessary to sustain 
high metabolic rates in brown adipose tissue. 
Keywords 
Uncoupling protein 3, brown adipose tissue, nonshivering thermogenesis, gene expression, 
cold tolerance 
Introduction 
Uncoupling protein 3 (Ucp3) is a transport protein located within the mitochondrial inner 
membrane. Initially, Ucp3 was discovered and named by its homology (57%) to the well 
known thermogenic uncoupling protein 1 (Ucp1) (Vidalpuig et al., 1997; Boss et al., 1997). 
The hypothesis that Ucp3 constituted another thermogenic protein at first seemed plausible 
(Gong et al., 1997) but it was soon demonstrated that neither Ucp3, nor Ucp2, or any other 
protein, was able to compensate the loss of thermogenic capacity and cold tolerance caused by 
disruption of the Ucp1 gene (Enerbäck et al., 1997). Subsequently, increased expression of 
Ucp3 in response to starvation (Boss et al., 1998) and its transcriptional regulation by 
circulating fatty acid levels (Weigle et al., 1998) was demonstrated, further denying a role of 
Ucp3 in thermogenesis. As a consequence, cold endurance or tolerance has not been tested in 
any of the three lines of Ucp3 knockout mice since they became available (Gong et al., 2000; 
Vidal-Puig et al., 2000; Brand et al., 2002). 
Based upon the regulation of gene expression by serum fatty acid levels and its tissue 
specificity in skeletal muscle and brown adipose tissue (BAT), a role in lipid metabolism has 
been proposed, possibly exporting non-esterified fatty acids from the matrix into the cytosol. 
Proton transport dependent on the presence of Ucp3 may therefore be a secondary effect 
mediated by passive re-entry of protonated fatty acids into the mitochondrial matrix. This 
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mechanism has in fact also been proposed to be a molecular basis for Ucp1 function in 
endothermic vertebrates (Jezek et al., 1998). 
An alternative hypothesis assigns Ucp3 a role as functional uncoupling protein acting as an 
overpressure valve to prevent exceedingly high membrane potentials and thus protecting the 
cell against reactive oxygen species (ROS) formation. Several studies report enhanced Ucp3 
gene expression and activation of Ucp3 function by ROS or  downstream metabolites of lipid 
peroxidation (Echtay et al., 2002; Echtay et al., 2003). 
Very recently, it has been shown that Ucp3 and Ucp2 are essential for Ca2+ uniport into 
mitochondria (Trenker et al., 2007). Until now, this novel finding has not been widely 
discussed in the literature and is inadequate to assess whether this provides the fundamental 
molecular basis for Ucp3 function or represents an accompanying secondary phenomenon. 
We previously identified a mutation in the Djungarian hamster, Phodopus sungorus, that 
leads to BAT specific loss of Ucp3 expression (Liebig et al., 2004)(Fromme et al., submitted). 
Here we demonstrate that lack of Ucp3 expression in BAT of Djungarian hamsters is 
associated with impaired thermogenic capacity and results in lower cold tolerance in-vivo. 
The metabolic phenotype of the BAT-Ucp3 deficient hamster is associated with reduced gene 
expression of key metabolic enzymes in this tissue. These combined results support a role for 
Ucp3 in sustaining high metabolic flux and, hence, maximal nonshivering thermogenesis in 
BAT. 
 
Materials and Methods 
Animals 
Mutant Djungarian hamsters (Phodopus sungorus) and WT controls were derived from 
heterozygous breeding pairs in our colony and genotyped by AarI restriction fragment length 
polymorphism analysis (Fromme et al., submitted). Individuals were housed in single cages at 
an ambient temperature of 23°C, and a long day photoperiod of 16h light: 8h dark. Hamsters 
had ad libitum access to food and water unless stated otherwise. 
 
In vivo measurements 
In order to monitor core body temperature, hamsters at the age of 12 months were 
intraperitoneally implanted with minimitters (Mini Mitter Company Inc.). For surgery, 
hamsters were anesthetized with isoflurane (1-4Vol%) and an intraperitoneal injection of 
Ketamine (50 mg/kg) and Rompun (2%). Implanted hamsters were allowed to recover for at 
least two weeks before cold tolerance was measured. 
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For the metabolic measurements, genotypes of hamsters were blinded to the experimenter. 
Cold tolerance was determined by combined telemetry and indirect calorimetry. The principal 
setup of the open respirometric system has been reported previously (Heldmaier and Ruf, 
1992). In short, single hamsters were placed in a cuvette (1.8 l) inside a chamber which 
allowed for control of ambient temperatures (Ta) in a range of +30 to -40°C (±0.5°C). A 
second empty cuvette served as a reference control. Extracted air from the hamster cuvette 
(flow: 40 l/h) was dried and analyzed every 2 minutes for volumes of O2 (S3A, Ametek) and 
CO2 (Unor 6N, Maihak). Oxygen consumption (VO2 [ml*h-1]) was calculated as described 
(Heldmaier and Ruf, 1992). Respiratory quotient (RQ) was calculated by dividing volumes of 
CO2 produced by volumes of O2 consumed. 
At 8:00 CET a hamster was placed in the respirometry system at 26°C (thermoneutral, 
(Heldmaier and Steinlechner, 1981)) for 2 to 3 hours. Ambient temperature was then 
decreased stepwise (20°C, 10°C, 0°C, -10°C, -20°C, -30°C). Each ambient temperature was 
sustained for about 45 minutes and corresponding resting metabolic rates (RMRs) were 
determined by calculating the mean of four consecutive resting VO2 readings with the lowest 
variance (equivalent to 8 min). Measurements took on average 8 hours during which a 
hamster had no access to food or water. Throughout the entire experiment, body temperature 
was monitored. For each RMR, conductance could be calculated from heat production 
(HP=(4.44+1.43*RQ)*VO2) (Heldmaier, 1974) divided by heat loss (Tb-Ta). A hamster was 
rescued from the chamber if its body temperature dropped below 34°C despite an increase or 
plateau in metabolic rate. For calculation of individual cold limit, metabolic rates at each 
temperature level were plotted against ambient temperature, and the cold limit was 
determined by calculating the point of intersection of highest VO2 measured VO2max and the 
regression of VO2 with ambient temperature (Heldmaier et al., 1982).  
In small mammals such as hamsters, injection of norepinephrine (NE, Hoechst) can induce the 
maximal nonshivering thermogenic response normally induced by cold and can therefore be 
used to determine NST capacity (Böckler et al., 1982). 1-2 weeks after the cold limit test the 
individual thermogenic response to a subcutaneous injection of NE (0.7mg/kg) was measured, 
using the technical setup described above. Measurements were performed at an ambient 
temperature of 18°C to prevent the hamsters from developing hyperthermia (Böckler et al., 
1982). Maximal NE-induced thermogenesis was determined from the highest mean of three 
consecutive VO2 readings following injection. Because body mass of hamsters had not 
changed between the two sets of metabolic experiments, individual NST capacity could be 
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calculated from subtracting RMR measured at 26°C (= basal metabolic rate, BMR) in the cold 
limit test and VO2max induced by NE injection. 
2-way repeated measurement ANOVA (genotype x ambient temperature) was used to detect 
differences in VO2, RQ, conductance and Tb. 
All experimental procedures were approved by the German Animal Welfare authorities. 
 
Gene expression analysis 
In a seperate experiment eight wildtype and eight mutant hamsters were exposed to cold (5°C) 
for two days at the age of 81 days. They were anesthetized and killed with CO2 and 
suprasternal brown adipose tissue was dissected and frozen in liquid nitrogen. RNA was 
isolated with TRIzol (Invitrogen) and quantified photometrically. RNA was reverse 
transcribed with a poly-dT-primer and the Superscript III First Strand Synthesis Kit 
(Invitrogen). We used Platinum SYBR Green qPCR SuperMix UDG (Invitrogen) 
supplemented with 20nM Fluorescein (Biorad) to quantify transcript levels by qPCR on an 
iCycler (Biorad). The efficiency of amplification was calculated based on dilution series 
standard curves by the Biorad iCycler IQ3.0 software and used to determine starting quantity 
levels (PCR base line subtracted). Normalization was performed according to Vandesompele 
et al. (2002) using ß-Actin, TATA-box binding protein (TBP) and heat shock protein 90 
(HSP90) as housekeeping genes (Vandesompele et al., 2002). Briefly, the reliability (i.e. 
stability of expression levels) of these transcripts was verified by variance analyses. The 
geometric mean of all three housekeeping genes was then used for normalization of starting 
quantities in each individual sample. All primers are listed in Table 1. 
We performed two-sided t-tests to investigate differences statistically. 
 
Immunological detection of Ucp1 and Ucp3 
Crude protein homogenates were prepared from suprasternal BAT of hamsters of both 
genotypes and protein concentrations were determined using the Bradford method. 15µg of 
protein were loaded to each lane of an SDS-PAGE and transferred to a nitrocellulose 
membrane (Hybond-C extra, Amersham Biosciences) by semi-dry electroblotting. Protein 
transfer was controlled by Ponceau staining of the membrane. Ucp3 was detected using a 
polyclonal rabbit antibody (1:7,000) raised against a synthetic peptide as described previously 
(Liebig et al., 2004), whereas a rabbit anti-hamster- Ucp1 serum (1:10,000) served for the 
detection of Ucp1. Both antibodies were in turn detected by chemoluminescence (Supersignal, 
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Pierce) using a horseradish peroxidase-conjugated goat-anti rabbit secondary antibody 
(Dako). 
Results 
Mutants exhibit a lower cold tolerance 
Homozygous wildtype and mutant hamsters (n = 6 each) of comparable average body weight 
(mean WT: 31.9±5.3g (standard deviation, SD), mean mutant: 32.9±2.1g) were implanted 
with temperature sensitive transmitters. Core body temperature was registered for 8 
successive days and neither the average body temperature (Tb WT: 36.0°C±0.19 (SD), 
Tb mutant: 36.1±0.24) nor the daily body temperature pattern (not shown) were different 
between genotypes. 
We then subjected these hamsters to a defined series of decreasing ambient temperatures (Ta) 
in a climate chamber while simultaneously measuring oxygen consumption (VO2), CO2 
production and core body temperature (Tb) (Figure 1). With decreasing Ta, VO2 increased 
linearly and both groups defended a body temperature in the range of 35.0°C to 36.5°C. 
Numerically, mean RMRs of mutant hamsters were always higher than mean RMRs of WT 
hamsters but except for Ta=-10°C there were no significant differences. The respiratory 
quotient, and hence substrate usage, was not different between groups at any time point. 
Conductance displayed a consistent trend towards higher values in mutants, but this difference 
did not reach significance at any temperature level. 
More strikingly, five of the six wildtype animals were able to sustain their body temperature 
above 34°C at an ambient temperature of -30°C for >30 min, i.e. long enough to measure 
RMR at this ambient temperature. In contrast, five out of six mutant animals were not able to 
maintain a stable body temperature at -30°C and had to be rescued from the cold. In 
accordance with this observation we found the calculated cold tolerance limits to be 
significantly different from each other (Figure 2). Wildtype animals were able to withstand an 
average temperature of -32.8°C while mutants displayed a cold tolerance limit of -27.4°C 
(p<0.05). 
Nonshivering thermogenesis is impaired in mutants 
In response to severe cold small mammals employ both shivering and nonshivering 
thermogenic (NST) mechanisms. To identify whether NST is impaired in mutant hamsters, 
we injected hamsters with NE and measured the resulting increase in oxygen consumption to 
calculate NST capacity. When expressed as means, neither VO2max (data from cold tolerance 
measurement) nor NST capacity was different between mutant and wildtype hamsters 
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(VO2max WT: 323.4±44.1 ml O2 h-1(SD), mutant: 313.1±10.9 ml O2 h-1; NST capacity WT: 
154.5±29.1 ml O2 h-1, mutant: 135.5±12.0 ml O2 h-1). Since metabolic rates are highly 
dependent on body mass, we also analyzed the regression of metabolic parameters plotted 
against body mass (Figure 3). Individual datapoints of mutant RMRs at thermoneutrality 
(BMR) and VO2max fell within the wildtype regression. In contrast, NST capacity of mutant 
hamsters was lower than expected from the wildtype regression, indicative of a brown fat 
specific thermogenic abnormality. 
Overall metabolic gene expression but not Ucp1 expression, is 
decreased in mutant BAT 
To elucidate the molecular basis of the decreased brown fat thermogenic capacity we 
analyzed BAT mRNA expression levels of key metabolic genes representing major pathways, 
including fatty acid oxidation and synthesis, citrate cycle, and glycolysis by qPCR (Figure 5). 
We exposed the hamsters to cold to compare the in vivo cold response to molecular processes 
during cold adaptation. 
Ucp3 served as a control and was absent from BAT as reported previously (Liebig et al., 
2004). Notably, Ucp2 displayed a threefold increase in mRNA levels in mutant BAT in a 
possibly compensatory manner, while mRNA levels of the thermogenic Ucp1 remained 
unchanged. This observation was confirmed on the protein level by performing western blot 
experiments (Figure 4). 
Five genes involved in lipid mobilization and oxidation were analyzed (Figure 5B). On the 
mRNA level two of them were significantly downregulated in BAT of mutant animals 
(β-oxidation enzymes trifunctional protein (Tp) and enoyl-CoA-hydratase (Echs1)) while we 
observed the same trend for adipose triglyceride lipase (Atgl) and dodecenoyl-CoA-delta-
isomerase (Dci). The hydroxyacyl-CoA-dehydrogenase mRNA (Hadh) level was not different 
between mutant and wildtype BAT. 
Analyzing the converse process of fatty acid synthesis, we again found the mRNA levels of 
two genes to be down regulated in mutants, namely ATP citrate lyase (Acly) and Acetyl-CoA-
carboxylase α (Acaca), with a similar trend for Acetyl-CoA-carboxylase β (Acacb) 
(Figure 5C). 
Apart from lipid metabolism, we found a differential expression pattern of genes involved in 
glucose metabolism, citrate cycle, and ketone body utilization. All eight genes analyzed 
displayed the same trend towards reduced mRNA levels in BAT of mutant hamsters with a 
significant difference in 3-oxoacid-CoA-tranferase (Oxct) and glucose transporter 4 (Glut4) 
mRNA expression (Figure 5D-F). 
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Taken together, we quantified mRNA levels of 16 genes involved in energy metabolism and 
found 15 genes to be down regulated significantly or in trend in BAT of hamsters lacking 
Ucp3 in this tissue. These genes include the central steps of key cellular metabolic pathways. 
When all wildtype and mutant data sets of these 16 metabolic genes are pooled, there is a 
highly significant difference in overall BAT expression of metabolic genes (p<0,00001). 
To investigate whether the expression of transcription factors known to globally regulate 
energy metabolism genes may account for the observed expression pattern, we determined 
mRNA levels of Errα and Pparδ (data not shown). The mRNA levels of both transcription 
factors were not differentially expressed in wildtype and mutant BAT. 
 
Discussion 
The exceptional thermogenic capacity of the Djungarian hamster is well characterized. 
Winter-acclimated Djungarian hamsters can defend normothermia at ambient temperature as 
low as -68°C, predominantly by employing nonshivering thermogenesis (NST) in brown 
adipose tissue (BAT) (Heldmaier et al., 1982; Heldmaier et al., 1983). In order to unravel the 
full thermogenic in vivo capacity of hamsters specifically lacking Ucp3 in BAT, we subjected 
them to stepwise decreasing ambient temperatures to as low as -30°C. In both mutants and 
wildtypes, VO2 increased linearly during this process, in line with the Scholander model of 
thermoregulation (Scholander et al., 1950). However, mean VO2 values of mutant hamsters 
tended to be higher at all temperature steps (with a striking difference at -10°C that we are 
unable to fully explain) and we observed the same trend for conductance. This suggests that 
mutant hamsters have an increased heat loss. In order to maintain a stable body temperature 
they have to display a higher metabolic rate. On the other hand, cold tolerance was 
significantly lower in mutants compared to wildtype hamsters. The combined results allow the 
conclusion that lack of Ucp3 leads to lowered or more inefficient thermogenic capacity. In 
line with a model of impaired BAT function NST capacity was lower in mutant animals. In an 
earlier study we did not observe a similar trend, but at that timepoint the point mutation 
causing the mutant phenotype had not yet been identified (Liebig et al., 2004). Therefore, we 
were not able to distinguish between wildtype and heterozygous animals as both express Ucp3 
protein. Furthermore, the previous study was conducted in an inbred mutant line prone to 
founder effects and not based on a broad genetic background. 
If lack of Ucp3 causes an impaired BAT function there are three different principal 
explanations possible. Firstly, Ucp3 itself may be a thermogenic protein comparable to its 
relative Ucp1. Secondly, it could be a necessary constituent of the machinery delivering 
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energy to primary thermogenic mechanisms or, thirdly, lack of Ucp3 may lead to 
downregulation of Ucp1 expression by unknown mechanisms. To discriminate between these 
possibilities we analyzed BAT mRNA expression of uncoupling proteins and a set of energy 
metabolism genes. 
Ucp1 expression was not affected in mutant hamsters neither on mRNA nor on protein level. 
Ucp2 displayed a threefold increase in mRNA abundancy in the absence of Ucp3. Owing to 
the lack of an antibody against Ucp2 that reliably works in our hands, we were not able to 
verify increased Ucp2 protein levels. An increased mRNA abundancy does not necessarily 
reflect changes in protein levels since Ucp2 is decisively regulated on the level of translation 
(Hurtaud et al., 2006). Nevertheless, the apparent compensatory response implicates a 
common function of Ucp2 und Ucp3, e.g. in mitochondrial calcium uniport as recently 
suggested (Trenker et al., 2007). An increased compensatory Ucp2 expression might 
contribute to the rather small effect size we observe both in in vivo measurements and in gene 
expression studies. 
Strikingly, 15 out of 16 genes involved in energy metabolism displayed at least a trend 
towards lower mRNA levels in BAT of mutant hamsters. Among the genes most strongly 
regulated differentially were the central components of fatty acid synthesis (Acaca) and 
β-oxidation (Tp) but also pathways of alternative energy sources like ketone bodies (Oxct) or 
glucose (Glut4) were affected. These effects in response to lack of Ucp3 can only be 
accounted for by a remarkable global decrease in BAT energetic capacity. 
We also measured mRNA levels of the two transcription factors Errα and Pparδ. Both have 
been described as master regulators of energy metabolism pathways (Mootha et al., 2004; 
Luquet et al., 2004) and were therefore candidates to play a role in the observed differential 
gene expression pattern. However, there was no difference in expression, at least on the 
mRNA level. 
Summarizing our gene expression studies, we observed an overall decrease in mRNA 
expression of energy metabolism genes as a consequence of Ucp3 absence while Ucp1 
expression remained unchanged. These data strongly suggest Ucp3 not being itself a priori 
thermogenic but being a constituent of energy metabolism pathways necessary to tolerate 
situations of high energy flux. Molecular data on gene expression in response to cold and in 
vivo cold tolerance limits and NST capacity both agree with this model. In view of this 




Taken together, we compared wildtype hamsters with mutants lacking Ucp3 in BAT. Mutants 
displayed a reduced cold tolerance limit and a lower NST capacity, indicating defective BAT 
thermogenesis. This defect could not be attributed to Ucp1 protein levels, but to an overall 
decrease in expression of genes related to energy metabolism. These data implicates that 
Ucp3 is necessary to sustain high metabolic rates in BAT. 
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Figure 1 – Djungarian hamsters were subjected to stepwise decreasing ambient temperatures 
and oxygen consumption (VO2), CO2 production and body temperature were measured. We 
calculated the respiratory quotient and conductance for each temperature step. Animals with a 
lack of Ucp3 in BAT displayed a significantly different VO2 and Tb at -10°C only. We were 
unable to determine resting metabolic rates at -30° for 5 out of 6 mutant animals owing to 
incipient hypothermia, while 5 out 6 wildtype hamsters were able to sustain at -30°. Shown 
are mean values with standard deviations (WT = ■, mutant = □; n = 6 per genotype). 
* = p<0.05. 
 
Figure 2 – Djungarian hamsters with a lack of Ucp3 in BAT are less cold tolerant than 
wildtypes (-32.8 versus -27.4°C). Shown are individual cold tolerance limits and mean values 
with standard deviations (n = 6 per genotype, 3 males (■/□) and 3 females (▲/Δ) each). 
* = p<0.05. 
 
Figure 3 – NST capacity, but not VO2max or BMR is lower than expected from body mass in 
Djungarian hamsters lacking Ucp3 in BAT. Shown are individual values for each parameter 
plotted against body mass. In each plot, the dotted line indicates the WT regression (WT = 
black symbols, mutant = open symbols, n = 6 per genotype, 3 males (■/□) and 3 females 
(▲/Δ) each). 
 
Figure 4 – Immunological detection of Ucp1 and Ucp3 in BAT of WT and mutant 
Djungarian hamsters. While Ucp3 is clearly absent in BAT of mutants, UCP1 expression is 
comparable between genotypes. 
 
Figure 5 – The mRNA adundance of uncoupling proteins and genes implicated in energy 
metabolism was determined in brown adipose tissue by qPCR. Shown is mRNA abundance 
relative to the mean of wildtypes, dots are individual and bars mean values. A – Uncoupling 
proteins. B – Fatty acid oxidation and mobilization. C – Fatty acid synthesis. D – Glucose 
utilization. E – Citric acid cycle. F – Ketone body utilization. WT = ■, mutant = □; n = 8 per 
genotype. Significance levels of two-sided t-tests: * = p<0.05, ** = p<0.001. A list of 
p-values is provided in Table 1. 
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Table 1 – All primers used for qPCR analyses and reference sequence of the respective 
product. The given p-value is result of two-sided t-tests comparing expression levels of 
mutant versus WT hamsters as shown in Figure 5 (bold = p<0,05). 
 
Gene Primer 1 Primer 2 p-value Genbank 
Acac TTTTCGATGTCCTCCCAAAC ACATTCTGTTTAGCGTGGGG 0,007 EU107793 
Acac GATGCGCAACTTTGACTTGA CTGCAGGTACTCGAAGGAGG 0,174 EU107794 
Acly GAAGCTGACCTTGCTGAACC AGGTCTGTTGTTCACTGGGG 0,023 EU107795 
Atgl ACAGTGTCCCCATTCTCAGG CTGTTTGCACATCTCTCGGA 0,157 EU118752 
Aktb AGAGGGAAATCGTGCGTGAC CAATAGTGATGACCTGGCCG - EU107796 
Cs CTGAGGAAGACTGACCCTCG TTCATCTCCGTCATGCCATA 0,715 EU107797 
Dci GGAGATGTATGGCCGGAAC AGCAGGCTCTCATTCAATCC 0,222 EU107798 
Echs1 GAGAAAGCCCAGTTTGGACA TTCAAAGGCTGCATTCACAG 0,028 EU107799 
Erra GTCCTAGATGAAGAGGGGGC GCACAGAGTCAGAATTGGCA 0,614 EU107800 
Glut1 GACGACACTGAGCAGCAGAG GCTGTGCTTATGGGCTTCTC 0,076 EU107802 
Glut4 TCATTCTTGGACGGTTCCTC GACAGAAGGGCAGCAGAATC 0,040 EU107803 
Hadh CCACCAGACAAGACCGATTT CGGTTCACGATAAATCCAGG 0,661 EU107804 
Hexk GTGGCTGTGGTGAATGACAC ACATCCCGCTGATCATCTTC 0,054 EU107805 
Hsp9 AGGAGGGTCAAGGAAGTGGT TTTTTCTTGTCTTTGCCGCT - EU107806 
Idh3a AGTGCTGTGATGATGCTTCG GACTGACTGCAGCAAATCCA 0,096 EU107807 
Oxct AAGATTTATGTGCACCGCCT GTTAGCGTACATGCCGTCCT 0,004 EU107808 
Pdhb GTGTAGCTGCTCAGCACTCG ACTGGTCTTGAATGGGCAAC 0,054 EU107810 
Ppard TGGAGCTCGATGACAGTGAC GTACTGGCTGTCAGGGTGGT 0,761 EU107812 
Pkm AGATGCAAACACCATGTCCA CTGCAGGTGAAGGAGAAAGG 0,253 EU107811 
Tbp ACTTCACATCACAGCTCCCC CTTCGTGCAAGAAATGCTGA - EU107792 
Tp ATGGTCTCCAAGGGCTTCTT GATCCCTTCCTGTAGGCACA 0,003 EU118753 
Ucp1 GAAGGGTTGCCGAAACTGTA TGTAGGTGGCTCTGTGCTTG 0,400 AF271263 
Ucp2 TGCAGGTCCAAGGAGAGAGT GCTCTGAGCCCTTGGTGTAG <0,001 AF271264 
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Brown adipose tissue expressing uncoupling protein 1 (UCP1) is responsible for adaptive 
nonshivering thermogenesis giving eutherian mammals crucial advantage to survive the cold. 
The emergence of this thermogenic organ during mammalian evolution remained unknown as 
the identification of UCP1 in marsupials failed so far. Here, we unequivocally identify the 
marsupial UCP1 orthologue in a genomic library of Monodelphis domestica. In South American 
and Australian marsupials, UCP1 is exclusively expressed in distinct adipose tissue sites and 
appears to be recruited by cold exposure in the smallest species under investigation (Sminthopsis 
crassicaudata). Our data suggest that an archetypal brown adipose tissue was present at least 150 
million years ago allowing early mammals to produce endogenous heat in the cold, without 







The evolution of brown adipose tissue (BAT) and its thermogenic uncoupling protein 1 (UCP1) 
is of major interest in the understanding of successful mammalian radiation. Adaptive 
nonshivering thermogenesis generated in BAT enables small eutherian mammals to maintain 
high body temperature independent of daily and seasonal temperature fluctuations (6). Although 
brown adipose tissue was first described in 1551 (14), its thermogenic role was not recognized 
until the 1960s (8; 44) and it is now established that BAT contributes significantly to adaptive 
nonshivering thermogenesis of rodents, hibernators and newborns (6). During cold exposure, 
sympathetic noradrenaline release activates BAT by stimulation of lipolysis and futile UCP1-
dependent mitochondrial respiration, and recruitment of oxidative capacity.  UCP1, a 
mitochondrial carrier protein, is located in the inner membrane of BAT mitochondria and 
provides the molecular basis for nonshivering thermogenesis (32). The protein increases proton 
conductance and uncouples oxidative phosphorylation from ATP synthesis by dissipating proton 
motive force as heat. All eutherian species investigated so far possess UCP1, with the exception 
of pigs where a naturally disrupted UCP1 gene results in poor thermoregulation and sensitivity 
to cold exposure (3). The observation that UCP1-knockout mice are unable to defend their body 
temperature when exposed to the cold (15) confirms that UCP1 is crucial for adaptive 
nonshivering thermogenesis. In contrast to previous expectations, an ancient UCP1 orthologue 
was identified in the ectothermic teleost fish but it is not expressed in adipose tissue and the 
physiological function might be other than heat production (25). 
Marsupials are proficient thermoregulators and are capable of defending a stable body 
temperature during cold exposure (9; 13; 42). Evidence for nonshivering thermogenesis is a 
matter of debate in marsupial mammals, which separated from eutherians about 150 million 
years ago (4). In macropods the injection of noradrenaline led to an increase in thermogenesis 
(31; 33), a response attributed to skeletal muscle and not to BAT as found for eutherians (34; 
48). It was suggested that adaptive nonshivering thermogenesis may be of major importance in 
Australian dasyurids as they belong to the smallest marsupials. Indeed, a thermogenic response 
to noradrenaline has been observed in Sminthopsis crassicaudata acclimated at 24°C (7). No 
thermogenic response to noradrenaline, however, was observed in Antechinus stuartii (37), nor 
in South American marsupials (10; 36). Despite evidence for nonshivering thermogenesis in 
some marsupials, no study has demonstrated the molecular basis nor the presence of adaptive 
nonshivering thermogenesis in response to cold.  
Nonshivering thermogenesis is usually associated with BAT but the presence of this specialised 




multilocular fat droplets and vascularisation in the interscapular adipose tissue of Benett’s 
wallaby pouch young (Macropus rufogriseus rufogriseus) (31). Another study investigating 38 
different marsupial and one monotreme species precluded the presence of BAT in marsupials 
(16), by pointing out that morphological features for BAT also occurred in white adipose tissue 
during cold stress (29; 30). Reliance on morphological features only has misled to the erroneous 
conclusion that birds possess BAT (35). 
The discovery of UCP1 (17; 38) and the cloning of the cDNA sequence in rodents (2; 5) has 
stimulated work to identify UCP1 and its genomic presence in marsupials. Weak UCP1-like 
immunoreactivity has been seen in the interscapular fat deposit of S. crassicaudata (19), 
however, it is generally accepted that UCP1 antibodies cross-react with other mitochondrial 
carriers (39) or UCP2/3, both of which have been recently identified in marsupials (24). Previous 
studies suggested that UCP2/3 do not compensate for the lack of nonshivering thermogenesis 
mediated by UCP1, suggesting physiological roles other than heat production (15; 24). 
Unequivocal detection of marsupial UCP1 requires genomic or gene transcript sequence data. 
However, several attempts to identify the UCP1 sequence have failed so far (24; 27; 28; 41). In 
this study we searched for the presence of BAT and UCP1 in one South American (M. 
domestica) and two Australian marsupial species (S. crassicaudata and  A. flavipes). Our 
approach was to search the genomic trace archives for UCP-like sequence fragments of M. 





Materials and Methods 
Isolation of genomic DNA of M. domestica and polymerase chain reactions  
DNA was isolated from a tail tip of a female adult M. domestica using a standard phenol-
chloroform extraction protocol as described previously (24). Following extraction, fifty 
nanograms of photometrically quantified DNA was used in subsequent PCR. 
In order to define specific primers, we initially searched the M. domestica whole genome 
shotgun data provided by the National Centre for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov/Traces/trace.fcgi) for UCP-like sequence fragments using a 
consensus UCP1 coding sequence deduced from available eutherian sequences. The fragments 
were assembled according to the intron-exon structure of mouse Ucp1. Using the obtained trace 
alignments for primer definition, primers were generated (MWG Biotech, Ebersberg, Germany) 
to amplify a UCP1-like fragment (“forEx3”: 5'-AGTGGCACAGCCTACAGATGT-3'; 
“revEx4”: 5'-CTTGGAACGTCATC ATGTTTG-3').  
A second primer pair was deduced from M. domestica fragments displaying high identity to 
UCP2 (“forUCP2”: 5'-GCCTACAAGACTATTGCCCGAGAGGAG-3'; “revUCP2”: 5'-
AAGCGGAGAAAGGAAGGCATGAACCC-3'). 
Following 40 cycles of denaturation at 94°C for 1 min, annealing at 54°C (or  58°C for UCP2) 
for 1 min, and extension at 72°C  for 1 min (2 min for UCP2) were performed. A final extension 
at 72°C was applied for 10 min and followed by rapid cooling to 4°C. The PCR product was gel-
purified and ligated into a pGEMT-easy vector (Promega) for sequencing. Nested 
oligonucleotides were used for the screening of a genomic M. domestica BAC library.  
 
Sequence analysis of opossum BAC clones 
High density arrayed grids of the genomic opossum (Monodelphis domestica) BAC library 
VMRC-6 (Virginia Mason Research Center, distributed by BACPAC Resources, Oakland, CA; 
http://bacpac.chori.org) were screened by hybridization with radioactively end-labeled (T4-
Polynucleotidekinase, Roche) oligonucleotides (11): 
The M. domestica UCP1 specific primers were: md1.F 5'-GGGACTTTCCATGCCTACAA-
3', md2.R 5'-CAATAGCATTTCTTGCCACG-3', md3.F 5'-
AATAGCATCCGCAGAAGGAA-3', md4.R 5'-CGTCCCTGGAAAGAGGAAAT-3' and 
the M. domestica UCP2 specific primers were: md5.F 5'-CTCTTGCAGGTGGCATCC-3', 
md6.R 5'-GACATTGGGCGAAGTTCCT-3' (mdUCP2 specific). 
The identified BACs were verified by PCR using the probe oligos as primers. BACs VMRC6-




Acc.no. AC171737, containing md1UCP2 and mdUCP3) were sequenced by a combination of 
shotgun and directed approaches (46). Base calling and assembly were performed by 
Phred/Phrap. Finishing was performed in accordance to the Human Genome Project standards 
(http://genomeold.wustl.edu/Overview/g16stand.php) with the support of external Monodelphis 
domestica whole genome shotgun data (http://www.ncbi.nlm.nih.gov/Traces/trace.fcgi). 
 
Phylogenetic inference 
The coding and amino acid sequences of M. domestica UCP1, UCP2 and UCP3 were deduced 
from the corresponding genes. A comprehensive search for UCP sequences was performed in 
public databases (Ensembl genome browser, www.ensemb.org/ NCBI, www.ncbi.nlm.nih.gov) 
by employing the Blast algorithm (1). An alignment of the UCP amino acid sequences was 
generated using ClustalX 1.81 (ftp://ftp-igbmc.u-strasbg.fr/pub/ClustalX) and adjusted by eye. 
Bayesian phylogenetic analyses was performed employing MrBayes 3.1.2 
(http://mrbayes.csit.fsu.edu/) (40). The WAG model of amino acid substitution (47) with gamma 
distribution of rates was applied. Substitution rates were allowed to change across the tree under 
the covarion model (20). Prior probabilities for all trees were equal, starting trees were random. 
Two analyses were run in parallel for 1,000,000 generations. Trees were sampled every 100th 
generation and posterior probabilities were estimated on the final 3,000 trees (burnin = 7,000). 
The tree was visualized using Treeview (http://taxonomy.zoology.gla.ac.uk/rod/treeview). The 
branch lengths are mean branch lengths of the consensus tree representing substitution rates. 
 
Animal Care and Experimental Protocol 
The gray short-tailed opossums (M. domestica) were kindly donated by P. Giere and U. Zeller 
(Museum für Naturkunde, Humboldt-Universität zu Berlin, Germany). The opossums were held 
individually in the animal facility at the Philipps-Universität Marburg on a 12-hour/12-hour 
light/dark cycle (12:12 L:D) at an ambient temperature (Ta) of 24 °C ± 2 °C given water and fed 
cat food, curd mixed with fruit, and insects ad libitum. For cold acclimation experiments, two 
individuals were transferred into a separate chamber maintained at 12°C for 14 days.  
Seven yellow-footed Antechinus (A. flavipes) were captured with Elliott traps in several 
subtropical habitats in Southeast Queensland (Australia) between January and March 2005. 
Fourteen fat-tailed dunnarts (S. crassicaudata) were obtained from a breeding colony at La 
Trobe University, Melbourne. Both species were housed individually in the animal facility of the 
University of Southern Queensland (12:12 L:D, lights on at 0700h) at an ambient temperature 
(Ta) of 24 °C ± 2 °C. To investigate the effect of cold acclimation, seven S. crassicaudata and 




the other individuals remained at 24°C. Animals were given water and fed mealworms and cat 
food mix including calcium carbonate and vitamins ad libitum. 
For COX activity assays, ten S. crassicaudata used were acclimated to 14 and 28°C at the 
University of Adelaide animal holding facilities in November 1990. 
Experimental protocols for the use of Australian marsupials were approved by the Animal Ethics 
Committee of the University of Southern Queensland, Queensland Environmental Protection 
Agency (permit number WISP02633304) and Environment Australia (export number WT2005-
12380). Animal experiments involving M. domestica were performed in accordance with the 
German Animal Welfare Laws. 
 
Tissue dissection 
Two 22 and 25 days old M. domestica embryos were euthanased and immediately frozen on dry 
ice and stored at –70°C prior to cryosectioning. All other individuals of M. domestica, S. 
crassicaudata and A. flavipes were euthanased (carbon dioxide) and tissues were dissected. The 
samples were immediately snap frozen in liquid nitrogen. Frozen tissue samples were stored at –
70°C until use. Liver, skeletal muscle and adipose tissue of S. crassicaudata and A. flavipes were 
shipped from Australia in liquid nitrogen to Marburg, Germany. 
  
In situ hybridisation of M. domestica embryos  
Sagittal body sections (20 μm) were processed using a cryosectioning microtome (Leica CM 
3050) and were transferred to precooled object slides. A riboprobe complementary to M. 
domestica UCP1 (225 bp; primers forEx3, revEx4) and UCP2 (350 bp; forUCP2, revUCP2) was 
generated from a linearised cloned cDNA. Radioactive riboprobes using [35S]-UTP (1-2 x 107 
cpm ml-1), pre- and posthybridisation procedures were performed as described previously 
(Jastroch et al. 2007). Controls were performed by hybridising sections with equal length sense 
riboprobes of UCP1 and UCP2. 
 
RNA isolation and reverse transcriptase - polymerase chain reaction 
Total RNA was isolated with TRIzol (GIBCO-BRL) according to the manufacturer’s protocol. 
As an additional step, the RNA pellet was redissolved in a solution containing 6.3 mol L-1 
guanidinium thiocyanate, 40 mmol L-1 sodium citrate pH 7, 0.8% sarcosyl, 8 mmol L-1 2-
mercaptoethanol, precipitated with 1 volume isopropanol, washed in 75% ethanol, and finally 
dissolved in DEPC-treated water. Total RNA was photometrically quantified at 260 nm and 
stored at –70°C. The isolated RNA was used for first strand cDNA synthesis (SUPERSCRIPT II, 




M. domestica UCP1 primers   5'-AGGTGAAGCCCAGACCATGGAT-3' 
5'-GGCTGACACAAAGTGGCAAGGT-3' 
comprising 6.7 kb of the UCP1 gene and resulting in 550 bp cDNA sequence,  were subjected to 
polymerase chain reaction with cDNAs of selected tissues. 40 cycles of 94°C (1 min), 59°C (1 
min) and 72°C (1 min) were performed and terminated by a 10 min extension at 72°C. The PCR 
products were gel-purified and ligated into a pJET vector (Fermentas). The full coding sequence 
of S. crassicaudatastica UCP1 including 5'- and 3'-UTR was amplified using the smart RACE 
cDNA amplification kit (Clontech) combined with gene specific primers deduced from M. 
domestica 
  UCP1 3'-UTR: 5'-CTACAGATGTGGTGAAAGTCAGAC-3' 
   5'-UTR: 5'-GGCTGACACAAAGTGGCAAGGT-3'.  
Subsequent sequencing was used to confirm the identity of the PCR products.  
 
Northern blot analysis 
RNA was separated by gel electrophoresis, transferred onto a nylon membrane and hybridised as 
described previously (24). After hybridization, the blots were washed with 2x SSC/0.1% SDS for 20 
min, 1x SSC/0.1% SDS for 10 min, 0.5x SSC/0.1% SDS for 10 min at room temperature, blots where 
then transferred to 0.1x SSC/0.1% SDS and washed for 10 min at 60°C. Signal intensities were then 
monitored by exposure to a PhosphorScreen (Molecular Dynamics). The hybridized probes were then 
detected by phosphor imaging (Storm 860, Molecular Dynamics), and signal intensities were 
quantified using ArrayVision 7.0 (Imaging Research). Ethidium bromide staining of total RNA served 
to normalize gel loading. 
 
Cytochrome c oxidase (COX) activity 
COX activity of interscapular fat deposits of S. crassicaudata was measured polarographically at 
25°C with a Hansa Tech oxygen electrode chamber as described in (Heldmaier and Buchberger 
1985) and (Klaus et al 1988). 
 
Statistical Analysis 
Values for COX activity and UCP1 mRNA are expressed as means ± S.E.M. The Mann-Whitney 
U test was applied for two-sample comparisons. Results were considered statistically significant 




 Results and Discussion 
 
Identification of UCP1 in M. domestica and S. crassicaudata 
Following our trace archive search for UCP-like sequence fragments, a 346 bp fragment was 
amplified from genomic DNA of M. domestica containing a putative 121 bp intron. The 225 bp 
partial coding sequence displayed highest identity to eutherian UCP1 (76%) but lower similarity 
to eutherian UCP2 and UCP3 (69%). A second fragment was amplified using UCP2 primers 
exhibiting high identity to UCP2 of A. flavipes (92%, summarized in supplement 1). A genomic 
M. domestica BAC library was screened using homologous primers deduced from the cloned 
UCP fragments. The isolated BAC clones were sequenced, analysed and aligned to the human 
reference sequence (Fig. 1).  
The UCP-like gene of BAC VMRC6-66F14 is flanked by highly conserved orthologues of 
human ELMOD2 and human TBC1D9 and thereby resembling the region syntenic to the human 
UCP1 locus at chromosome 4. The two UCP genes on BAC VMRC6-60O3 found in 
juxtaposition as human UCP2 and UCP3 on chromosome 11 and were also enclosed by the 
orthologues of human DNAJB13 and DKFZP586P0123. The conserved synteny of the loci in 
vertebrates unequivocally identified the three M. domestica genes as UCP1, 2 and 3. Therewith, 
VMRC6-66F14 (GenBank AC171738) contains the M. domestica UCP1 and VMRC6-60O3 
(GenBank AC171737) the UCP2 and UCP3 orthologues. Compared to the corresponding human 
UCP orthologues, the deduced amino acid sequence of M. domestica UCP2 exhibited highest 
identity (91%; 95% similarity), followed by M .domestica UCP3 (82%; 90% similarity) and M. 
domestica UCP1 (65%; 77% similarity). 
Primers amplifying the M. domestica cDNA were also used to amplify a 250 bp UCP1 cDNA 
fragment of S. crassicaudata. Using 5’- and 3’-RACE-PCR, we identified 1,386 bp of UCP1 
transcript including the full coding sequence (Genbank Acc. No. EF622232). An alignment of 
the S. crassicaudata UCP1 coding sequence showed highest identity with M. domestica UCP1 
(92%), and lower identity to eutherian and marsupial UCP2 and UCP3 (70 –75%) (supplement 
2). 
Although an ancestral UCP1 orthologue appears in the vertebrate lineage as early as the 
divergence of ray-finned and lobe-finned fish 420 million years ago (25), UCP1 disappears 
during evolution in the bird lineage (e.g. the chicken genome, unpublished observation) and 
became inactivated in pigs among eutheria (3). Biochemical studies suggest that fish UCP1 is an 
uncoupling protein with broadly the same activatory and inhibitory characteristics as mammalian 
UCP1 (23). The physiological role of the ancient fish UCP1 may be other than heat production 




demonstration of marsupial UCP1 in the present study is important because not only did 
previous studies fail to demonstrate UCP1 in marsupials but also marsupial UCP1 represents a 
functional intermediate of ectothermic fish UCP1 and the highly thermogenic eutherian UCP1. 
 
Phylogenetic inference 
For classification of the UCP sequences from M. domestica and S. crassicaudata, we generated a 
phylogenetic tree using a Bayesian method (21). Our comprehensive search for UCP sequences 
in public databases revealed 80 UCPs in the animal kingdom. The addition of further sequences, 
including UCP1 of M. domestica and S. crassicaudata, allowed a solid reconstruction of the 
UCP1, UCP2 and UCP3 clades (Fig. 2A, supplement 3). In contrast to previous studies (24; 26), 
this phylogenetic tree clearly resolves a monophyletic clade of all UCP1 proteins, including the 
fish UCP1 orthologues (Fig. 2B). The overall  structure of the UCP1 clade reflects the phylogeny 
of the major vertebrate groups. A closer inspection of the UCP1 clade revealed, that the branch 
length (substitution rate) between marsupials and eutherians is twice the length (0.4 expected 
mutations per site) than between marsupials and amphibians (0.2 expected mutations per site). 
This unexpected large distance indicates accelerated evolution of UCP1 in eutherians in contrast 
to steady substitution rates found in the UCP2/3 clades. 
 
Tissue-specific UCP gene expression in the South American marsupial M. domestica 
Based on the identification of the UCP1 gene in M. domestica, we investigated UCP1 gene 
expression. We sampled cryosections of pouch embryos (22- and 25-days old), sampled tissues 
of a juvenile (70 days old, post nest vacation) and young adults (3 month old).  
Only in the juvenile we found dispersed adipose tissue deposits (brownish appearance) on the 
ribcage embedded in between pectoral muscle fibres (pectoral fat).  Northern blotting analysis 
with a UCP1 cDNA probe was insensitive but using M. domestica UCP1 primers comprising 6.7 
kb of genomic sequence amplified a 550 bp cDNA fragment by PCR only in the pectoral fat 
(Fig. 3A) and subsequent sequencing clearly identified UCP1 cDNA.  
Hybridisation techniques in all other individuals using a M. domestica UCP1 cDNA probe 
demonstrated the lack of significant UCP1 mRNA expression whereas UCP2 mRNA was 
detectable (Fig. 3B, C). In whole-body cryosections of the embryos, UCP2 mRNA was 
ubiquitously expressed with highest levels in spleen, heart and liver (Fig. 3B). Non-specific 
signals, as judged by comparison to the sense-control, occurred in calcified bone tissue. Northern 




spleen and intestine (Fig. 3C). Notably, UCP1 mRNA expression in the interscapular fat, a 
typical brown adipose tissue site in eutherians, was undetectable. 
Although the observed expression pattern in M. domestica is different from rodents, we have to 
consider that numerous eutherians do not possess significant amounts of BAT during their whole 
lifespan. In contrast to rodents and hibernators possessing BAT during their entire life, rabbits 
lose the ability to express UCP1 one month after birth (Cambon 1998), while in newborn bovine 
and lambs UCP1 expression is of significance only two days after physiological birth (Casteilla 
1989). BAT, or at least UCP1, in marsupials may therefore only be of importance to overcome 
cold-stress around pouch or nest vacation. Increased responsiveness to noradrenaline coincides 
with pouch vacation (wallaby (31); Eastern barred bandicoot Perameles gunnii (22)). Given the 
identification of marsupial UCP1 in this study, these observations can be revisited and the 
contribution of BAT investigated. 
 
Analysis of the UCP1 promoter region in M. domestica 
Our experiments show a high specificity of marsupial UCP1 expression in distinct adipose tissue 
sites. In rodents and humans, an enhancer box in the upstream promoter region contains 
condensed elements targeting UCP1 expression to BAT and allows responsiveness to the cold 
(for review see (43)). We searched a 10 kb genomic sequence upstream of the UCP1 
transcriptional start site of M. domestica for the presence of the enhancer box. Although we 
localised the enhancer box in all eutherians, including the ancient Afrotherian species Echinops 
telfairii, M. domestica lacks this distinct region suggesting that the enhancer box first evolved in 
eutherian mammals (supplement 4). Despite the lack of the enhancer box, marsupial UCP1 
shows a remarkably high tissue-specificity targeting gene expression to distinct adipose tissue 
sites. The respective response elements may be dispersed across the promoter upstream region 
and their presence cannot be categorically excluded.  
 
Tissue-specific UCP gene expression in the Australian marsupials S. crassicaudata and A. 
flavipes 
In S. crassicaudata, but not A. flavipes, we detected UCP1 mRNA expression exclusively in the 
interscapular fat deposit whereas no signal was detectable in liver and skeletal muscle (Fig. 4A).  
Probing with a UCP2 fragment cloned from Sminthopsis macroura (24) detected highest UCP2 
mRNA levels in the interscapular fat region of S. crassicaudata and A. flavipes whereas mRNA 




to UCP2 could be excluded as the UCP1 probe exhibited only 61% to 69% identity to 
Sminthopsis and Antechinus UCP2, respectively. Using a A. flavipes UCP3 probe, we detected 
UCP3 mRNA in skeletal muscle of both species confirming a previous study (24).  
Here, we demonstrate that UCP1 is constitutively expressed in S. crassicaudata, the smallest 
marsupial under investigation, in contrast to a close dasyurid relative, A. flavipes. Previous 
studies in Sminthopsis and Antechinus species support the interdependence of nonshivering 
thermogenesis and marsupial UCP1.  As would be likely to occur in the presence of brown 
adipose tissue, Sminthopsis spec. elevate metabolic rate by 30% in response to 0.25 mg kg-1 
noradrenaline at 24°C (S. crassicaudata) (7), or in response to cold exposure (S. macroura) (13).  
In contrast, Antechinus ssp. does not show a thermogenic response to noradrenaline (37).  It is 
likely that the differences seen in UCP expression are a functional adaptation to reflect the 
significant life history differences between these species. Sminthopsis ssp. from arid Australia 
are exposed to pronounced seasonal fluctuations in environmental temperature while the coastal 
Antechinus ssp. experiences less climatic fluctuations (12).   
The lack of UCP1 in adult A. flavipes and M. domestica is a distinct difference to eutherian 
species of similar body mass (18). Conventional heating mechanisms like shivering in these 
marsupials may be adaequate to defend body temperature in mild climates. 
 
Effect of cold exposure on the marsupial interscapular fat deposit 
Adaptive nonshivering thermogenesis in rodents requires the recruitment of oxidative capacity 
and UCP1 to increase heat production. In a preliminary study on S. crassicaudata in 1990, there 
was a strong trend towards increased cytochrome c oxidase (COX) activity in the interscapular 
fat deposit of cold-acclimated individuals (Fig. 4B) but we were not able to detect UCP1 mRNA 
using a rat UCP1 cDNA probe. By using a marsupial UCP1 probe in the present study, we 
demonstrated a significant up-regulation of UCP1 gene expression in response to cold. UCP1 
mRNA levels in cold-acclimated S. crassicaudata were two-fold higher than in animals exposed 
to 24°C (n = 7, p = 0.018, Fig. 4C). Furthermore, appearance of the interscapular fat deposit 
changed from white in animals held at 24°C to brown in cold-acclimated S. crassicaudata (Fig. 
4D), a transition that was absent in M. domestica. Together with the absence of brownish colour, 
UCP1 mRNA expression was absent in the interscapular fat deposit in young adult M. domestica 
(3 months old) after cold exposure (supplement 5). Even post-hybridisation procedures under 
less stringent conditions revealed no signal in the interscapular fat of M. domestica but visualised 
cross-reactivity of the M. domestica UCP1 cDNA probe to mouse UCP1. M. domestica UCP2 




Despite some evidence for nonshivering thermogenesis in marsupials, no studies so far had 
investigated adaptiveness to the cold. In this study, cold-exposure elevated oxidative capacity 
and UCP1 expression in the interscapular fat of S. crassicaudata resembling adaptive molecular 
adjustments of eutherian BAT. Response of S. crassicaudata UCP1 gene expression to cold 
exposure demonstrates different transcriptional control compared to M. domestica. Therefore, 
genomic UCP1 promotor data of an Australian marsupial are required to identify UCP1 response 
elements that are conserved during mammalian evolution.  
 
Conclusive remarks 
The successful radiation of eutherian mammals to cold environments was most likely facilitated 
by classical adaptive nonshivering thermogenesis depending on BAT and its crucial protein 
UCP1 (6). However, the origin and evolution of this thermogenic organ is unknown. Textbooks 
illustrate BAT as monophyletic trait of eutherians (45),and both UCP1 and BAT have been 
regarded as absent in marsupials (10; 16; 24; 27; 28; 34; 42), however our study represents the 
first unequivocal demonstration of UCP1 gene expression in adipose tissue of South American 
and Australian marsupials. In some marsupials like M. domestica or A. flavipes, UCP1 may be 
recruited transiently during early stages of development and is lost during adulthood, whereas 
other marsupials like S. crassicaudata retain UCP1 expression during the entire lifespan. These 
findings provide the molecular basis to investigate adaptive nonshivering thermogenesis and lead 
to interesting insights into the evolution of UCP1-mediated heat production. Our results suggest 
the presence of an archetypal BAT before the divergence of marsupials and eutherians more than 
150 million years ago allowing early mammals to pursue life in the cold.  
 
Acknowledgements 
This research was supported by Deutsche Forschungsgemeinschaft DFG KL973/7 (to M. K.), by 
the Centre for rural and environmental biology, Department of Biological and Physical 
Sciences, University of Southern Queensland (to K.W. and M.J.) and the NGFN2. We thank 









 1.  Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ. Basic local alignment 
search tool. J Mol Biol 215: 403-410, 1990. 
 2.  Aquila H, Link TA and Klingenberg M. The uncoupling protein from brown fat 
mitochondria is related to the mitochondrial ADP/ATP carrier. Analysis of sequence 
homologies and of folding of the protein in the membrane. EMBO J 4: 2369-2376, 1985. 
 3.  Berg F, Gustafson U and Andersson L. The uncoupling protein 1 gene (UCP1) is 
disrupted in the pig lineage: a genetic explanation for poor thermoregulation in piglets. 
PLoS Genet 2: e129, 2006. 
 4.  Bininda-Emonds OR, Cardillo M, Jones KE, MacPhee RD, Beck RM, Grenyer R, 
Price SA, Vos RA, Gittleman JL and Purvis A. The delayed rise of present-day 
mammals. Nature 446: 507-512, 2007. 
 5.  Bouillaud F, Ricquier D, Thibault J and Weissenbach J. Molecular approach to 
thermogenesis in brown adipose tissue: cDNA cloning of the mitochondrial uncoupling 
protein. Proc Natl Acad Sci U S A 82: 445-448, 1985. 
 6.  Cannon B and Nedergaard J. Brown adipose tissue: function and physiological 
significance. Physiol Rev 84: 277-359, 2004. 
 7.  Clements F, Hope PJ, Daniels CB, Chapman I and Wittert G. Thermogenesis in the 
marsupial Sminthopsis crassicaudata: effect of catecholamines and diet. Aust J Zool 46: 
381-390, 1998. 
 8.  Dawkins MJR and Hull D. Brown adipose tissue and the response of new-born rabbits to 




 9.  Dawson TJ and Dawson WR. Metabolic scope and conductance in response to cold of 
some dasyurid marsupials and australian rodents. Comp Biochem Physiol 71A: 59-64, 
1982. 
 10.  Dawson TJ and Olson JM. Thermogenic capabilities of the opossum Monodelphis 
domestica when warm and cold acclimated: similarities between American and Australian 
marsupials. Comp Biochem Physiol A 89: 85-91, 1988. 
 11.  Galgoczy P, Rosenthal A and Platzer M. Human-mouse comparative sequence analysis 
of the NEMO gene reveals an alternative promoter within the neighboring G6PD gene. 
Gene 271: 93-98, 2001. 
 12.  Geiser F. Daily torpor and thermoregulation in Antechinus (Marsupialia). influence of 
body mass, season, development, reproduction, and sex. Oecologia 77: 395-399, 1988. 
 13.  Geiser F, Drury RL, McAllan BM and Wang DH. Effects of temperature acclimation on 
maximum heat production, thermal tolerance, and torpor in a marsupial. J Comp Physiol 
[B] 173: 437-442, 2003. 
 14.  Gesner C. Medici Tigurini Historiae Animalium Liber I de Quadrupedibusuiuiparis 840-
844, 1551. 
 15.  Golozoubova V, Hohtola E, Matthias A, Jacobsson A, Cannon B and Nedergaard J. 
Only UCP1 can mediate adaptive nonshivering thermogenesis in the cold. FASEB J 15: 
2048-2050, 2001. 
 16.  Hayward JS and Lisson PA. Evolution of brown fat: its absence in marsupials and 
monotremes. Can J Zool 70: 171-179, 1992. 
 17.  Heaton GM, Wagenvoord RJ, Kemp A and Nicholls DG. Brown-adipose-tissue 
mitochondria: photoaffinity labelling of the regulatory site of energy dissipation. Eur J 




 18.  Heldmaier G. Zitterfreie Wärmebildung und Körpergröβe bei Säugetieren. Z vergl Physiol 
73: 222-248, 1971. 
 19.  Hope PJ, Pyle D, Daniels CB, Chapman I, Horowitz M, Morley JE, Trayhurn P, 
Kumaratilake J and Wittert G. Identification of brown fat and mechanisms for energy 
balance in the marsupial, Sminthopsis crassicaudata. Am J Physiol 42: R161-R167, 1997. 
 20.  Huelsenbeck JP. Testing a covariotide model of DNA substitution. Molecular Biology and 
Evolution 19: 698-707, 2002. 
 21.  Huelsenbeck JP and Ronquist F. MRBAYES: Bayesian inference of phylogenetic trees. 
Bioinformatics 17: 754-755, 2001. 
 22.  Ikonomopoulou MP and Rose RW. The development of endothermy during pouch life in 
the eastern barred bandicoot (Perameles gunnii), a marsupial. Physiol Biochem Zool 79: 
468-473, 2006. 
 23.  Jastroch M, Buckingham JA, Helwig M, Klingenspor M and Brand MD. Functional 
characterisation of UCP1 in the common carp: uncoupling activity in liver mitochondria 
and cold-induced expression in the brain. J Comp Physiol [B] DOI 10.1007/s00360-007-
0171-6: 2007. 
 24.  Jastroch M, Withers K and Klingenspor M. Uncoupling protein 2 and 3 in marsupials: 
identification, phylogeny, and gene expression in response to cold and fasting in 
Antechinus flavipes. Physiol Genomics 17: 130-139, 2004. 
 25.  Jastroch M, Wuertz S, Kloas W and Klingenspor M. Uncoupling protein 1 in fish 
uncovers an ancient evolutionary history of mammalian nonshivering thermogenesis. 
Physiol Genomics 22: 150-156, 2005. 
 26.  Jimenez-Jimenez J, Zardoya R, Ledesma A, Garcia dL, Zaragoza P, Mar Gonzalez-
Barroso M and Rial E. Evolutionarily distinct residues in the uncoupling protein UCP1 





 27.  Kabat AP, Rose RW, Harris J and West AK. Molecular identification of uncoupling 
proteins (UCP2 and UCP3) and absence of UCP1 in the marsupial Tasmanian bettong, 
Bettongia gaimardi. Comp Biochem Physiol B Biochem Mol Biol 134: 71-77, 2003. 
 28.  Kabat AP, Rose RW and West AK. Non-shivering thermogenesis in a carnivorous 
marsupial Sarcophilus harrisii, in the absence of UCP1. Journal of Thermal Biology 28: 
413-420, 2003. 
 29.  Loncar D, Afzelius BA and Cannon B. Epididymal white adipose tissue after cold stress 
in rats. I. Nonmitochondrial changes. J Ultrastruct Mol Struct Res 101: 109-122, 1988. 
 30.  Loncar D, Afzelius BA and Cannon B. Epididymal white adipose tissue after cold stress 
in rats. II. Mitochondrial changes. J Ultrastruct Mol Struct Res 101: 199-209, 1988. 
 31.  Loudon ASI, Rothwell NJ and Stock MJ. Brown fat, thermogenesis and physiological 
birth in a marsupial. Comp Biochem Physiol 81A: 815-819, 1985. 
 32.  Nicholls DG and Locke RM. Thermogenic mechanisms in brown fat. Physiol Rev 64: 1-
64, 1984. 
 33.  Nicol SC. Non-shivering thermogenesis in the potoroo, Potorous tridactylus (Kerr). Comp 
Biochem Physiol 59: 33-37, 1978. 
 34.  Nicol SC, Pavlides D and Andersen NA. Nonshivering thermogenesis in marsupials: 
Absence of thermogenic response to beta 3-adrenergic agonists. Comp Biochem Physiol A 
117: 399-405, 1997. 
 35.  Oliphant LW. First observations of brown fat in birds. Condor 85: 350-354, 1983. 
 36.  Opazo JC, Nespolo RF and Bozinovic F. Arousal from torpor in the chilean mouse-
opposum (Thylamys elegans): does non-shivering thermogenesis play a role? Comp 




 37.  Reynolds W and Hulbert AJ. Cold acclimation in a small dasyurid marsupial: Antechinus 
stuartii. edited by Archer M.  Mosman, N.S.W.: Royal Zoological Society of NSW, 1982, 
p. 278-283. 
 38.  Ricquier D and Kader JC. Mitochondrial protein alteration in active brown fat: a soidum 
dodecyl sulfate-polyacrylamide gel electrophoretic study. Biochem Biophys Res Commun 
73: 577-583, 1976. 
 39.  Ricquier D, Raimbault S, Champigny O, Miroux B and Bouillaud F. Comment to 
Shinohara et al. (1991) FEBS Letters 293, 173-174. The uncoupling protein is not 
expressed in rat liver. FEBS Lett 303: 103-106, 1992. 
 40.  Ronquist F and Huelsenbeck JP. MrBayes 3: Bayesian phylogenetic inference under 
mixed models. Bioinformatics 19: 1572-1574, 2003. 
 41.  Rose RW, West AK, Ye JM, McCormick GH and Colquhoun EQ. Nonshivering 
thermogenesis in a marsupial (the tasmanian bettong Bettongia gaimardi) is not attributable 
to brown adipose tissue. Physiol Biochem Zool 72: 699-704, 1999. 
 42.  Schaeffer PJ, Villarin JJ and Lindstedt SL. Chronic cold exposure increases skeletal 
muscle oxidative structure and function in Monodelphis domestica, a marsupial lacking 
brown adipose tissue. Physiol Biochem Zool 76: 877-887, 2003. 
 43.  Silva JE and Rabelo R. Regulation of the uncoupling protein gene expression. Eur J 
Endocrinol 136: 251-264, 1997. 
 44.  Smith RE. Thermoregulation by brown adipose tissue in cold. Fed Proc 21: 221, 1962. 
 45.  Vaughan TA, Ryan JM and Czaplewski NJ. Mammalogy. Saunders College Publishing, 
2000. 
 46.  Wen G, Ramser J, Taudien S, Gausmann U, Blechschmidt K, Frankish A, Ashurst J, 




Xp11.4 revealed differences to the organization of the orthologous mouse locus. Mamm 
Genome 16: 934-941, 2005. 
 47.  Whelan S and Goldman N. A general empirical model of protein evolution derived from 
multiple protein families using a maximum-likelihood approach. Mol Biol Evol 18: 691-
699, 2001. 
 48.  Ye JM, Edwards SJ, Rose RW, Steen JT, Clark MG and Colquhoun EQ. alpha-
adrenergic stimulation of thermogenesis in a rat kangaroo (Marsupialia, Bettongia 







Fig.1: Conservation of UCP1, UCP2, UCP3 and their flanking genes between human and 
opossum (M. domestica). The upper panel illustrates the genomic organisation of the human 
UCP1, 2 and 3 locus, the lower panel the opossum orthologues. Nucleotide and amino acid 
identities between the orthologues are compared in the middle panel. 
 
Fig. 2: Bayesian phylogeny of the core UCP family in vertebrates including marsupial UCP1 (M. 
domestica and S. crassicaudata). An alignment of all available UCP sequences was analysed by 
MrBayes 3.1.2, assuming a Whelan and Goldmann model of evolution. A. Simplified tree 
resolving the phylogenetic relations of the core UCP family. The oxalacetate-malate carrier 
(OMCP) represents the outgroup. B. Detailed illustration of the UCP1 subgroup. Bayesian 
posterior probabilities are given at the branch nodes and the scale bar indicates the substitution 
rate per aligned amino acid position. The complete phylogenetic tree can be found in 
supplement 3. 
 
Fig. 3: Regulation of UCP1 and UCP2 gene expression in multiple tissues of the developing 
marsupial M. domestica. Homologous primers and radioactively-labelled cDNA and riboprobes 
used. A. Low levels of UCP1 cDNA detected by PCR in multiple tissues of a 70 days old 
juvenile. The 550 bp UCP1 fragment was amplified from adipose tissue embedded in the ribcage 
(pectoral fat). β-actin mRNA served as a cDNA quality control. B. Representative sagittal 
section showing whole-body in situ hybridisation of 22 – 25 old embryos. The UCP2 antisense 
riboprobe clearly hybridised with UCP2 mRNA in spleen, heart and liver while no UCP1 signals 
could be detected using a M. domestica UCP1 antisense riboprobe (left panel). All riboprobes 
hybridised artefactually with calcified bone as judged by comparison to sense controls (right 
panel). A photograph of a sagittal transection served to assign radioactive signals to organs. C. 
Multiple tissue Northern blot analysis of three months old M. domestica incl. interscapular fat of 
warm-acclimated and cold-acclimated individuals (n = 4); and mouse BAT controls. Total RNA 
(10 µg) isolated from selected tissues was hybridised with a 225 bp UCP1 and a 350 bp UCP2 
cDNA fragment of M. domestica. Total RNA from mouse BAT served as a control. Post-
hybridisation for UCP1 was performed under less stringent conditions, detecting mouse UCP1. 
The M. domestica UCP2 probe detected mRNA in spleen, inguinal and interscapular fat of M. 






Fig. 4: A. UCP expression in selected tissues of the marsupials S. crassicaudata and A. flavipes. 
Ten micrograms of total RNA were hybridised with a M. domestica UCP1, S. macroura (S.cr.) 
UCP2 and a A. flavipes (A. fl.) UCP3 cDNA probe. Skm, skeletal muscle; int.fat, interscapular 
fat deposit. B. COX activity in interscapular adipose tissue homogenates of warm-acclimated 
and cold-acclimated S. crassicaudata. C. The effect of cold exposure (10°C) on UCP1 gene 
expression in S. crassicaudata. Radioactive intensities of specific signals are shown as relative 
units corrected by ethidium bromide staining of the 18S rRNA. The effects of cold acclimation 
was evaluated by Mann Whitney U test; *p < 0.05. D. Appearance of interscapular fat due to 
cold exposure. The photograph shows a dorsal view on the interscapular fat deposits of a warm-
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Material and Methods of Supplements 
S1 Gene soeing 
Northern blot analysis required the excision of intron sequence from the genomic UCP1 
fragment of M. domestica. Therefore, we excised intron 3/4 using PCR based gene SOEing 
(Horton RM, Ho SN, Pullen JK, Hunt HD, Cai Z and Pease LR. Gene splicing by overlap 
extension. Methods Enzymol 217: 270-279, 1993). The M. domestica exon 3 fragment (amplified 
by using primers “forEx3” and 5'-CATCGTCCCTTTCCAAAGCC -3') and exon 4 fragment 
(using primers forward 2: CTTTGGAAAGGGACGATGCC and “revEx4”) were amplified 
separately (30 cycles of 94° C (20s), 54°C (30s), and 72°C (1 min) with a final extension at 72°C 
(10 min)). Both fragments were subjected to a single PCR with an annealing temperature of 
52°C using primers “forEx3” and “revEx4”. The resulting fragment was cloned and used as a 
template for radioactively labelled probing. 
 
S2 Alignment of S. crassicaudata and M. domestica UCP1 with mouse UCPs 
The deduced UCP protein sequences were aligned using clustalX. The alignement file was 
exported to genedoc for shaded illustration of amino acid conservation.  
 
S3 Bayesian phylogenetic tree 
For methods see material and methods section.S3 Bayesian phylogenetic tree 
 
S4 Syntenic promotor region 
4A The lack of the UCP1-specific enhancer box controlling UCP1 expression in M. domestica.  
–10000 bp to 0 bp upstream region of UCP1 transcriptional start was retrieved from the ensembl 
genome browser (www.ensembl.org) and searched for the presence of the UCP1-enhancer box in 
selected placental mammals and M. domestica. The M. musculus upstream region (x-axis) was 
plotted against the upstream region of the other species (y-axis) using the dotplot function of the 
spin module (Staden Package; http://staden.sourceforge.net/). Red dots indicate a score 9 out of 
10. A 45° virtual line indicates conserved regions. The predicted enhancer box is marked with a 
circle and magnified. 4B. The predict regions for the enhancer box were aligned using clustalX. 
 
S5 UCP gene expression in the interscapular fat deposit of warm- and cold-acclimated 
opossums, M. domestica, and the mouse, M. musculus 
Total RNA was extracted from interscapular fat deposits of the Ten micrograms of total RNA 




domestica UCP1 cDNA probe. Specific signals were detected in mouse BAT under less 
stringend post-hybridising conditions (2x SSC/0.1% SDS for 20 min, 1x SSC/0.1% SDS for 10 







Captions for supplements: 
 
S1 Amplification of genomic UCP fragment from M. domestica 
Upper panel: Gel electrophoresis of a 324 bp UCP1-like genomic fragment (lane 2) of M. 
domestica. Excision of the intron using geneSOEing resulted in a 225 bp fragment (lane 1). 
Lower panel: Gel electrophoresis of a 1200 bp UCP2 fragment from genomic DNA of M. 
domestica (lane 1/2). 
 
S2 Alignment of S. crassicaudata and M. domestica UCP1 with mouse UCPs 
The alignment of the deduced amino acid sequences is illustrated in the conservation mode using 
genedoc. 
 
S3 Bayesian phylogenetic tree  
Phylogenetic relations of the UCP family in vertebrates including UCP1 of marsupials using 
Bayesian methods. The oxaloacetate-malate carrier served as the outgroup. P-values are given as 
internal node labels. UCP sequences other than marsupials were either found predicted in public 
databases or found by search genomic sequence. Table 1 contains according to the abbreviations 
of the species,  full species names and sequence accession numbers. 
 
S4.1 Lack of the UCP1-enhancer box in M. domestica  
The M. musculus upstream region (y-axis) was plotted against the upstream region of the other 
species (x-axis). Red dots indicate a score 9 out of 10. A 45° virtual line indicates conserved 
regions. The predicted enhancer box is marked with a circle and magnified. 
 
S4.2 Conservation of the UCP1-enhancer box in eutherians 
Alignment of the UCP1-enhancer box from selected placental species. Dark shading indicates 
conservation, responsive elements are underscored, published in blue and novel predicted in red.  
 
S5 UCP gene expression in the interscapular fat deposit of warm- and cold-acclimated 
opossums, M. domestica, and the mouse, M. musculus 
Neither warm- nor cold-acclimated young adult (3 months old) M. domestica express significant 
amounts of UCP1 mRNA. UCP2 mRNA is expressed in the interscapular fat deposit but not 






























































Rapid single step subcloning procedure by combined action of type II and type IIs 
endunucleases with ligase 
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The subcloning of a DNA fragment from an entry vector into a destination vector is a 
routinely performed task in molecular biology labs. We here present a novel benchtop 
procedure to achieve rapid recombination into any destination vector of choice with the sole 
requirement of an endonuclease recognition site. The method relies on a specifically designed 
entry vector and the combined action of type II and type IIs endonucleases with ligase. The 
formulation leads to accumulation of a single stable cloning product representing the desired 
insert carrying destination vector. 
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One of the most routinely performed tasks in molecular biology labs around the world 
undoubtly is the subcloning of a given DNA fragment from one plasmid vector into a 
different one. The reasons to do so are as numerous and diverse as are the applied methods. 
We here describe a further such technique involving the orchestrated action of a type II and a 
type IIs endonuclease (“outside cutter”) with ligase. This procedure achieves the speed of 
recombinase based methods without the need for unusual recognition elements in the target 
vector.  
In an example experiment we subcloned a 1167 bp long DNA fragment from an entry vector 
(modified pGEM-T easy, Promega) into a NheI site of a destination vector (pEGFP-N1, 
Clontech). The method relies on a specifically engineered entry vector which comprises two 
key elements flanking the insert to be subcloned (Figure 1A). To test our method we 
accordingly modified the plasmid pGEM-T easy and included a BglII site to be able to insert 
a DNA fragment between these elements. A blunt end cutting enzyme to Taq-generate T 
overhangs for TA cloning of PCR products or any other means to insert a fragment of choice 
are of course feasible as well. Both of the two identical key elements comprise a recognition 
sequence for a type IIs restriction endonuclease - Esp3I in our case – and a restriction site 
(Figure 1B). The latter one is specifically designed to yield a NheI-compatible single 
stranded overhang upon digestion with Esp3I. It is essential to design the key element 
restriction site in a way that the bases directly adjacent to the single stranded overhang are 
different from those in a NheI recognition site (compare Figure 1 B and C). 
We combined entry vector, destination vector, Esp3I (Fermentas), NheI (Fermentas) and T4 
ligase (Promega) in a buffer allowing all three enzyme actions (*) and incubated at room 
temperature for 1 hour (Figure 2). We transformed 2 µl of the resulting solution into DH5α 
chemically competent E. coli (Invitrogen) and plated on two plates either containing 
kanamycin or ampicillin. In three independent tests we found between 40 and 73 colonies on 
the kanamycin plate (indicating pEGFP-N1) and no colonies at all (in two tests) or 10 
colonies (in one test) on the ampicillin plate (harbouring pGEM-T easy). Of 10 colonies per 
kanamycin plate tested for the presence of the subcloned insert in pEGFP-N1 by restriction 
analysis all proved to be the desired product. Noteworthy the two different resistance markers 
on entry and destination vector are not necessary for the procedure to function but were used 
for the sole purpose of easy discrimination between products in out tests. Following this proof 
of principle the procedure can surely be further optimized. 
A limitation of this technique is of course that the entry vector once constructed can only 
serve to subclone into one selected restriction site. We feel, however, that the speed of this 
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single-step benchtop procedure makes up for this when routinely cloning PCR products into a 
variety of destination vectors all containing the same restriction site. 
 
 
*  Y+/tango-buffer (Fermentas; 33mM Tris acetate, 10mM Mg-acetate, 66mM K-acetate, 0.1 g/L 
BSA) supplemented with 5 % (w/v) PEG, 10mM DTT and 1mM rATP in a final volume of 10µL. 






Figure 1 – (A) We cloned this double stranded oligonucleotide into pGEM-T easy to provide two key 
elements flanking a BglII site. We inserted our PCR amplified fragment into this restriction site. In a 
future application this step may as well be achieved by TA cloning or other methods. (B) A key 
element consists of a Esp3I recognition site and a cut site generating a NheI compatible overhang, that 
is not a NheI recognition site. (C) We used NheI as target recognition site in the destination vector. 
 
Figure 2 – The upper box contains the two vectors the reaction starts with, i.e. the entry vector with 
its two key elements flanking an insert and the destination vector with its NheI recognition site. By the 
enzymatic action (arrows) of Esp3I and NheI these vectors are linearized to form linear intermediate 
products as shown in the central box. These intermediates are subject to T4 ligase activity and can be 
ligated to yield a range of products: the initial vectors (upper box), circular intermediate products 
(lower box) and the desired product vector. Note that all circular intermediate products are again 
substrate for Esp3I and thus again linearized. There is a sole stable product in this reaction system, 
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____________________________________________________________Chapter 5Beschreibung
[0001] Die vorliegende Erfindung betrifft ein Verfahren zur effizienten und spezifischen Subklonierung eines 
Nukleinsäure-Fragmentes von einem Vektor in andere Vektoren.
Stand der Technik
Stand der Forschung
[0002] Eine der häufigsten Routinearbeiten in der Molekularbiologie und Gentechnologie ist die Klonierung 
von Nukleinsäuren (DNA und RNA) und Nukleinsäure-Fragmenten wie z.B. PCR-Produkten in einen geeigne-
ten Vektor bzw. ein Plasmid. Plasmide sind extrachromosomale ringförmige doppelsträngige DNA-Moleküle 
mit einer Größe von 3 bis 200 kb, die sich unabhängig vom Chromosom der Wirtszelle vermehren können. Sie 
werden als Vektoren für Klonierung, Vermehrung und Expression beliebiger DNA-Stücke eingesetzt. Man un-
terscheidet je nach Kopien der Plasmide pro Zelle zwischen low (single)-copy-number Plasmiden mit einer Ko-
pienzahl von 1-2 Kopien pro Zelle, multi-copy-number Plasmiden mit einer Kopienzahl von 10-200 Kopien pro 
Zelle high-copy-number Plasmiden mit einer Kopienzahl von mehr als 200 Kopien pro Zelle.
[0003] Auf dem Weg von der Klonierung eines Nukleinsäure-Fragmentes bis zur Expression von Proteinen 
im Zielorganismus ist es oft erforderlich, nach der initialen Klonierung des Nukleinsäure-Fragmentes in einen 
initialen Klonierungsvektor (Quellplasmid) mehrere Subklonierungsschritte durchzuführen und dabei das Nuk-
leinsäure-Fragment in spezialisierte Vektoren (Zielplasmide), je nach Anwendung sogar mehrere verschiede-
ne, zu überführen.
[0004] Die prinzipiellen Grundverfahren zum Klonieren sind dem Fachmann seit vielen Jahren bekannt und 
in Laborstandardwerken, wie Sambrook, Fritsch, Maniatis, 1989, Molecular Cloning, CSH Laboratory Press, 
Cold Spring Harbour, NY. etc ausführlich beschrieben.
[0005] Sie umfassen die Schritte: 
1) Schneiden der Nukleinsäure mit einem oder mehreren Restriktionsenzymen
2) Reinigen der Nukleinsäure-Fragmente z.B. über ein Gelsystem
3) Vorbereitung des Vektors durch Linearisieren und Schneiden mit einem oder mehreren Restriktionsen-
zymen, Behandlung mit alkalischer Phosphatase, Gelaufreinigung
4) Ligation des Nukleinsäure-Fragmente in den Vektor
5) Transformation in eine Wirtszelle
6) Selektion der Zellen
7) Isolierung der Nukleinsäure und Restriktionsanalyse
[0006] Eine Subklonierung ist erforderlich, wenn z.B. Gen-Experimente in verschiedenen Organismen durch-
geführt werden, die Genexpression unterschiedlich reguliert wird oder besondere Antibiotika-Resistenzen, 
Markierungen oder andere für die Expression vorteilhaften genetischen Zusätze benutzt werden.
[0007] Einfache Subklonierungen, bei denen das Nukleinsäure-Fragment klein ist und die Restriktionsstellen 
mit dem Zielvektor kompatibel sind, können innerhalb von 24 Stunden durchgeführt werden. Andere Subklo-
nierungen erweisen sich als wesentlich aufwändiger und unzuverlässig. Sie können sogar bis zu mehreren 
Wochen dauern, wenn toxische Gene, lange Nukleinsäure-Fragmente oder nicht kompatible Restriktionsstel-
len vorliegen.
[0008] Für eine erfolgreiche Subklonierung muss das zu klonierende Nukleinsäure-Fragment aus dem Quell-
plasmid mittels Restriktionsenzymen herausgeschnitten und in einem Gel aufgereinigt werden. Anschließend 
wird es evtl. mit Enzymen nachbehandelt, um entsprechend kompatible Restriktionsstellen (Zielsequenzen) 
mit dem Zielvektor herzustellen, falls diese noch nicht vorhanden sind. Das herausgeschnittene Nukleinsäu-
re-Fragment wird in die Zielsequenzen eines linearisierten dephosphorylierten Zielvektors mit DNA-Ligase li-
giert. Die DNA-Ligase knüpft dabei zwischen einem Ende des zu klonierenden Nukleinsäure-Fragmentes und 
einem Ende des Plasmids eine Phosphodiesterbindung.
[0009] Dieses Subklonierungssystem mit Restriktionsenzymen und Ligase ist sehr stark beschränkt auf die 
im Zielvektor vorhandene Art und Anzahl von Restriktionsstellen. So verfügen die derzeit käuflich erwerbbaren 
Plasmide (Bsp. pGem®-Plasmide, pSP70-Plasmid, pBR322-Plasmid und pCAT®-Plasmide der Firma Promega 
u.a.) in einer sogenannten multiple cloning site oder in Polylinkern über eine Folge von Restriktionsstellen in 2/11
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zen für die 150 häufigsten Restriktionsendonukleasen nur etwa 15 Zielsequenzen in den Polylinker-Regionen 
vor und sind auch dann nicht exklusiv auf diese Region beschränkt, sondern schneiden oft auch an einigen 
weiteren Stellen im Plasmid. Ebenfalls nachteilig an dieser Art und Weise der Subklonierung ist vor allem der 
hohe Zeitaufwand.
[0010] Eine Verbesserung bei der Klonierung erfolgt durch das Gateway®-Cloning System der Firma Invitro-
gen (DE 696 23 057 T2), dem das Lambda-Phagen spezifische att-Rekombinationssystem zugrunde liegt. In 
diesem System ist es erforderlich, die zu klonierende Nukleinsäure mit einer attB-flankierenden Rekombinati-
onsstelle zu versehen, die dann über Rekombination und eine Transferase in attR-Rekombinationstellen der 
Zielvektoren kloniert wird.
[0011] Nachteil dieser Technik ist die Abhängigkeit vom Vorhandensein entsprechender Rekombinationsstel-
len in Quell- und Zielplasmid. Oft ist es sogar erforderlich, den gewünschte Zielvektor zuvor dahingehend zu 
modifizieren, dass er den Ansprüchen genügt.
Aufgabenstellung
[0012] Aufgabe der vorliegenden Erfindung ist es daher, ein Verfahren zur Subklonierung eines Nukleinsäu-
re-Fragmentes von einem Quellvektor in einen Zielvektor bereitzustellen, dass unabhängig von der Art des 
Zielvektors, dessen Resistenzmarkern und Zielsequenzen ist und das zeit- und kostensparend durchführbar 
ist.
Lösung der Aufgabe
[0013] Diese Aufgabe wird erfindungsgemäß gelöst durch Ansprüche 1-12.
[0014] Das erfindungsgemäße Verfahren umfasst die folgenden Schritte: 
a) Bereitstellen eines Quellvektors, der zwei Sequenzabschnitte trägt, die jeweils enthalten, eine Erken-
nungssequenz für ein outside cutter Restriktionsenzym und angrenzende Nukleotide, die bei Spaltung mit 
dem outside cutter Restriktionsenzym einen spezifischen Basenüberhang bilden.
b) Ligation des zu klonierenden Nukleinsäure-Fragmentes in den Quellvektor zwischen die Sequenzab-
schnitte aus a)
c) Bereitstellen eines Zielvektors, der mindestens eine Erkennungssequenz für ein spezifisches Restrikti-
onsenzym enthält
d) Inkubation von Quellvektor und Zielvektor in Gegenwart von outside cutter Restriktionsenzym zur Spal-
tung der Erkennungssequenzen im Quellvektor, spezifischem Restriktionsenzym zur Spaltung der Erken-
nungssequenz im Zielvektor und Ligase
[0015] Die Vorteile des erfindungsgemäßen Verfahrens liegen darin, dass als einziges Erfordernis zur Sub-
klonierung ein Quellvektor mit zwei Sequenzabschnitten erforderlich ist, die jeweils mindestens eine Erken-
nungssequenz für ein outside cutter Restriktionsenzym tragen und angrenzende Nukleotide, die bei Spaltung 
mit dem outside cutter Restriktionsenzym einen spezifischen Basenüberhang bilden. Ein einmal in den Quell-
vektor ligiertes Nukleinsäure-Fragment kann dann leicht in einem Schritt über die Spaltung mit dem outside 
cutter Restriktionsenzym aus dem Quellplasmid herausgeschnitten werden und in jeden beliebigen Zielvektor 
ligiert werden. Das Verfahren zeichnet sich daher insgesamt durch sehr kurze Inkubationszeiten aus und wird 
unabhängig von der Art des Zielvektors, dessen Resistenzmarkern und Zielsequenzen in einem einzigen 
Schritt durchgeführt.
[0016] Überraschenderweise wurde gefunden, dass Restriktionsendonukleasen, die als sogenannte outside 
cutter oder Typlls-Restriktionsenzyme beschrieben sind, sehr gut für ein Subklonierungssystem geeignet sind. 
Die Erkennungssequenz der outside cutter besteht in der Regel aus 4-8 Basenpaaren, die nicht symmetrisch 
sind und kein Palindrom darstellen. Charakteristisch ist, dass Schnittstelle und Erkennungsstelle nicht iden-
tisch sind, sondern häufig die Schnittstelle in einer definierten Entfernung zur Erkennungssequenz liegt.
[0017] Bekannt ist das outside cutter Restriktionsenzym AarL mit der Erkennungssequenz:  
5' CACCTGC NNNN NNN 3'  
3' GTGGACG NNNNNNNN NNN 5'  
wobei die Schnittstelle zwischen der vierten und fünften beliebigen Base (N), die in 5' → 3' Richtung auf die 
Erkennungssequenz CACCTGC folgt, bzw. der achten und neunten beliebigen Base (N), die in 3' → 5' Richtung 3/11
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[0018] Erfindungsgemäß trägt der Quellvektor im Abstand von 5-20 Basen zum zu klonierenden Insert zwei 
Sequenzabschnitte mit jeweils einer Erkennungssequenz für ein outside cutter Restriktionsenzym und dazu 
benachbart Nukleotide, die bei Spaltung mit dem outside cutter Restriktionsenzym einen spezifischen Basen-
überhang erzeugen, der kompatibel zu einem spezifischen Basenüberhang im Zielvektor ist. So erzeugt bei-
spielsweise erfindungsgemäß die Spaltung des outside cutter Esp3I durch die Auswahl der Nukleotide einen 
Nhel-kompatiblen Überhang. Alternativ wird die Auswahl der Nukleotide so gestaltet, dass durch Spaltung mit 
dem outside cutter Restriktionsenzym jeder beliebige Überhang entsteht, der kompatibel zu einer beliebigen 
Schnittstelle wie beispielsweise EcoRI, BamHI oder ApaI ist. Entscheidend ist: Esp3I schneidet immer einen 
Überhang von 4 Basen in einem definierten Abstand zu seiner Erkennungs-Stelle. Daher ist Esp3I geeignet, 
wenn das Restriktionsenzym, das im Zielvektor schneidet auch einen 4-Basen-Überhang schneidet, wie es für 
die meisten gängigen Enzyme zutrifft.
[0019] Andere Beispiele für Restriktionsenzyme, die als outside cutter außerhalb der Erkennungssequenz 
spalten sind AceIII, AloI, BaeI, Bbr7I, BbvI, BbvII, BccI, Bce83I, BceAI, BcefI, BcgI, BciVI, BfiI, BinI, BpII, BsaXI, 
BscAI, BseMII, BseRI, BsgI, BsmI, BsmAI, BsmFI, Bsp24I, BspCNI, BspMI, BsrI, BsrDI, BstF5I, BtsI, CjeI, Cje-
PI, EciI, Eco31I, Eco57I, Eco57MI, Esp3I, FaII, FauI, FokI, GsuI, HaeIV, HgaI, Hin4I, HphI, HpyAV, Ksp632I, 
MboII, MlyI, MmeI, MnII, PleI, PpiI, PsrI, RIeAI, SapI, SfaNI, SspD5I, Sth132I, StsI, TaqII, TspDTI, TspGWI, 
Tth111II deren Erkennungssequenzen aus http://rebase.neb.com/cgi-bin/outsidelist bekannt sind.
[0020] Alle outside cutter Restriktionsenzyme zeichnen sich durch eine charakteristische Anzahl an Nukleo-
tiden aus, die als Überhang nach der Spaltung entstehen. Die Länge des Überhanges variiert im Durchschnitt 
zwischen 1-10 Nukleotide. Durch Auswahl eines bestimmten outside cutter Restriktionsenzyms ist das Klonie-
rungssystem für die Nutzung von verschiedenen Erkennungsstellungen für Restriktionsenzymen im Zielvektor, 
die nach Spaltung einen entsprechend langen oder kurzen Überhang erzeugen, geeignet.
[0021] Die Verwendung eines outside cutter Restriktionsenzymes ist besonders vorteilhaft, da beim Schnei-
den eines Nukleinsäure-Fragmentes mit einem outside cutter die Erkennungsstelle des outside cutter Restrik-
tionsenzymes selbst erhalten bleibt, während die Erkennungssequenzen beim Schneiden mit anderen Rest-
riktionsenzymen zerstört werden und nicht mehr genutzt werden können.
[0022] Die nachfolgende Abbildung erläutert den Erfindungsgegenstand:
[0023] Fig. 1 zeigt in einer schematischen Darstellung die Modifikation des pGEMTeasy-Vektors zum Quell-
vektor (1) für die Subklonierung. Dazu werden die Oligonukleotide Oligo 1: AGTCCGTCTCACTAGAAGT-
CAGATCTAGTCTCTAGTGAGACGAGTCA (4) und Oligo 2: GACTCGTCTCACTAGAGACTAGATCT-
GACTTCTAGTGAGACGGACTA (5) zu doppelsträngigen DNA-Molekülen zusammengefügt. Diese werden in 
den TA-Vektor pGEM-Teasy der Firma Promega an Position 60 ligiert über die am 3'-Ende überhängenden 
Adenosin-Nukleotide. Zentral liegt die Erkennungssequenz für ein Restriktionsenzym, hier beispielsweise die 
unterstrichen eingezeichnete BgI II-Schnittstelle, in die ein beliebiges vorzugsweise doppelsträngiges Nukle-
insäure-Fragment (3), hier beispielsweise ein 1167 Bp langes DNA-Fragment einkloniert wird. Die grau hinter-
legten in fettgeschriebenen Buchstaben markierten Nukleotide zeigen die beiden Erkennungsstelten (2b) 
rechts und (2a) links für das outside cutter Restriktionsenzym Esp3I der restliche graue Bereich markiert des-
sen Schnittstelle, die unterstrichenen Nukleotide im zentralen Bereich zeigen die Erkennungsstelle für das Re-
striktionsenzym BgI II.
[0024] Alternativ zur Schnittstelle für ein Restriktionsenzym liegt der Vektor linearisiert vor, trägt MonoT-Über-
hänge und wird für TA-Cloning vorbereitet (nicht dargestellt).
[0025] Die zu den Erkennungsstellen für das outside-cutter Restriktionsenzym Esp3I benachbarten Sequenz-
abschnitte sind so gewählt, dass bei Einsatz des outside-cutters Esp3I ein spezifischer Überhang entsteht, der 
kompatibel ist mit der Zielschnittstelle das Restriktionsenzym NheI im Zielvektor, jedoch in angrenzenden Ba-
sen differiert.
[0026] Fig. 2 zeigt in einer schematischen Darstellung das erfindungsgemäße Subklonierungsverfahren, wo-
bei das Nukleinsäure-Fragment (3) aus dem Quellvektor (1) in den Zielvektor (6) überführt wird. Der Quellvek-
tor (1), der das zu klonierende Nukleinsäure-Fragment (3) beinhaltet, wird mit dem outside cutter Esp3I gespal-
ten, wobei die Produkte a und b entstehen.4/11
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und (2a) links für das outside cutter Restriktionsenzym Esp3I und den durch die Spaltung entstandenen 5'
überhängenden Enden dar.
[0028] Produkt b stellt das herausgeschnittene Nukleinsäure-Fragment (3) dar. Der Grossbuchstabe T zeigt 
auf beiden Seiten den Beginn des doppelsträngigen Bereiches. Die kleinen Buchstaben markieren die entste-
henden Nukleotide des Überhanges. Sie bilden reguläre NheI-Überhange. Durch Zugabe des Zielvektors (6), 
spezifischem restriktionsenzym NheI und Ligase wird der Zielvektor linearisiert (Produkt c) und das zu klonie-
rende Nukleinsäure-Fragment wird mittels Ligase zu einem zirkulären Plasmid verbunden. Da sich die Enzyme 
NheI und outside cutter Esp3I noch immer im Reaktionsgemisch befinden, werden Nebenprodukte, die „falsch"
ligiert wurden wieder geschnitten, nicht aber das Zielplasmid (6) mit dem darin enthaltenen Nukleinsäure-Frag-
ment (3) (Produkt d).
[0029] Erfindungsgemäß enthält der Quellvektor (1), in dem sich das zu klonierende Nukleinsäure-Fragment 
(3) befindet, unmittelbar dazu benachbart kurze Sequenzabschnitte (2a und 2b), welche die Zielsequenz für 
ein outside cutter Restriktionsenzym tragen. Die benachbarten Abschnitte sind in ihrer Nukleotidabfolge derart 
gewählt, dass bei Einsatz eines bestimmten outside-cutter Restriktionsenzyms ein bestimmter Überhang ent-
steht, der kompatibel ist mit der durch ein spezifisches Restriktionsenzym entstandenen Zielschnittstelle im 
Zielvektor (6), jedoch in angrenzenden Basen differiert. Gibt man in geeignetem Puffer Quell- und Zielvektor 
zusammen mit Ligase, outside cutter-Restriktionsenzym und einem spezifischen Restriktionsenzym für die 
Zielschnittstelle im Zielvektor, entstehen durch Restriktion mehrere Fragmente (Fig. 2a, b und c). Diese kön-
nen prinzipiell von der Ligase kombiniert werden, so dass mehrere Produkte entstehen. Alle diese Produkte 
sind jedoch von den beiden Restriktionsenzymen wieder schneidbar mit einer Ausnahme: das zu klonierende 
Nukleinsäure-Fragment plus Zielvektor (d) ist als einziges stabil.
[0030] Beispielhaft zeigt Fig. 1 die Klonierung eines 1167 bp großen Nukleinsäure-Fragmentes (3) in einen 
Bereich des Quellvektors (1), der eine zentrale Schnittstelle für ein Restriktionsenzym, beispielsweise BgI II, 
aufweist (unterstrichene Sequenz in Fig. 1) mit daran flankierenden Erkennungssequenzen (2a und 2b) für ein 
outside-cutter Restriktionsenzym, beispielsweise Esp3I, die so zueinander angeordnet sind, dass die Schnitt-
stelle des outside cutter Restriktionsenzymes dem zu klonierenden Nukleinsäure-Fragment zugewandt ist. Die 
Erkennungssequenzen (2a und 2b) weisen flankierende Bereiche auf, die durch Hybridisierung der Oligonuk-
leotide 4 und 5 und deren Einklonierung erzeugt werden. Fig. 2 zeigt den Vorgang der Subklonierung des 1167 
bp großen Nukleinsäure-Fragmentes (3) aus dem Quellvektor (1) in einen Zielvektor (6), der in der Multiple 
cloning site eine Erkennungssequenz für ein spezifisches Restriktionsenzym, beispielsweise NheI aufweist. In 
Puffer führt die Zugabe von Ligase, outside cutter-Restriktionsenzym Esp3I und dem Restriktionsenzym NheI 
zu mehreren Fragmenten: linearisierter Quellvektor mit NheI*-Überhängen (Fig. 2 Fragment a), ausgeschnit-
tenes Nukleinsäure-Fragment (3) mit kompatiblen NheI*-Überhängen (Fig. 2 Fragment b) und linearisierter 
Zielvektor (6) mit NheI-Überhängen (Fig. 2 Fragment c). Mit NheI* werden hierbei die vom outside cutter Re-
striktionsenzym generierten NheI-kompatiblen Überhange bezeichnet. Mit NheI ohne Stern werden dagegen 
die „echten" von dem Restriktionsenzym NheI erzeugten Überhange bezeichnet.
[0031] Fragment c in Fig. 2 (linearisierter Zielvektor) besitzt einfache „NheI"-Überhänge, Fragment a (lineari-
sierter Quellvektor) trägt NheI*-Überhänge, Fragment b (zu klonierendes Nukleinsäure-Fragment) hat eben-
falls NheI*-Überhange. Die Sequenzen ergeben sich wie folgt: NheI* = 3'-Tgatc-5', davon ist mit das großen 
Buchstaben geschriebene T noch im doppelsträngigen Bereich das mit kleinen Buchstaben geschriebene gatc 
das überhängende 5'-Ende; NheI = CGATC, davon stellen die mit kleinen Buchstaben geschriebenen Nukle-
otide gatc das überhängendes 5'-Ende dar.
[0032] Falsche Kombinationen mit dem Quellvektor (1) NheI/NheI*, NheI*/NheI* werden vom outside cut-
ter-Restriktionsenzym Esp3I wieder geschnitten, jede Kombination aus zwei NheI-Überhängen ergibt eine 
neue NheI-Stelle und wird entsprechend erneut durch NheI geschnitten.
[0033] Das einzig stabile Erzeugnis ist das Produkt d, die Kombination eines NheI-Überhanges aus dem Ziel-
vektor (6) mit dem NheI*-Überhang des zu klonierenden Nukleinsäure-Fragmentes, das aus der Spaltung mit 
dem outside-cutter Restriktionsenzym Esp3I entstanden ist und eine „falsche" flankierende Base trägt, ein T 
anstelle eines C bzw. auf dem Gegenstrang A statt G.
[0034] Nach Inkubation bei Raumtemperatur, anschließender Transformation in Zielzellen und Anzucht der 
Zielzellen erhält man fast ausschließlich Klone, die das zu klonierende Nukleinsäure-Fragment im Zielplasmid 
tragen.5/11
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auch auf eucaryotische z.B. Hefeplasmide, Cosmide und auf Phagemide anwendbar, auf low- und high-co-
py-Plasmide.
[0036] Dies gilt auch für die Auswahl des Zielvektors (6). Es werden alle gängigen Vektoren, die beispielswei-
se ein Selektionsgen (z.B. Antibiotikum-Resistenz-Gen), ein Markergen (z.B. IacZ-Gen zur Farbunterschei-
dung von Vektoren mit und ohne Insert), origin of replication, Promotorregion, multiple cloning site und/oder 
Elemente für die Expression fremder Proteine enthalten, verwendet.
[0037] Der Puffer, in dem die Subklonierungsreaktion abläuft, ist vorteilhafterweise so gewählt, dass sowohl 
das outside cutter Restriktionsenzym als auch das spezifische Restriktionsenzym darin biologisch wirksam 
sind. Allerdings ist es zulässig, nach der „double digest"-Empfehlung von z.B. New England Biolabs vorzuge-
hen und bei einer beispielsweise nur 50%igen Aktivität des einen Enzyms im Puffer des anderen mit dem Ein-
satz der doppelten Enzymunits zu arbeiten.
[0038] Als outside-cutter Restriktionsenzyme werden sämtliche bekannten Enzyme verwendet, die außer an 
den beiden gewünschten Sequenzabschnitten nicht an weiteren Stellen in Quell- oder Zielplasmid und nicht 
im zu klonierenden Nukleinsäure-Fragment schneiden.
[0039] Es werden mit dem erfindungsgemäßen Verfahren Nukleinsäure-Fragmente einer Größe von ca. 20 
bp bis zu 20 kb kloniert.
[0040] Eine Ausführungsform der Erfindung betrifft einen Kit zur Subklonierung eines Nukleinsäure-Fragmen-
tes in einen beliebigen Zielvektor, mindestens enthaltend 
a) Quellvektor mit wenigstens zwei Sequenzabschnitten, die jeweils enthalten Erkennungssequenzen für 
ein outside cutter Restriktionsenzym und angrenzende Nukleotide, wobei die Nukleotide bei Spaltung mit 
dem outside cutter Restriktionsenzym einen Basenüberhang bilden.
b) Ligase
c) ein oder mehrere spezifische Restriktionsenzyme
d) mindestens ein outside cutter Restriktionsenzym
e) geeignete Reaktionspuffer für die in a) bis d) genannten Vektoren und Enzyme
[0041] Auf Grund der Lehre der vorliegenden Erfindung sowie auf Grund des allgemeinen Fachwissens in die-
sem technischen Gebiet ist dem Hersteller des erfindungsgemäßen Kits bekannt, wie er die einzelnen Kom-
ponenten des Kits, z.B. die Puffer herstellt, formuliert und lagert. Der Kit kann, falls es für die Kundenfreund-
lichkeit gewünscht wird, auch einen bereits linearisierten Quellvektor enthalten. Die Auswahl der im Kit enthal-




Subklonierung eines Nukleinsäure-Fragmentes mit dem outside cutter Esp3I
[0042] Beispielsweise handelt es sich um die Subklonierung einer 1167 bp große Promotorsequenz des 
UCP3-Gens von Phodopus sungorus aus einem modifizierten pGEMTeasy-Vektor (Firma Promega) mit dem 
outside-cutter Esp3I in die Zielschnittstelle NheI in der Multiple cloning site des Vektors pEGFP-N1 (Firma 
Clontech).
[0043] Als Ausgangsmaterial zur Herstellung des Quellvektors wird beispielsweise der pGEMTeasy-Vektor 
der Firma Promega verwendet und so verändert, dass er in seinem Polylinker kurze Sequenzabschnitte trägt, 
welche die Zielsequenz für ein outside cutter Restriktionsenzym enthalten und dazu benachbarte Sequenzab-
schnitte, die derart gewählt sind, dass bei Einsatz des outside-cutters Esp3I ein Überhang entsteht, der kom-
patibel ist mit der Zielschnittstelle im Zielvektor, jedoch in angrenzenden Basen differiert.
[0044] Dazu werden die komplementären Oligonukleotide verwendet6/11
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outside cutter Restriktionsenzym Esp3I der restliche graue Bereich markiert dessen Schnittstelle, die unterstri-
chenen Nukleotide im zentralen Bereich zeigen die Erkennungsstelle für das Restriktionsenzym BgI II.
[0046] Durch Erhitzen und langsames Abkühlen werden die Oligonukleotide Oligo 1 und Oligo 2 zu doppel-
strängigen DNA-Molekülen zusammengefügt. An beiden 3'-Enden entsteht ein überhängendes Adenosin-Nu-
kleotid, mit dessen Hilfe das doppelsträngige DNA-Molekül nach Standardvorgaben in den bereits linear mit 
überhängenden T's vorliegenden pGEMTeasy-Vektor der Firma Promega kloniert wird. Die unterstrichen mar-
kierte zentrale BgI II-Schnittstelle des doppelsträngiges DNA-Moleküls wird genutzt, um ein beliebiges Nukle-
insäure-Fragment beispielsweise ein 1167 Basenpaare langes DNA-Fragment, beispielsweise ein UCP3-Pro-
moter-Fragment, nach Standardverfahren einzuklonieren. Dieses Produkt wird im folgenden „Quellvektor" ge-
nannt. Als „Zielvektor" wird beispielsweise der pEGFP-N1 der Fa. Clontech verwendet. Dieser trägt eine Ka-
namycinresistenz, während pGEM-T easy das beta-Lactamase-Gen (Amp') als Selektionsmarker trägt. Es ist 
allerdings nicht unbedingt erforderlich, dass beide Vektoren unterschiedliche Resistenzen haben, es können 
auch Quell- und Zielvektoren mit jeweils gleichen Resistenzen verwendet werden.
[0047] Als outside-cutter Restriktionsenzym wird beispielsweise Esp3I der Fa. MBI Fermentas genutzt, spe-
zifisches Restriktionsenzym für die multiple cloning site des Zielvektors ist beispielsweise NheI (MBI Fermen-
tas). Als Reaktionspuffer wird beispielsweise der Puffer „y+/tango" (MBI Fermentas) entsprechend den Her-
stellerangaben verwendet.
[0048] Durch die Spaltung mit dem outside cutter entsteht ein für ein spezifisches Restriktionsenzym kompa-
tibler Überhang (mit* markiert), der zum Klonieren in den Zielvektor, welcher Erkennungssequenzen für NheI 
aufweist, genutzt wird.
[0049] So erzeugt beispielsweise die Spaltung mit Esp3I einen NheI-kompatiblen Überhang (NheI*).
[0050] Die Reaktionszusammensetzung zur Subklonierung ist so gewählt, dass folgende Verhältnisse entste-
hen: 7/11
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(PEG) optimiert.
[0052] Der Reaktionsansatz wird bei Raumtemperatur (23°C–25°C) inkubiert und anschliessend transfor-
miert. Alternativ wird der Reaktionsansatz zur Inaktivierung der Enzyme vor der Transformation für 30 Minuten 
auf 65°C erhitzt. Die Transformation erfolgt in kompetente E. coli Zellen, beispielsweise DH5alpha (Firma In-
vitrogen). 50 μl kompetente E. coli DH5alpha (Transformationseffizienz 2·106 cfu/μg) werden mit 2 μl des be-
schriebenen Ansatzes nach einer Standardmethode transformiert: 20 Minuten auf Eis, 55 Sekunden 42°C, 2 
Minuten auf Eis, +950 μl SOC-Medium, 90 Minuten bei 37°C. Jeweils die Hälfte des Transformationsansatzes 
wird auf LB-Agarplatten mit Ampicillin bzw. Kanamycin plattiert.
[0053] Die Klone werden isoliert, und nach Übernachtkultur wird mit Standardmethoden eine Plasmidpräpa-
ration und analytische Restriktionen durchgeführt. Bei allen Plasmiden handelt es sich um das pEGFP-N1 Ziel-
plasmid mit dem 1167 bp großen Nukleinsäure-Fragment in der NheI-site der multiple cloning site.
[0054] Die Inkubationszeiten sind so gewählt, dass keine Nebenprodukte, sondern nur das einzig stabile Pro-
dukt akkumuliert vorliegt.
[0055] Der Fachmann kennt viele Entsprechungen oder kann diese mit Hilfe üblicher Experimente zu den 
spezifischen Anwendungen der hier beschriebenen Erfindung feststellen. Solche Entsprechungen liegen be-
absichtigterweise im Rahmen der Ansprüche.
Bezugszeichenliste
1 Quellvektor
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1.  Verfahren zur Subklonierung eines Nukleinsäure-Fragmentes, umfassend die folgenden Schritte  
a) Bereitstellen eines Quellvektors, der zwei Sequenzabschnitte trägt, die jeweils enthalten, eine Erkennungs-
sequenz für ein outside cutter Restriktionsenzym und angrenzende Nukleotide, die bei Spaltung mit dem out-
side cutter Restriktionsenzym einen spezifischen Basenüberhang bilden.  
b) Ligation des zu klonierenden Nukleinsäure-Fragmentes in den Quellvektor zwischen die Sequenzabschnitte 
aus a)  
c) Bereitstellen eines Zielvektors, der mindestens eine Erkennungssequenz für ein spezifisches Restriktions-
enzym enthält  
d) Inkubation von Quellvektor und Zielvektor in Gegenwart von outside cutter Restriktionsenzym zur Spaltung 
der Erkennungssequenzen im Quellvektor, spezifischem Restriktionsenzym zur Spaltung der Erkennungsse-
quenz im Zielvektor und Ligase
2.  Verfahren gemäß Anspruch 1, dadurch gekennzeichnet, dass das Quellplasmid ausgewählt ist aus der 
Gruppe der procaryotischen oder eucaryotischen Plasmide, ein Hefeplasmid, Cosmid oder Phagemid sowie 
ein low- oder high-copy-Plasmid ist.
3.  Verfahren gemäß Anspruch 1 und 2, dadurch gekennzeichnet, dass der Quellvektor linear oder zirkulär 
vorliegt.
4.  Verfahren gemäß Anspruch 1, dadurch gekennzeichnet, dass das Zielplasmid ausgewählt ist aus der 
Gruppe der procaryotischen oder eucaryotischen Plasmide, ein Hefeplasmid, Cosmid oder Phagemid sowie 
ein low- oder high-copy-Plasmid ist.
5.  Verfahren gemäß einem der vorangegangenen Ansprüche, dadurch gekennzeichnet, dass das zu klo-
nierende Nukleinsäure-Fragment eine Größe von 20 bp bis 20 kbp besitzt. 
6.  Verfahren gemäß einem der vorangegangenen Ansprüche, dadurch gekennzeichnet, dass die Subklo-
nierung während der Inkubation von Quellvektor, Zielvektor, outside cutter Restriktionsenzym, spezifischem 
Restriktionsenzym und Ligase innerhalb von 10 Minuten bis 2 Stunden vorzugsweise 30 bis 60 Minuten erfolgt.
7.  Verfahren gemäß einem der vorangegangenen Ansprüche, dadurch gekennzeichnet, dass die Subklo-
nierung bei einer Reaktionstemperatur von 4°C bis 37°C, vorzugsweise bei 25°C erfolgt.
8.  Verfahren gemäss einem der vorangegangenen Ansprüche, dadurch gekennzeichnet, dass die Reakti-
onsbedingung für die Subklonierung durch chemische Additiva optimiert ist.
9.  Verfahren gemäss einem der vorangegangenen Ansprüche, dadurch gekennzeichnet, dass die chemi-
schen Additiva Dithiotreitol (DTT) und/oder Polyethylenglycol (PEG) sind.
10.  Kit zur Subklonierung eines Nukleinsäure-Fragmentes in einen beliebigen Zielvektor, mindestens ent-
haltend  
a) Quellvektor mit wenigstens zwei Sequenzabschnitten die jeweils enthalten Erkennungssequenzen für ein 
outside cutter Restriktionsenzym und angrenzende Nukleotide, die bei Spaltung mit dem outside cutter Rest-
riktionsenzym einen Basenüberhang bilden  
b) Ligase  
c) ein oder mehrere spezifische Restriktionsenzyme  
d) mindestens ein outside cutter Restriktionsenzym  
e) geeignete Reaktionspuffer für die in a) bis d) genannten Vektoren und Enzyme 
11.  Kit gemäß Anspruch 10, dadurch gekennzeichnet, dass der Quellvektor ausgewählt ist aus der Gruppe 
der procaryotischen oder eucaryotischen Plasmide, ein Hefeplasmid, Cosmid oder Phagemid sowie ein low- 
oder high-copy-Plasmid ist.
12.  Kit gemäß Anspruch 10, dadurch gekennzeichnet, dass der Quellvektor linear oder zirkulär vorliegt.
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Das Entkopplerprotein 3 (Ucp3) wird im Braunen Fettgewebe (BAT) und in der 
Skelettmuskulatur exprimiert und führt dort eine bisher nicht eindeutig belegte Funktion aus. 
In dieser Arbeit wurde versucht, sich der Funktion des Genprodukts über die Regulation der 
Transkription des Gens zu nähern. 
In einer computergestützten Analyse des Ucp3 Promotors wurde ein phylogenetisch 
konserviertes Sequenzelement identifiziert, dass den Transkriptionsfaktor Coup-TFII bindet. 
Dieser Faktor scheint dafür zuständig zu sein, die genaue Transkriptmenge sowohl im BAT, 
als auch in der Skelettmuskulatur fein einzustellen. Der Mechanismus der Aktivierung durch 
Coup-TFII scheint die Deaktivierung oder Verdrängung eines noch unbekannten 
Repressorproteins einzuschließen. Coup-TFII ist ein Regulator des Wechsels des 
metabolischen Substrats von Kohlenhydraten zu Fetten. Die Tatsache, dass Coup-TFII das 
Ucp3-Gen positiv reguliert, bestärkt die Hypothese, dass Ucp3 eine Rolle im Fettstoffwechsel 
spielt. 
Ein Vergleich genomischer Sequenzen von Djungarischen Hamstern (Phodopus sungorus) 
mit und ohne einem erblichen Defekt in der BAT-spezifischen Ucp3 Expression führte zur 
Identifizierung einer möglichen Forkhead-Faktor Bindestelle weit im ersten Intron des Ucp3-
Gens. Ist diese durch eine Punktmutation betroffen, so fällt die Ucp3 Expression im BAT 
komplett aus, während sie in der Skelettmuskulatur nur wenig verändert ist. Dies ist der erste 
und einzige bis heute bekannte, gewebespezifische Regulationsmechanismus des Ucp3 Gens 
und könnte zur Entdeckung eines unbekannten Regulators BAT-spezifischer Genexpression 
führen. Darüber hinaus ist die intronische Lokalisation des Elements in sich ungewöhnlich 
und weitere Untersuchung wert. 
Phänotypisch zeigen Djungarische Hamster mit einem Ucp3 Mangel im BAT eine globale 
Verminderung der mRNA Expression stoffwechselrelevanter Gene. Dies könnte der Grund 
sein für eine reduzierte Kältetoleranz dieser Tiere, die auf einem Defekt in der zitterfreien 
Wärmebildung beruht. Die betroffenen Hamster zeichnen sich außerdem durch ein erhöhtes 
Körpergewicht aus, welches auf einen Defekt in der energieaufwändigen Wärmebildung 
zurückführbar sein kann. 
Zusammengefasst haben diese Studien zwei bisher unbekannte Mechanismen der 
transkriptionellen Ucp3-Regulation mit einzigartigen Eigenschaften entdeckt und 
charakterisiert. Diese liefern wertvolle Hinweise auf die Rolle von Ucp3 im Stoffwechsel und 
zeigen die Bedeutung von Promotoranalysen für Erkenntnisse über Regulation, Funktion und 
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